BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol. 2009;9:729-740. [PMID: 19730437 DOI: 10.1038/nri2620] [Cited by in Crossref: 780] [Cited by in F6Publishing: 720] [Article Influence: 60.0] [Reference Citation Analysis]
Number Citing Articles
1 Luo S, Wang M, Wang H, Hu D, Zipfel PF, Hu Y. How Does Complement Affect Hematological Malignancies: From Basic Mechanisms to Clinical Application. Front Immunol 2020;11:593610. [PMID: 33193442 DOI: 10.3389/fimmu.2020.593610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Furniss RCD, Low WW, Mavridou DAI, Dagley LF, Webb AI, Tate EW, Clements A. Plasma membrane profiling during enterohemorrhagic E. coli infection reveals that the metalloprotease StcE cleaves CD55 from host epithelial surfaces. J Biol Chem 2018;293:17188-99. [PMID: 30190327 DOI: 10.1074/jbc.RA118.005114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Johnson S, Waters A. Is complement a culprit in infection-induced forms of haemolytic uraemic syndrome? Immunobiology 2012;217:235-43. [PMID: 21852019 DOI: 10.1016/j.imbio.2011.07.022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
4 Yao X, Verkman AS. Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G. Acta Neuropathol Commun 2017;5:57. [PMID: 28750658 DOI: 10.1186/s40478-017-0462-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
5 Karumanchi SA, Thadhani R. A complement to kidney disease: CFHR5 nephropathy. Lancet 2010;376:748-50. [PMID: 20800272 DOI: 10.1016/S0140-6736(10)60967-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Hovingh ES, de Maat S, Cloherty APM, Johnson S, Pinelli E, Maas C, Jongerius I. Virulence Associated Gene 8 of Bordetella pertussis Enhances Contact System Activity by Inhibiting the Regulatory Function of Complement Regulator C1 Inhibitor. Front Immunol 2018;9:1172. [PMID: 29915576 DOI: 10.3389/fimmu.2018.01172] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Ford L, Tufts DM. Lyme Neuroborreliosis: Mechanisms of B. burgdorferi Infection of the Nervous System. Brain Sci 2021;11:789. [PMID: 34203671 DOI: 10.3390/brainsci11060789] [Reference Citation Analysis]
8 Danobeitia JS, Djamali A, Fernandez LA. The role of complement in the pathogenesis of renal ischemia-reperfusion injury and fibrosis. Fibrogenesis Tissue Repair 2014;7:16. [PMID: 25383094 DOI: 10.1186/1755-1536-7-16] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 6.8] [Reference Citation Analysis]
9 Ueda M, Sato Y, Horie A, Tani H, Miyazaki Y, Okunomiya A, Matsumoto H, Hamanishi J, Kondoh E, Mandai M. Endovascular trophoblast expresses CD59 to evade complement-dependent cytotoxicity. Mol Cell Endocrinol 2019;490:57-67. [PMID: 30981734 DOI: 10.1016/j.mce.2019.04.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Burgess ST, Frew D, Nunn F, Watkins CA, McNeilly TN, Nisbet AJ, Huntley JF. Transcriptomic analysis of the temporal host response to skin infestation with the ectoparasitic mite Psoroptes ovis. BMC Genomics 2010;11:624. [PMID: 21067579 DOI: 10.1186/1471-2164-11-624] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
11 Mustafa N, Nee AHF, Chooi JY, Toh SHM, Chung TH, Selvarajan V, Fan S, Ng SB, Poon M, Chan E, Lee J, Chee YL, Jeyasekharan AD, Zhou L, Yang J, Chng WJ. Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma. J Immunother Cancer 2021;9:e002123. [PMID: 34215687 DOI: 10.1136/jitc-2020-002123] [Reference Citation Analysis]
12 Asok Kumar N, Muraleedharan Suma S, Kunnakkadan U, Nag J, Koolaparambil Mukesh R, Lyles DS, Johnson JB. Functional Dissection of the Dominant Role of CD55 in Protecting Vesicular Stomatitis Virus against Complement-Mediated Neutralization. Viruses 2021;13:373. [PMID: 33652918 DOI: 10.3390/v13030373] [Reference Citation Analysis]
13 Boshra H, Zelek WM, Hughes TR, Rodriguez de Cordoba S, Morgan BP. Absence of CD59 in Guinea Pigs: Analysis of the Cavia porcellus Genome Suggests the Evolution of a CD59 Pseudogene. J Immunol 2018;200:327-35. [PMID: 29167230 DOI: 10.4049/jimmunol.1701238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
14 Herwald H, Egesten A. Unexpected and novel functions of complement proteins. J Innate Immun 2014;6:405-6. [PMID: 24853386 DOI: 10.1159/000363198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Zarantonello A, Mortensen S, Laursen NS, Andersen GR. Purification of Human Complement Component C4 and Sample Preparation for Structural Biology Applications. Methods Mol Biol 2021;2227:249-64. [PMID: 33847947 DOI: 10.1007/978-1-0716-1016-9_22] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Siegel C, Hallström T, Skerka C, Eberhardt H, Uzonyi B, Beckhaus T, Karas M, Wallich R, Stevenson B, Zipfel PF, Kraiczy P. Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi. PLoS One 2010;5:e13519. [PMID: 20975954 DOI: 10.1371/journal.pone.0013519] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
17 Lebeer S, Claes IJ, Verhoeven TL, Vanderleyden J, De Keersmaecker SC. Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innate immune factors in the intestine. Microb Biotechnol 2011;4:368-74. [PMID: 21375696 DOI: 10.1111/j.1751-7915.2010.00199.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 101] [Article Influence: 9.7] [Reference Citation Analysis]
18 Bedoui Y, Neal JW, Gasque P. The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation. J Neuroimmune Pharmacol 2018;13:309-29. [PMID: 29909495 DOI: 10.1007/s11481-018-9793-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
19 Kadam AP, Sahu A. Identification of Complin, a novel complement inhibitor that targets complement proteins factor B and C2. J Immunol 2010;184:7116-24. [PMID: 20483772 DOI: 10.4049/jimmunol.1000200] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
20 Sochaj-Gregorczyk AM, Ludzia P, Kozdrowska E, Jakimowicz P, Sokolowska-Wedzina A, Otlewski J. Design and In Vitro Evaluation of a Cytotoxic Conjugate Based on the Anti-HER2 Affibody Fused to the Fc Fragment of IgG1. Int J Mol Sci 2017;18:E1688. [PMID: 28771178 DOI: 10.3390/ijms18081688] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
21 Stach L, Dinley EKH, Tournier N, Bingham RP, Gormley DA, Bramhall JL, Taylor A, Clarkson JE, Welbeck KA, Harris CL, Feeney M, Hughes JP, Sepp A, Batuwangala TD, Kitchen SJ, Nichols EM. Novel Selection Approaches to Identify Antibodies Targeting Neoepitopes on the C5b6 Intermediate Complex to Inhibit Membrane Attack Complex Formation. Antibodies (Basel) 2021;10:39. [PMID: 34698051 DOI: 10.3390/antib10040039] [Reference Citation Analysis]
22 Kametani Y, Miyamoto A, Tsuda B, Tokuda Y. B Cell Epitope-Based Vaccination Therapy. Antibodies 2015;4:225-39. [DOI: 10.3390/antib4030225] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
23 Escudero-Esparza A, Kalchishkova N, Kurbasic E, Jiang WG, Blom AM. The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly. FASEB J 2013;27:5083-93. [PMID: 23964079 DOI: 10.1096/fj.13-230706] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 5.7] [Reference Citation Analysis]
24 Wright K, Dziuk R, Mital P, Kaur G, Dufour JM. Xenotransplanted Pig Sertoli Cells Inhibit Both the Alternative and Classical Pathways of Complement-Mediated Cell Lysis While Pig Islets Are Killed. Cell Transplant 2016;25:2027-40. [PMID: 27305664 DOI: 10.3727/096368916X692032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
25 Cai Y, Deng J, Chen Z, Mei H, Tang L, Luo S, Hu Y. Brief report on the relation between complement C3a and anti dsDNA antibody in systemic lupus erythematosus. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-10936-z] [Reference Citation Analysis]
26 Schmidt CQ, Kennedy AT, Tham WH. More than just immune evasion: Hijacking complement by Plasmodium falciparum. Mol Immunol 2015;67:71-84. [PMID: 25816986 DOI: 10.1016/j.molimm.2015.03.006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
27 Tsakiri M, Naziris N, Demetzos C. Innovative vaccine platforms against infectious diseases: Under the scope of the COVID-19 pandemic. Int J Pharm 2021;610:121212. [PMID: 34687816 DOI: 10.1016/j.ijpharm.2021.121212] [Reference Citation Analysis]
28 Dieterich R, Hammerschmidt C, Richter D, Skerka C, Wallich R, Matuschka FR, Zipfel PF, Kraiczy P. Inadequate binding of immune regulator factor H is associated with sensitivity of Borrelia lusitaniae to human complement. Infect Immun 2010;78:4467-76. [PMID: 20823202 DOI: 10.1128/IAI.00138-10] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
29 Fervenza FC, Sethi S, Glassock RJ. Idiopathic membranoproliferative glomerulonephritis: does it exist? Nephrol Dial Transplant 2012;27:4288-94. [PMID: 22798508 DOI: 10.1093/ndt/gfs288] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
30 Smathers RL, Chiang DJ, McMullen MR, Feldstein AE, Roychowdhury S, Nagy LE. Soluble IgM links apoptosis to complement activation in early alcoholic liver disease in mice. Mol Immunol 2016;72:9-18. [PMID: 26922040 DOI: 10.1016/j.molimm.2016.02.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
31 Biglarnia AR, Ekdahl KN, Nilsson B. Complement Interception Across Humoral Incompatibility in Solid Organ Transplantation: A Clinical Perspective. Adv Exp Med Biol 2015;865:211-33. [PMID: 26306452 DOI: 10.1007/978-3-319-18603-0_13] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
32 Fridkis-Hareli M, Storek M, Mazsaroff I, Risitano AM, Lundberg AS, Horvath CJ, Holers VM. Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases. Blood 2011;118:4705-13. [PMID: 21860027 DOI: 10.1182/blood-2011-06-359646] [Cited by in Crossref: 90] [Cited by in F6Publishing: 86] [Article Influence: 8.2] [Reference Citation Analysis]
33 Johnson JB, Borisevich V, Rockx B, Parks GD. A novel factor I activity in Nipah virus inhibits human complement pathways through cleavage of C3b. J Virol 2015;89:989-98. [PMID: 25355897 DOI: 10.1128/JVI.02427-14] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
34 Garcia BL, Zwarthoff SA, Rooijakkers SH, Geisbrecht BV. Novel Evasion Mechanisms of the Classical Complement Pathway. J Immunol 2016;197:2051-60. [PMID: 27591336 DOI: 10.4049/jimmunol.1600863] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
35 Kemp MW. Preterm birth, intrauterine infection, and fetal inflammation. Front Immunol 2014;5:574. [PMID: 25520716 DOI: 10.3389/fimmu.2014.00574] [Cited by in Crossref: 82] [Cited by in F6Publishing: 80] [Article Influence: 10.3] [Reference Citation Analysis]
36 Michielsen LA, van Zuilen AD, Muskens IS, Verhaar MC, Otten HG. Complement Polymorphisms in Kidney Transplantation: Critical in Graft Rejection? Am J Transplant 2017;17:2000-7. [PMID: 28097805 DOI: 10.1111/ajt.14199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
37 Unal CM, Schaar V, Riesbeck K. Bacterial outer membrane vesicles in disease and preventive medicine. Semin Immunopathol 2011;33:395-408. [PMID: 21153593 DOI: 10.1007/s00281-010-0231-y] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
38 Pérez-Alós L, Bayarri-Olmos R, Skjoedt MO, Garred P. Combining MAP-1:CD35 or MAP-1:CD55 fusion proteins with pattern-recognition molecules as novel targeted modulators of the complement cascade. FASEB J 2019;33:12723-34. [PMID: 31469600 DOI: 10.1096/fj.201901643R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
39 Zimmer J, Hobkirk J, Mohamed F, Browning MJ, Stover CM. On the Functional Overlap between Complement and Anti-Microbial Peptides. Front Immunol 2014;5:689. [PMID: 25646095 DOI: 10.3389/fimmu.2014.00689] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
40 Bradley DT, Zipfel PF, Hughes AE. Complement in age-related macular degeneration: a focus on function. Eye (Lond). 2011;25:683-693. [PMID: 21394116 DOI: 10.1038/eye.2011.37] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
41 Souto EB, Lima B, Campos JR, Martins-Gomes C, Souto SB, Silva AM. Myasthenia gravis: State of the art and new therapeutic strategies. J Neuroimmunol 2019;337:577080. [PMID: 31670062 DOI: 10.1016/j.jneuroim.2019.577080] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
42 Mueller M, Herzog C, Larmann J, Schmitz M, Hilfiker-Kleiner D, Gessner JE, Theilmeier G. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration. Immunobiology 2013;218:1131-8. [PMID: 23642836 DOI: 10.1016/j.imbio.2013.03.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
43 Prohászka Z, Kirschfink M, Frazer-Abel A. Complement analysis in the era of targeted therapeutics. Mol Immunol 2018;102:84-8. [PMID: 29933889 DOI: 10.1016/j.molimm.2018.06.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
44 Pio R, Ajona D, Ortiz-Espinosa S, Mantovani A, Lambris JD. Complementing the Cancer-Immunity Cycle. Front Immunol 2019;10:774. [PMID: 31031765 DOI: 10.3389/fimmu.2019.00774] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 17.7] [Reference Citation Analysis]
45 Kurniyati K, Zhang W, Zhang K, Li C. A surface-exposed neuraminidase affects complement resistance and virulence of the oral spirochaete Treponema denticola. Mol Microbiol 2013;89:842-56. [PMID: 23808705 DOI: 10.1111/mmi.12311] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
46 Luo S, Skerka C, Kurzai O, Zipfel PF. Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicans. Molecular Immunology 2013;56:161-9. [DOI: 10.1016/j.molimm.2013.05.218] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
47 Ramanujam S, Muthuvel B, Aravind C B, Biswas J, Konerirajapuram NS. The 88-kDa Eales' protein in serum is a complex of haptoglobin, complement C3, and galectin-1 as identified by liquid chromatography coupled mass spectrometry. Proteomics Clin Appl 2017;11. [PMID: 27739660 DOI: 10.1002/prca.201600068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
48 Dasari P, Shopova IA, Stroe M, Wartenberg D, Martin-Dahse H, Beyersdorf N, Hortschansky P, Dietrich S, Cseresnyés Z, Figge MT, Westermann M, Skerka C, Brakhage AA, Zipfel PF. Aspf2 From Aspergillus fumigatus Recruits Human Immune Regulators for Immune Evasion and Cell Damage. Front Immunol 2018;9:1635. [PMID: 30166981 DOI: 10.3389/fimmu.2018.01635] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
49 Hovingh ES, van den Broek B, Kuipers B, Pinelli E, Rooijakkers SHM, Jongerius I. Acquisition of C1 inhibitor by Bordetella pertussis virulence associated gene 8 results in C2 and C4 consumption away from the bacterial surface. PLoS Pathog 2017;13:e1006531. [PMID: 28742139 DOI: 10.1371/journal.ppat.1006531] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
50 Hallström T, Nordström T, Tan TT, Manolov T, Lambris JD, Isenman DE, Zipfel PF, Blom AM, Riesbeck K. Immune evasion of Moraxella catarrhalis involves ubiquitous surface protein A-dependent C3d binding. J Immunol 2011;186:3120-9. [PMID: 21270401 DOI: 10.4049/jimmunol.1002621] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
51 Banadakoppa M, Balakrishnan M, Yallampalli C. Upregulation and release of soluble fms-like tyrosine kinase receptor 1 mediated by complement activation in human syncytiotrophoblast cells. Am J Reprod Immunol 2018;80:e13033. [PMID: 30099798 DOI: 10.1111/aji.13033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
52 Ruan CC, Ge Q, Li Y, Li XD, Chen DR, Ji KD, Wu YJ, Sheng LJ, Yan C, Zhu DL, Gao PJ. Complement-mediated macrophage polarization in perivascular adipose tissue contributes to vascular injury in deoxycorticosterone acetate-salt mice. Arterioscler Thromb Vasc Biol 2015;35:598-606. [PMID: 25573852 DOI: 10.1161/ATVBAHA.114.304927] [Cited by in Crossref: 44] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
53 de Boer ECW, van Mourik AG, Jongerius I. Therapeutic Lessons to be Learned From the Role of Complement Regulators as Double-Edged Sword in Health and Disease. Front Immunol 2020;11:578069. [PMID: 33362763 DOI: 10.3389/fimmu.2020.578069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Ducruet AF, Zacharia BE, Sosunov SA, Gigante PR, Yeh ML, Gorski JW, Otten ML, Hwang RY, DeRosa PA, Hickman ZL. Complement inhibition promotes endogenous neurogenesis and sustained anti-inflammatory neuroprotection following reperfused stroke. PLoS One. 2012;7:e38664. [PMID: 22761695 DOI: 10.1371/journal.pone.0038664] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
55 Vacchelli E, Aranda F, Eggermont A, Galon J, Sautès-Fridman C, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy. Oncoimmunology 2014;3:e27048. [PMID: 24605265 DOI: 10.4161/onci.27048] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 59.0] [Reference Citation Analysis]
56 Dasari P, Bhakdi S. Pathogenesis of malaria revisited. Med Microbiol Immunol 2012;201:599-604. [PMID: 22955244 DOI: 10.1007/s00430-012-0265-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
57 Mohan RR, Huber GA, Morikis D. Electrostatic Steering Accelerates C3d:CR2 Association. J Phys Chem B 2016;120:8416-23. [PMID: 27092816 DOI: 10.1021/acs.jpcb.6b02095] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
58 Herrmann P, Cowing JA, Cristante E, Liyanage SE, Ribeiro J, Duran Y, Abelleira Hervas L, Carvalho LS, Bainbridge JW, Luhmann UF, Ali RR. Cd59a deficiency in mice leads to preferential innate immune activation in the retinal pigment epithelium-choroid with age. Neurobiol Aging 2015;36:2637-48. [PMID: 26234657 DOI: 10.1016/j.neurobiolaging.2015.05.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
59 Pauly D, Nagel BM, Reinders J, Killian T, Wulf M, Ackermann S, Ehrenstein B, Zipfel PF, Skerka C, Weber BH. A novel antibody against human properdin inhibits the alternative complement system and specifically detects properdin from blood samples. PLoS One. 2014;9:e96371. [PMID: 24797388 DOI: 10.1371/journal.pone.0096371] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
60 Reuter M, Caswell CC, Lukomski S, Zipfel PF. Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels. J Biol Chem 2010;285:38473-85. [PMID: 20855886 DOI: 10.1074/jbc.M110.143727] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
61 Halder LD, Abdelfatah MA, Jo EA, Jacobsen ID, Westermann M, Beyersdorf N, Lorkowski S, Zipfel PF, Skerka C. Factor H Binds to Extracellular DNA Traps Released from Human Blood Monocytes in Response to Candida albicans. Front Immunol 2016;7:671. [PMID: 28133459 DOI: 10.3389/fimmu.2016.00671] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
62 Cai Y, Zhang W, Xiong S. Mannose-binding lectin blunts macrophage polarization and ameliorates lupus nephritis. PLoS One 2013;8:e62465. [PMID: 23626823 DOI: 10.1371/journal.pone.0062465] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
63 Ozen A. CHAPLE syndrome uncovers the primary role of complement in a familial form of Waldmann's disease. Immunol Rev 2019;287:20-32. [PMID: 30565236 DOI: 10.1111/imr.12715] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
64 Wild J, Wenzel P. Myeloid cells, tissue homeostasis, and anatomical barriers as innate immune effectors in arterial hypertension. J Mol Med (Berl) 2021;99:315-26. [PMID: 33443617 DOI: 10.1007/s00109-020-02019-1] [Reference Citation Analysis]
65 Haerynck F, Stordeur P, Vandewalle J, Van Coster R, Bordon V, De Baets F, Schelstraete P, Javaux C, Bouvry M, Fremeaux-bacchi V, Dehoorne J. Complete Factor I Deficiency Due to Dysfunctional Factor I with Recurrent Aseptic Meningo-Encephalitis. J Clin Immunol 2013;33:1293-301. [DOI: 10.1007/s10875-013-9944-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
66 Duan T, Smith AJ, Verkman AS. Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica. J Neuroinflammation 2018;15:294. [PMID: 30348195 DOI: 10.1186/s12974-018-1333-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
67 Cohen ME, Xiao Y, Eisenberg RJ, Cohen GH, Isaacs SN. Antibody against extracellular vaccinia virus (EV) protects mice through complement and Fc receptors. PLoS One 2011;6:e20597. [PMID: 21687676 DOI: 10.1371/journal.pone.0020597] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
68 Wendt R, Siwy J, He T, Latosinska A, Wiech T, Zipfel PF, Tserga A, Vlahou A, Rupprecht H, Catanese L, Mischak H, Beige J. Molecular Mapping of Urinary Complement Peptides in Kidney Diseases. Proteomes 2021;9:49. [DOI: 10.3390/proteomes9040049] [Reference Citation Analysis]
69 Rodriguez EF, Cosio FG, Nasr SH, Sethi S, Fidler ME, Stegall MD, Grande JP, Fervenza FC, Cornell LD. The Pathology and Clinical Features of Early Recurrent Membranous Glomerulonephritis: Recurrent Membranous Glomerulonephritis. American Journal of Transplantation 2012;12:1029-38. [DOI: 10.1111/j.1600-6143.2011.03903.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
70 Chen F, Wang G, Griffin JI, Brenneman B, Banda NK, Holers VM, Backos DS, Wu L, Moghimi SM, Simberg D. Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo. Nat Nanotechnol 2017;12:387-93. [PMID: 27992410 DOI: 10.1038/nnano.2016.269] [Cited by in Crossref: 246] [Cited by in F6Publishing: 229] [Article Influence: 41.0] [Reference Citation Analysis]
71 Wen Q, Jin X, Lu Y, Chen D. Anticomplement ent-labdane diterpenoids from the aerial parts of Andrographis paniculata. Fitoterapia 2020;142:104528. [DOI: 10.1016/j.fitote.2020.104528] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
72 Simon N, Lasonder E, Scheuermayer M, Kuehn A, Tews S, Fischer R, Zipfel P, Skerka C, Pradel G. Malaria Parasites Co-opt Human Factor H to Prevent Complement-Mediated Lysis in the Mosquito Midgut. Cell Host & Microbe 2013;13:29-41. [DOI: 10.1016/j.chom.2012.11.013] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 6.6] [Reference Citation Analysis]
73 Małecki P, Tracz J, Łuczak M, Figlerowicz M, Mazur-Melewska K, Służewski W, Mania A. Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study. Expert Rev Proteomics 2020;17:623-32. [PMID: 32921203 DOI: 10.1080/14789450.2020.1810020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Sparrow JR, Ueda K, Zhou J. WITHDRAWN: Complement dysregulation in AMD: RPE-Bruch's membrane-choroid. Mol Aspects Med 2012. [PMID: 22542573 DOI: 10.1016/j.mam.2012.03.011] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
75 Schmidt CQ, Bai H, Lin Z, Risitano AM, Barlow PN, Ricklin D, Lambris JD. Rational engineering of a minimized immune inhibitor with unique triple-targeting properties. J Immunol 2013;190:5712-21. [PMID: 23616575 DOI: 10.4049/jimmunol.1203548] [Cited by in Crossref: 87] [Cited by in F6Publishing: 81] [Article Influence: 9.7] [Reference Citation Analysis]
76 Lauer N, Mihlan M, Hartmann A, Schlötzer-schrehardt U, Keilhauer C, Scholl HPN, Charbel Issa P, Holz F, Weber BHF, Skerka C, Zipfel PF. Complement Regulation at Necrotic Cell Lesions Is Impaired by the Age-Related Macular Degeneration-Associated Factor-H His 402 Risk Variant. J I 2011;187:4374-83. [DOI: 10.4049/jimmunol.1002488] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
77 Chrzanowska M, Modrzejewska A, Modrzejewska M. New insight into the role of the complement in the most common types of retinopathy-current literature review. Int J Ophthalmol 2018;11:1856-64. [PMID: 30450319 DOI: 10.18240/ijo.2018.11.19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
78 Hawksworth OA, Coulthard LG, Woodruff TM. Complement in the fundamental processes of the cell. Mol Immunol 2017;84:17-25. [PMID: 27894513 DOI: 10.1016/j.molimm.2016.11.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
79 Brakhage AA, Bruns S, Thywissen A, Zipfel PF, Behnsen J. Interaction of phagocytes with filamentous fungi. Curr Opin Microbiol 2010;13:409-15. [PMID: 20627805 DOI: 10.1016/j.mib.2010.04.009] [Cited by in Crossref: 93] [Cited by in F6Publishing: 93] [Article Influence: 7.8] [Reference Citation Analysis]
80 Malekshahi Z, Bernklau S, Schiela B, Koske I, Banki Z, Stiasny K, Harris CL, Würzner R, Stoiber H. Incorporation of CD55 into the Zika Viral Envelope Contributes to Its Stability against Human Complement. Viruses 2021;13:510. [PMID: 33808725 DOI: 10.3390/v13030510] [Reference Citation Analysis]
81 Zipfel PF, Skerka C. Staphylococcus aureus: the multi headed hydra resists and controls human complement response in multiple ways. Int J Med Microbiol 2014;304:188-94. [PMID: 24461453 DOI: 10.1016/j.ijmm.2013.11.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
82 Rajasekaran N, Chester C, Yonezawa A, Zhao X, Kohrt HE. Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment. Immunotargets Ther 2015;4:91-100. [PMID: 27471715 DOI: 10.2147/ITT.S61292] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
83 Carr JM, Cabezas-Falcon S, Dubowsky JG, Hulme-Jones J, Gordon DL. Dengue virus and the complement alternative pathway. FEBS Lett 2020;594:2543-55. [PMID: 31943152 DOI: 10.1002/1873-3468.13730] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
84 Heinekamp T, Schmidt H, Lapp K, Pähtz V, Shopova I, Köster-Eiserfunke N, Krüger T, Kniemeyer O, Brakhage AA. Interference of Aspergillus fumigatus with the immune response. Semin Immunopathol 2015;37:141-52. [PMID: 25404120 DOI: 10.1007/s00281-014-0465-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 8.1] [Reference Citation Analysis]
85 Gavin C, Meinke S, Heldring N, Heck KA, Achour A, Iacobaeus E, Höglund P, Le Blanc K, Kadri N. The Complement System Is Essential for the Phagocytosis of Mesenchymal Stromal Cells by Monocytes. Front Immunol 2019;10:2249. [PMID: 31616424 DOI: 10.3389/fimmu.2019.02249] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
86 Bradley DT, Badger SA, Bown MJ, Sayers RD, Hughes AE. Coding polymorphisms in the genes of the alternative complement pathway and abdominal aortic aneurysm. Int J Immunogenet 2011;38:243-8. [PMID: 21352499 DOI: 10.1111/j.1744-313X.2011.01002.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
87 Singh B, Blom AM, Unal C, Nilson B, Mörgelin M, Riesbeck K. Vitronectin binds to the head region of Moraxella catarrhalis ubiquitous surface protein A2 and confers complement-inhibitory activity. Molecular Microbiology 2010;75:1426-44. [DOI: 10.1111/j.1365-2958.2010.07066.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
88 Barthel D, Schindler S, Zipfel PF. Plasminogen is a complement inhibitor. J Biol Chem 2012;287:18831-42. [PMID: 22451663 DOI: 10.1074/jbc.M111.323287] [Cited by in Crossref: 104] [Cited by in F6Publishing: 60] [Article Influence: 10.4] [Reference Citation Analysis]
89 Mühleip JJ, Lin YP, Kraiczy P. Further Insights Into the Interaction of Human and Animal Complement Regulator Factor H With Viable Lyme Disease Spirochetes. Front Vet Sci 2018;5:346. [PMID: 30766876 DOI: 10.3389/fvets.2018.00346] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
90 Bazzi S, Modjtahedi H, Mudan S, Akle C, Bahr GM. Analysis of the immunomodulatory properties of two heat-killed mycobacterial preparations in a human whole blood model. Immunobiology 2015;220:1293-304. [PMID: 26253276 DOI: 10.1016/j.imbio.2015.07.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
91 Lage SL, Rocco JM, Laidlaw E, Rupert A, Galindo F, Kellogg A, Kumar P, Poon R, Wortmann GW, Lisco A, Manion M, Sereti I. Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients. Front Immunol 2022;13:815833. [DOI: 10.3389/fimmu.2022.815833] [Reference Citation Analysis]
92 Bongoni AK, Salvaris E, Nordling S, Klymiuk N, Wolf E, Ayares DL, Rieben R, Magnusson PU, Cowan PJ. Surface modification of pig endothelial cells with a branched heparin conjugate improves their compatibility with human blood. Sci Rep 2017;7:4450. [PMID: 28667310 DOI: 10.1038/s41598-017-04898-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
93 Lu P, Ma Y, Wei S, Liang X. The dual role of complement in cancers, from destroying tumors to promoting tumor development. Cytokine 2021;143:155522. [PMID: 33849765 DOI: 10.1016/j.cyto.2021.155522] [Reference Citation Analysis]
94 Galluzzi L, Senovilla L, Zitvogel L, Kroemer G. The secret ally: immunostimulation by anticancer drugs. Nat Rev Drug Discov. 2012;11:215-233. [PMID: 22301798 DOI: 10.1038/nrd3626] [Cited by in Crossref: 443] [Cited by in F6Publishing: 434] [Article Influence: 44.3] [Reference Citation Analysis]
95 Gautam AK, Panse Y, Ghosh P, Reza MJ, Mullick J, Sahu A. Mutational analysis of Kaposica reveals that bridging of MG2 and CUB domains of target protein is crucial for the cofactor activity of RCA proteins. Proc Natl Acad Sci U S A 2015;112:12794-9. [PMID: 26420870 DOI: 10.1073/pnas.1506449112] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
96 Jia M, Zhu L, Zhai YL, Chen P, Xu BY, Guo WY, Shi SF, Liu LJ, Lv JC, Zhang H. Variation in complement factor H affects complement activation in immunoglobulin A vasculitis with nephritis. Nephrology (Carlton) 2020;25:40-7. [PMID: 30838755 DOI: 10.1111/nep.13580] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
97 Liszewski MK, Atkinson JP. Complement regulators in human disease: lessons from modern genetics. J Intern Med 2015;277:294-305. [PMID: 25495259 DOI: 10.1111/joim.12338] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
98 Ozen A, Kasap N, Vujkovic-Cvijin I, Apps R, Cheung F, Karakoc-Aydiner E, Akkelle B, Sari S, Tutar E, Ozcay F, Uygun DK, Islek A, Akgun G, Selcuk M, Sezer OB, Zhang Y, Kutluk G, Topal E, Sayar E, Celikel C, Houwen RHJ, Bingol A, Ogulur I, Eltan SB, Snow AL, Lake C, Fantoni G, Alba C, Sellers B, Chauvin SD, Dalgard CL, Harari O, Ni YG, Wang MD, Devalaraja-Narashimha K, Subramanian P, Ergelen R, Artan R, Guner SN, Dalgic B, Tsang J, Belkaid Y, Ertem D, Baris S, Lenardo MJ. Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease. Nat Immunol 2021;22:128-39. [PMID: 33398182 DOI: 10.1038/s41590-020-00830-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
99 Xiong F, Qin L, Hao Y, Zhao D, Li W, Zou H, Li M, Wu S, Wang G. Gut microbiota modulation and immunity response induced by Citrobacter freundii strain GC01 in grass carp (Ctenopharyngodon idellus). Aquaculture 2020;521:735015. [DOI: 10.1016/j.aquaculture.2020.735015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
100 Aranda F, Vacchelli E, Eggermont A, Galon J, Fridman WH, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy. Oncoimmunology 2014;3:e27297. [PMID: 24701370 DOI: 10.4161/onci.27297] [Cited by in Crossref: 84] [Cited by in F6Publishing: 84] [Article Influence: 10.5] [Reference Citation Analysis]
101 Miller DP, McDowell JV, Bell JK, Marconi RT. Crystallization of the factor H-binding protein, FhbB, from the periopathogen Treponema denticola. Acta Crystallogr Sect F Struct Biol Cryst Commun 2011;67:678-81. [PMID: 21636910 DOI: 10.1107/S1744309111011298] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
102 Shao S, Sun X, Chen Y, Zhan B, Zhu X. Complement Evasion: An Effective Strategy That Parasites Utilize to Survive in the Host. Front Microbiol 2019;10:532. [PMID: 30949145 DOI: 10.3389/fmicb.2019.00532] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
103 Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, McIntosh ML, Alsam A, Kirkwood KL, Lambris JD. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe. 2011;10:497-506. [PMID: 22036469 DOI: 10.1016/j.chom.2011.10.006] [Cited by in Crossref: 620] [Cited by in F6Publishing: 574] [Article Influence: 56.4] [Reference Citation Analysis]
104 Parker SE, Bellingham MC, Woodruff TM. Complement drives circuit modulation in the adult brain. Progress in Neurobiology 2022. [DOI: 10.1016/j.pneurobio.2022.102282] [Reference Citation Analysis]
105 Simberg D, Moghimi SM. Complement Activation by Nanomaterials. In: Bonner JC, Brown JM, editors. Interaction of Nanomaterials with the Immune System. Cham: Springer International Publishing; 2020. pp. 83-98. [DOI: 10.1007/978-3-030-33962-3_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
106 Saab NAA, Nascimento AAS, Queiroz DC, da Cunha IGM, Filho AAP, D'Ávila Pessoa GC, Koerich LB, Pereira MH, Sant'Anna MRV, Araújo RN, Gontijo NF. How Lutzomyia longipalpis deals with the complement system present in the ingested blood: The role of soluble inhibitors and the adsorption of factor H by midgut. J Insect Physiol 2020;120:103992. [PMID: 31816296 DOI: 10.1016/j.jinsphys.2019.103992] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
107 Ren M, Hu Z, Chen Q, Jaffe A, Li Y, Sadashivaiah V, Zhu S, Rajpurohit N, Heon Shin J, Xia W, Jia Y, Wu J, Lang Qin S, Li X, Zhu J, Tian Q, Paredes D, Zhang F, Wang KH, Mattay VS, Callicott JH, Berman KF, Weinberger DR, Yang F. KCNH2-3.1 mediates aberrant complement activation and impaired hippocampal-medial prefrontal circuitry associated with working memory deficits. Mol Psychiatry 2020;25:206-29. [PMID: 31570775 DOI: 10.1038/s41380-019-0530-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Walter L, Sürth V, Röttgerding F, Zipfel PF, Fritz-Wolf K, Kraiczy P. Elucidating the Immune Evasion Mechanisms of Borrelia mayonii, the Causative Agent of Lyme Disease. Front Immunol 2019;10:2722. [PMID: 31849943 DOI: 10.3389/fimmu.2019.02722] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
109 Gaggl M, Aigner C, Sunder-Plassmann G, Schmidt A. [Thrombotic microangiopathy : Relevant new aspects for intensive care physicians]. Med Klin Intensivmed Notfmed 2016;111:434-9. [PMID: 27255224 DOI: 10.1007/s00063-016-0176-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
110 Khan A, Das BC, Abiha U, Sisodiya S, Chikara A, Nazir SU, Das AM, Rodrigues AG, Passari AK, Tanwar P, Hussain S, Rashid S, Rashid S. Insights into the role of complement regulatory proteins in HPV mediated cervical carcinogenesis. Semin Cancer Biol 2021:S1044-579X(21)00161-9. [PMID: 34087416 DOI: 10.1016/j.semcancer.2021.05.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Moghimi SM, Simberg D, Papini E, Farhangrazi ZS. Complement activation by drug carriers and particulate pharmaceuticals: Principles, challenges and opportunities. Adv Drug Deliv Rev 2020;157:83-95. [PMID: 32389761 DOI: 10.1016/j.addr.2020.04.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
112 Zhang Q, Li Y, Tang CM. The role of the exopolyphosphatase PPX in avoidance by Neisseria meningitidis of complement-mediated killing. J Biol Chem 2010;285:34259-68. [PMID: 20736171 DOI: 10.1074/jbc.M110.154393] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
113 Narayanan GA, Murray IA, Krishnegowda G, Amin S, Perdew GH. Selective aryl hydrocarbon receptor modulator-mediated repression of CD55 expression induced by cytokine exposure. J Pharmacol Exp Ther 2012;342:345-55. [PMID: 22553215 DOI: 10.1124/jpet.112.193482] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
114 van den Hoogen LL, van Roon JA, Radstake TR, Fritsch-Stork RD, Derksen RH. Delineating the deranged immune system in the antiphospholipid syndrome. Autoimmun Rev 2016;15:50-60. [PMID: 26318678 DOI: 10.1016/j.autrev.2015.08.011] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 6.1] [Reference Citation Analysis]
115 Sharif O, Gawish R, Warszawska JM, Martins R, Lakovits K, Hladik A, Doninger B, Brunner J, Korosec A, Schwarzenbacher RE, Berg T, Kralovics R, Colinge J, Mesteri I, Gilfillan S, Salmaggi A, Verschoor A, Colonna M, Knapp S. The triggering receptor expressed on myeloid cells 2 inhibits complement component 1q effector mechanisms and exerts detrimental effects during pneumococcal pneumonia. PLoS Pathog 2014;10:e1004167. [PMID: 24945405 DOI: 10.1371/journal.ppat.1004167] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
116 Pollmächer J, Figge MT. Agent-based model of human alveoli predicts chemotactic signaling by epithelial cells during early Aspergillus fumigatus infection. PLoS One 2014;9:e111630. [PMID: 25360787 DOI: 10.1371/journal.pone.0111630] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
117 Lynch AM, Mandava N, Patnaik JL, Frazer-abel AA, Wagner BD, Palestine AG, Mathias MT, Siringo FS, Cathcart JN, Holers VM. Systemic activation of the complement system in patients with advanced age-related macular degeneration. European Journal of Ophthalmology 2020;30:1061-8. [DOI: 10.1177/1120672119857896] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
118 Schmidt C, Weißmüller S, Bohländer F, Germer M, König M, Staus A, Wartenberg-Demand A, Heinz CC, Schüttrumpf J. The Dual Role of a Polyvalent IgM/IgA-Enriched Immunoglobulin Preparation in Activating and Inhibiting the Complement System. Biomedicines 2021;9:817. [PMID: 34356880 DOI: 10.3390/biomedicines9070817] [Reference Citation Analysis]
119 Mandava N, Tirado-Gonzalez V, Geiger MD, Patnaik JL, Frazer-Abel A, Lynch AM, Mandava N, Palestine AG, Holers VM, Wagner BD, Sanchez-Santos I, Meizner D, Quiroz-Mercado H, Smith JM. Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy. Invest Ophthalmol Vis Sci 2020;61:39. [PMID: 32965482 DOI: 10.1167/iovs.61.11.39] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
120 Burgess ST, Greer A, Frew D, Wells B, Marr EJ, Nisbet AJ, Huntley JF. Transcriptomic analysis of circulating leukocytes reveals novel aspects of the host systemic inflammatory response to sheep scab mites. PLoS One 2012;7:e42778. [PMID: 22880105 DOI: 10.1371/journal.pone.0042778] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
121 Guo Y, Nguyen KA, Potempa J. Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins. Periodontol 2000 2010;54:15-44. [PMID: 20712631 DOI: 10.1111/j.1600-0757.2010.00377.x] [Cited by in Crossref: 199] [Cited by in F6Publishing: 180] [Article Influence: 16.6] [Reference Citation Analysis]
122 Radi ZA. Immunopathogenesis of Acute Kidney Injury. Toxicol Pathol 2018;46:930-43. [DOI: 10.1177/0192623318799976] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
123 Carter AM. Complement activation: an emerging player in the pathogenesis of cardiovascular disease. Scientifica (Cairo) 2012;2012:402783. [PMID: 24278688 DOI: 10.6064/2012/402783] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
124 Chen Q, Wiesener M, Eberhardt HU, Hartmann A, Uzonyi B, Kirschfink M, Amann K, Buettner M, Goodship T, Hugo C. Complement factor H-related hybrid protein deregulates complement in dense deposit disease. J Clin Invest. 2014;124:145-155. [PMID: 24334459 DOI: 10.1172/jci71866] [Cited by in Crossref: 81] [Cited by in F6Publishing: 49] [Article Influence: 9.0] [Reference Citation Analysis]
125 Zhou H, Hara H, Cooper DKC. The complex functioning of the complement system in xenotransplantation. Xenotransplantation 2019;26:e12517. [PMID: 31033064 DOI: 10.1111/xen.12517] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
126 Kolev M, Le Friec G, Kemper C. Complement--tapping into new sites and effector systems. Nat Rev Immunol 2014;14:811-20. [PMID: 25394942 DOI: 10.1038/nri3761] [Cited by in Crossref: 193] [Cited by in F6Publishing: 177] [Article Influence: 24.1] [Reference Citation Analysis]
127 Ahmad S, Pandya C, Kindelin A, Bhatia K, Chaudhary R, Dwivedi AK, Eschbacher JM, Liu Q, Waters MF, Hoda MN, Ducruet AF. C3a receptor antagonist therapy is protective with or without thrombolysis in murine thromboembolic stroke. Br J Pharmacol 2020;177:2466-77. [PMID: 31975437 DOI: 10.1111/bph.14989] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
128 Perkins SJ, Fung KW, Khan S. Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands. Front Immunol 2014;5:126. [PMID: 24744754 DOI: 10.3389/fimmu.2014.00126] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
129 Dopler A, Stibitzky S, Hevey R, Mannes M, Guariento M, Höchsmann B, Schrezenmeier H, Ricklin D, Schmidt CQ. Deregulation of Factor H by Factor H-Related Protein 1 Depends on Sialylation of Host Surfaces. Front Immunol 2021;12:615748. [PMID: 33732239 DOI: 10.3389/fimmu.2021.615748] [Reference Citation Analysis]
130 Schröder-Braunstein J, Kirschfink M. Complement deficiencies and dysregulation: Pathophysiological consequences, modern analysis, and clinical management. Mol Immunol 2019;114:299-311. [PMID: 31421540 DOI: 10.1016/j.molimm.2019.08.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
131 Matuszewska E, Matysiak J, Bręborowicz A, Olejniczak K, Kycler Z, Kokot ZJ, Matysiak J. Proteomic features characterization of Hymenoptera venom allergy. Allergy Asthma Clin Immunol 2019;15:77. [PMID: 31798646 DOI: 10.1186/s13223-019-0387-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
132 Qiu Y, Korteweg C, Chen Z, Li J, Luo J, Huang G, Gu J. Immunoglobulin G expression and its colocalization with complement proteins in papillary thyroid cancer. Mod Pathol. 2012;25:36-45. [PMID: 21909078 DOI: 10.1038/modpathol.2011.139] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
133 Lesher AM, Song WC. Review: Complement and its regulatory proteins in kidney diseases. Nephrology (Carlton) 2010;15:663-75. [PMID: 21040161 DOI: 10.1111/j.1440-1797.2010.01373.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
134 Lindorfer M, Beum P, Taylor R. CD20 mAb-Mediated Complement Dependent Cytotoxicity of Tumor Cells is Enhanced by Blocking the Action of Factor I. Antibodies 2013;2:598-616. [DOI: 10.3390/antib2040598] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
135 Xu H, Chen M. Targeting the complement system for the management of retinal inflammatory and degenerative diseases. Eur J Pharmacol. 2016;787:94-104. [PMID: 26948311 DOI: 10.1016/j.ejphar.2016.03.001] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 11.0] [Reference Citation Analysis]
136 Hillreiner M, Flinspach C, Pfaffl MW, Kliem H. Effect of the Ketone Body Beta-Hydroxybutyrate on the Innate Defense Capability of Primary Bovine Mammary Epithelial Cells. PLoS One 2016;11:e0157774. [PMID: 27310007 DOI: 10.1371/journal.pone.0157774] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
137 Peterson SL, Anderson AJ. Complement and spinal cord injury: traditional and non-traditional aspects of complement cascade function in the injured spinal cord microenvironment. Exp Neurol 2014;258:35-47. [PMID: 25017886 DOI: 10.1016/j.expneurol.2014.04.028] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
138 Seldeen KL, Thiyagarajan R, Redae Y, Jacob A, Troen BR, Quigg RJ, Alexander JJ. Absence of complement factor H reduces physical performance in C57BL6 mice. Immunobiology 2020;225:152003. [PMID: 32962822 DOI: 10.1016/j.imbio.2020.152003] [Reference Citation Analysis]
139 Ekdahl KN, Lambris JD, Elwing H, Ricklin D, Nilsson PH, Teramura Y, Nicholls IA, Nilsson B. Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies. Adv Drug Deliv Rev 2011;63:1042-50. [PMID: 21771620 DOI: 10.1016/j.addr.2011.06.012] [Cited by in Crossref: 127] [Cited by in F6Publishing: 109] [Article Influence: 11.5] [Reference Citation Analysis]
140 Reis ES, Mastellos DC, Ricklin D, Mantovani A, Lambris JD. Complement in cancer: untangling an intricate relationship. Nat Rev Immunol 2018;18:5-18. [PMID: 28920587 DOI: 10.1038/nri.2017.97] [Cited by in Crossref: 157] [Cited by in F6Publishing: 155] [Article Influence: 31.4] [Reference Citation Analysis]
141 Lin YP, Diuk-Wasser MA, Stevenson B, Kraiczy P. Complement Evasion Contributes to Lyme Borreliae-Host Associations. Trends Parasitol 2020;36:634-45. [PMID: 32456964 DOI: 10.1016/j.pt.2020.04.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
142 Thurman JM. Complement and the Kidney: An Overview. Adv Chronic Kidney Dis 2020;27:86-94. [PMID: 32553250 DOI: 10.1053/j.ackd.2019.10.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
143 Kraiczy P. Hide and Seek: How Lyme Disease Spirochetes Overcome Complement Attack. Front Immunol 2016;7:385. [PMID: 27725820 DOI: 10.3389/fimmu.2016.00385] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
144 Harpf V, Rambach G, Würzner R, Lass-Flörl C, Speth C. Candida and Complement: New Aspects in an Old Battle. Front Immunol 2020;11:1471. [PMID: 32765510 DOI: 10.3389/fimmu.2020.01471] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
145 Li Y, Lin F. Mesenchymal stem cells are injured by complement after their contact with serum. Blood. 2012;120:3436-3443. [PMID: 22966167 DOI: 10.1182/blood-2012-03-420612] [Cited by in Crossref: 100] [Cited by in F6Publishing: 86] [Article Influence: 10.0] [Reference Citation Analysis]
146 Poppelaars F, Goicoechea de Jorge E, Jongerius I, Baeumner AJ, Steiner MS, Józsi M, Toonen EJM, Pauly D; SciFiMed consortium. A Family Affair: Addressing the Challenges of Factor H and the Related Proteins. Front Immunol 2021;12:660194. [PMID: 33868311 DOI: 10.3389/fimmu.2021.660194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
147 Zhu H, Yu X, Zhang S, Shu K. Targeting the Complement Pathway in Malignant Glioma Microenvironments. Front Cell Dev Biol 2021;9:657472. [PMID: 33869223 DOI: 10.3389/fcell.2021.657472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Nijhof IS, Casneuf T, van Velzen J, van Kessel B, Axel AE, Syed K, Groen RWJ, van Duin M, Sonneveld P, Minnema MC, Zweegman S, Chiu C, Bloem AC, Mutis T, Lokhorst HM, Sasser AK, van de Donk NWCJ. CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma. Blood 2016;128:959-70. [DOI: 10.1182/blood-2016-03-703439] [Cited by in Crossref: 166] [Cited by in F6Publishing: 156] [Article Influence: 27.7] [Reference Citation Analysis]
149 Shastri A, Bonifati DM, Kishore U. Innate immunity and neuroinflammation. Mediators Inflamm 2013;2013:342931. [PMID: 23843682 DOI: 10.1155/2013/342931] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 9.6] [Reference Citation Analysis]
150 Chen M, Muckersie E, Luo C, Forrester JV, Xu H. Inhibition of the alternative pathway of complement activation reduces inflammation in experimental autoimmune uveoretinitis. Eur J Immunol 2010;40:2870-81. [DOI: 10.1002/eji.201040323] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
151 Behnsen J, Lessing F, Schindler S, Wartenberg D, Jacobsen ID, Thoen M, Zipfel PF, Brakhage AA. Secreted Aspergillus fumigatus protease Alp1 degrades human complement proteins C3, C4, and C5. Infect Immun 2010;78:3585-94. [PMID: 20498262 DOI: 10.1128/IAI.01353-09] [Cited by in Crossref: 64] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
152 Landowski M, Kelly U, Klingeborn M, Groelle M, Ding JD, Grigsby D, Bowes Rickman C. Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice. Proc Natl Acad Sci U S A 2019;116:3703-11. [PMID: 30808757 DOI: 10.1073/pnas.1814014116] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 13.3] [Reference Citation Analysis]
153 Ostrycharz E, Hukowska-szematowicz B. New Insights into the Role of the Complement System in Human Viral Diseases. Biomolecules 2022;12:226. [DOI: 10.3390/biom12020226] [Reference Citation Analysis]
154 Henry N, Mellaza C, Fage N, Beloncle F, Genevieve F, Legendre G, Orvain C, Garnier AS, Cousin M, Besson V, Subra JF, Duveau A, Augusto JF, Brilland B. Retrospective and Systematic Analysis of Causes and Outcomes of Thrombotic Microangiopathies in Routine Clinical Practice: An 11-Year Study. Front Med (Lausanne) 2021;8:566678. [PMID: 33718396 DOI: 10.3389/fmed.2021.566678] [Reference Citation Analysis]
155 Röttgerding F, Kraiczy P. Immune Evasion Strategies of Relapsing Fever Spirochetes. Front Immunol 2020;11:1560. [PMID: 32793216 DOI: 10.3389/fimmu.2020.01560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
156 Williams CB, Eisenstein EM, Cole FS. Immunology of the Fetus and Newborn. Avery's Diseases of the Newborn. Elsevier; 2012. pp. 445-67. [DOI: 10.1016/b978-1-4377-0134-0.10036-8] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
157 Othman Z, Mohren RJC, Cillero-Pastor B, Shen Z, Lacroix YSNW, Guttenplan APM, Tahmasebi Birgani Z, Eijssen L, Luider TM, van Rijt S, Habibovic P. Comparative proteomic analysis of human mesenchymal stromal cell behavior on calcium phosphate ceramics with different osteoinductive potential. Mater Today Bio 2020;7:100066. [PMID: 32642640 DOI: 10.1016/j.mtbio.2020.100066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
158 Frazer-Abel A, Kirschfink M, Prohászka Z. Expanding Horizons in Complement Analysis and Quality Control. Front Immunol 2021;12:697313. [PMID: 34434189 DOI: 10.3389/fimmu.2021.697313] [Reference Citation Analysis]
159 Hallström T, Singh B, Kraiczy P, Hammerschmidt S, Skerka C, Zipfel PF, Riesbeck K. Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif. PLoS One 2016;11:e0147709. [PMID: 26808444 DOI: 10.1371/journal.pone.0147709] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
160 Kolev M, Towner L, Donev R. Complement in cancer and cancer immunotherapy. Arch Immunol Ther Exp (Warsz) 2011;59:407-19. [PMID: 21960413 DOI: 10.1007/s00005-011-0146-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
161 Toomey CB, Kelly U, Saban DR, Bowes Rickman C. Regulation of age-related macular degeneration-like pathology by complement factor H. Proc Natl Acad Sci U S A 2015;112:E3040-9. [PMID: 25991857 DOI: 10.1073/pnas.1424391112] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 11.1] [Reference Citation Analysis]
162 Mihlan M, Blom AM, Kupreishvili K, Lauer N, Stelzner K, Bergström F, Niessen HWM, Zipfel PF. Monomeric C‐reactive protein modulates classic complement activation on necrotic cells. FASEB j 2011;25:4198-210. [DOI: 10.1096/fj.11-186460] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 6.4] [Reference Citation Analysis]
163 Bisanz JE, Seney S, McMillan A, Vongsa R, Koenig D, Wong L, Dvoracek B, Gloor GB, Sumarah M, Ford B. A systems biology approach investigating the effect of probiotics on the vaginal microbiome and host responses in a double blind, placebo-controlled clinical trial of post-menopausal women. PLoS One. 2014;9:e104511. [PMID: 25127240 DOI: 10.1371/journal.pone.0104511] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
164 Láng A, Szilágyi K, Major B, Gál P, Závodszky P, Perczel A. Intermodule cooperativity in the structure and dynamics of consecutive complement control modules in human C1r: structural biology. FEBS J 2010;277:3986-98. [PMID: 20796027 DOI: 10.1111/j.1742-4658.2010.07790.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
165 Papac-Milicevic N, Busch CJ, Binder CJ. Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis. Adv Immunol 2016;131:1-59. [PMID: 27235680 DOI: 10.1016/bs.ai.2016.02.001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 8.3] [Reference Citation Analysis]
166 Hallstensen RF, Bergseth G, Foss S, Jæger S, Gedde-dahl T, Holt J, Christiansen D, Lau C, Brekke O, Armstrong E, Stefanovic V, Andersen JT, Sandlie I, Mollnes TE. Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn. Immunobiology 2015;220:452-9. [DOI: 10.1016/j.imbio.2014.11.003] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 8.4] [Reference Citation Analysis]
167 Relle M, Schwarting A. Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus. Clin Dev Immunol 2012;2012:584374. [PMID: 22761632 DOI: 10.1155/2012/584374] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
168 Lim R, Lappas M. Decreased expression of complement 3a receptor (C3aR) in human placentas from severe preeclamptic pregnancies. Eur J Obstet Gynecol Reprod Biol 2012;165:194-8. [PMID: 22901903 DOI: 10.1016/j.ejogrb.2012.08.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
169 Lionaki S, Gakiopoulou H, Boletis JN. Understanding the complement-mediated glomerular diseases: focus on membranoproliferative glomerulonephritis and C3 glomerulopathies. APMIS 2016;124:725-35. [PMID: 27356907 DOI: 10.1111/apm.12566] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
170 Medjeral-Thomas N, Pickering MC. The complement factor H-related proteins. Immunol Rev. 2016;274:191-201. [PMID: 27782332 DOI: 10.1111/imr.12477] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
171 Liszewski MK, Atkinson JP. Complement regulator CD46: genetic variants and disease associations. Hum Genomics 2015;9:7. [PMID: 26054645 DOI: 10.1186/s40246-015-0029-z] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 8.7] [Reference Citation Analysis]
172 Hu J, Yang Y, Wang M, Yao Y, Chang Y, He Q, Ma R, Li G. Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways. Eur J Pharmacol 2019;850:135-40. [PMID: 30771350 DOI: 10.1016/j.ejphar.2019.02.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
173 Ewald J, Sieber P, Garde R, Lang SN, Schuster S, Ibrahim B. Trends in mathematical modeling of host-pathogen interactions. Cell Mol Life Sci 2020;77:467-80. [PMID: 31776589 DOI: 10.1007/s00018-019-03382-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
174 Haldar S, Mishra R, Billet S, Thiruvalluvan M, Placencio-Hickok VR, Madhav A, Duong F, Angara B, Agarwal P, Tighiouart M, Posadas EM, Bhowmick NA. Cancer epithelia-derived mitochondrial DNA is a targetable initiator of a paracrine signaling loop that confers taxane resistance. Proc Natl Acad Sci U S A 2020;117:8515-23. [PMID: 32238563 DOI: 10.1073/pnas.1910952117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
175 Song NJ, Kim S, Jang BH, Chang SH, Yun UJ, Park KM, Waki H, Li DY, Tontonoz P, Park KW. Small Molecule-Induced Complement Factor D (Adipsin) Promotes Lipid Accumulation and Adipocyte Differentiation. PLoS One 2016;11:e0162228. [PMID: 27611793 DOI: 10.1371/journal.pone.0162228] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
176 Kraiczy P, Stevenson B. Complement regulator-acquiring surface proteins of Borrelia burgdorferi: Structure, function and regulation of gene expression. Ticks Tick Borne Dis 2013;4:26-34. [PMID: 23219363 DOI: 10.1016/j.ttbdis.2012.10.039] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 7.5] [Reference Citation Analysis]
177 Wibroe PP, Helvig SY, Moein Moghimi S, Crowe Jr. JE, Boraschi D, Rappuoli R. The Role of Complement in Antibody Therapy for Infectious Diseases. Microbiol Spectr 2014;2. [DOI: 10.1128/microbiolspec.aid-0015-2014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
178 Eriksson O, Mohlin C, Nilsson B, Ekdahl KN. The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System. Front Immunol 2019;10:1590. [PMID: 31354729 DOI: 10.3389/fimmu.2019.01590] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 12.7] [Reference Citation Analysis]
179 Kemper C, Köhl J. Novel roles for complement receptors in T cell regulation and beyond. Mol Immunol 2013;56:181-90. [PMID: 23796748 DOI: 10.1016/j.molimm.2013.05.223] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 5.7] [Reference Citation Analysis]
180 Huang X, Li J, Xie J, Li Y, Gao Y, Li X, Xu X, Shi R, Yao W, Ke C. Neuronal complement cascade drives bone cancer pain via C3R mediated microglial activation. Brain Res 2018;1698:81-8. [PMID: 29909203 DOI: 10.1016/j.brainres.2018.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
181 Lohman RJ, Hamidon JK, Reid RC, Rowley JA, Yau MK, Halili MA, Nielsen DS, Lim J, Wu KC, Loh Z, Do A, Suen JY, Iyer A, Fairlie DP. Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a. Nat Commun 2017;8:351. [PMID: 28839129 DOI: 10.1038/s41467-017-00414-w] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
182 Cardone J, Le Friec G, Kemper C. CD46 in innate and adaptive immunity: an update. Clin Exp Immunol 2011;164:301-11. [PMID: 21488871 DOI: 10.1111/j.1365-2249.2011.04400.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
183 Hasenbein M, Werner I, Deanovic LA, Geist J, Fritsch EB, Javidmehr A, Foe C, Fangue NA, Connon RE. Transcriptomic profiling permits the identification of pollutant sources and effects in ambient water samples. Sci Total Environ 2014;468-469:688-98. [PMID: 24061060 DOI: 10.1016/j.scitotenv.2013.08.081] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
184 Sethi S, Fervenza FC, Zhang Y, Zand L, Meyer NC, Borsa N, Nasr SH, Smith RJ. Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney Int. 2013;83:293-299. [PMID: 23235567 DOI: 10.1038/ki.2012.384] [Cited by in Crossref: 117] [Cited by in F6Publishing: 101] [Article Influence: 11.7] [Reference Citation Analysis]
185 Kwon YC, Kim H, Meyer K, Di Bisceglie AM, Ray R. Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus. J Immunol 2016;197:1127-36. [PMID: 27357152 DOI: 10.4049/jimmunol.1600631] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
186 Pritchard MT, Apte U. Models to Study Liver Regeneration. Liver Regeneration. Elsevier; 2015. pp. 15-40. [DOI: 10.1016/b978-0-12-420128-6.00002-6] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
187 Hughes AE, Bridgett S, Meng W, Li M, Curcio CA, Stambolian D, Bradley DT. Sequence and Expression of Complement Factor H Gene Cluster Variants and Their Roles in Age-Related Macular Degeneration Risk. Invest Ophthalmol Vis Sci 2016;57:2763-9. [PMID: 27196323 DOI: 10.1167/iovs.15-18744] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
188 Na M, Jarneborn A, Ali A, Welin A, Magnusson M, Stokowska A, Pekna M, Jin T. Deficiency of the Complement Component 3 but Not Factor B Aggravates Staphylococcus aureus Septic Arthritis in Mice. Infect Immun 2016;84:930-9. [PMID: 26787717 DOI: 10.1128/IAI.01520-15] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
189 Aeinehband S, Lindblom RP, Al Nimer F, Vijayaraghavan S, Sandholm K, Khademi M, Olsson T, Nilsson B, Ekdahl KN, Darreh-Shori T, Piehl F. Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis. PLoS One 2015;10:e0122048. [PMID: 25835709 DOI: 10.1371/journal.pone.0122048] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
190 Yu Z, Ono C, Aiba S, Kikuchi Y, Sora I, Matsuoka H, Tomita H. Therapeutic concentration of lithium stimulates complement C3 production in dendritic cells and microglia via GSK-3 inhibition. Glia 2015;63:257-70. [PMID: 25179772 DOI: 10.1002/glia.22749] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
191 Smith RJ, Harris CL, Pickering MC. Dense deposit disease. Mol Immunol. 2011;48:1604-1610. [PMID: 21601923 DOI: 10.1016/j.molimm.2011.04.005] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 5.7] [Reference Citation Analysis]
192 Arora V, Grover R, Kumar A, Anand D, Das N. Relationship of leukocyte CR1 transcript and protein with the pathophysiology and prognosis of systemic lupus erythematosus: a follow-up study. Lupus 2011;20:1010-8. [PMID: 21659422 DOI: 10.1177/0961203311400112] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
193 Foster MH, Ord JR. Emerging immunotherapies for autoimmune kidney disease. Hum Vaccin Immunother 2019;15:876-90. [PMID: 30550361 DOI: 10.1080/21645515.2018.1555569] [Reference Citation Analysis]
194 Poppelaars F, Thurman JM. Complement-mediated kidney diseases. Molecular Immunology 2020;128:175-87. [DOI: 10.1016/j.molimm.2020.10.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
195 Kiss MG, Ozsvár-Kozma M, Porsch F, Göderle L, Papac-Miličević N, Bartolini-Gritti B, Tsiantoulas D, Pickering MC, Binder CJ. Complement Factor H Modulates Splenic B Cell Development and Limits Autoantibody Production. Front Immunol 2019;10:1607. [PMID: 31354740 DOI: 10.3389/fimmu.2019.01607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
196 Zipfel PF, Skerka C. Complement, Candida, and cytokines: the role of C5a in host response to fungi. Eur J Immunol 2012;42:822-5. [PMID: 22531909 DOI: 10.1002/eji.201242466] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
197 Riihilä PM, Nissinen LM, Ala-Aho R, Kallajoki M, Grénman R, Meri S, Peltonen S, Peltonen J, Kähäri VM. Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma. J Invest Dermatol 2014;134:498-506. [PMID: 23938460 DOI: 10.1038/jid.2013.346] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
198 Mohlin C, Sandholm K, Kvanta A, Ekdahl KN, Johansson K. A model to study complement involvement in experimental retinal degeneration. Ups J Med Sci 2018;123:28-42. [PMID: 29436895 DOI: 10.1080/03009734.2018.1431744] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
199 Agarwal V, Asmat TM, Luo S, Jensch I, Zipfel PF, Hammerschmidt S. Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells. J Biol Chem 2010;285:23486-95. [PMID: 20504767 DOI: 10.1074/jbc.M110.142703] [Cited by in Crossref: 63] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
200 Hammerschmidt C, Hallström T, Skerka C, Wallich R, Stevenson B, Zipfel PF, Kraiczy P. Contribution of the infection-associated complement regulator-acquiring surface protein 4 (ErpC) to complement resistance of Borrelia burgdorferi. Clin Dev Immunol 2012;2012:349657. [PMID: 22400034 DOI: 10.1155/2012/349657] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
201 Singh B, Su Y, Riesbeck K. Vitronectin in bacterial pathogenesis: a host protein used in complement escape and cellular invasion: Vitronectin and bacterial pathogenesis. Molecular Microbiology 2010;78:545-60. [DOI: 10.1111/j.1365-2958.2010.07373.x] [Cited by in Crossref: 123] [Cited by in F6Publishing: 120] [Article Influence: 10.3] [Reference Citation Analysis]
202 Sparrow JR, Ueda K, Zhou J. Complement dysregulation in AMD: RPE-Bruch's membrane-choroid. Mol Aspects Med 2012;33:436-45. [PMID: 22504022 DOI: 10.1016/j.mam.2012.03.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
203 Wang Y, Chen B, Ke Y, Wang C, Ye B. Molecular characterization and expression analysis of the complement factor I (CpFI) in the whitespotted bamboo shark (Chiloscyllium plagiosum). Fish & Shellfish Immunology 2014;40:414-23. [DOI: 10.1016/j.fsi.2014.07.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
204 Mitsdoerffer M, Kuchroo V, Korn T. Immunology of neuromyelitis optica: a T cell-B cell collaboration. Ann N Y Acad Sci 2013;1283:57-66. [PMID: 23617588 DOI: 10.1111/nyas.12118] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
205 Lin YP, Frye AM, Nowak TA, Kraiczy P. New Insights Into CRASP-Mediated Complement Evasion in the Lyme Disease Enzootic Cycle. Front Cell Infect Microbiol 2020;10:1. [PMID: 32083019 DOI: 10.3389/fcimb.2020.00001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
206 Mu L, Wu H, Han K, Wu L, Bian X, Li B, Guo Z, Yin X, Ye J. Molecular and functional characterization of a mannose-binding lectin/ficolin-associated protein (MAp44) from Nile tilapia (Oreochromis niloticus) involved in the immune response to bacterial infection. Dev Comp Immunol 2019;101:103438. [PMID: 31299190 DOI: 10.1016/j.dci.2019.103438] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
207 Ferluga J, Kouser L, Murugaiah V, Sim RB, Kishore U. Potential influences of complement factor H in autoimmune inflammatory and thrombotic disorders. Mol Immunol 2017;84:84-106. [PMID: 28216098 DOI: 10.1016/j.molimm.2017.01.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
208 Glassock RJ, Bleyer AJ, Bargman JM, Fervenza FC. The 2010 nephrology quiz and questionnaire: part 2. Clin J Am Soc Nephrol 2011;6:2534-47. [PMID: 21903985 DOI: 10.2215/CJN.06500711] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
209 Cho H. Complement regulation: physiology and disease relevance. Korean J Pediatr 2015;58:239-44. [PMID: 26300937 DOI: 10.3345/kjp.2015.58.7.239] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
210 Ahmad FM, A Al-binni M, Bani Hani A, Abu Abeeleh M, Abu-humaidan AH. Complement Terminal Pathway Activation is Associated with Organ Failure in Sepsis Patients. JIR 2022;Volume 15:153-62. [DOI: 10.2147/jir.s344282] [Reference Citation Analysis]
211 Schindler MK, Schütz MS, Mühlenkamp MC, Rooijakkers SH, Hallström T, Zipfel PF, Autenrieth IB. Yersinia enterocolitica YadA mediates complement evasion by recruitment and inactivation of C3 products. J Immunol 2012;189:4900-8. [PMID: 23071281 DOI: 10.4049/jimmunol.1201383] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
212 Phuan PW, Zhang H, Asavapanumas N, Leviten M, Rosenthal A, Tradtrantip L, Verkman AS. C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica. Acta Neuropathol 2013;125:829-40. [PMID: 23677375 DOI: 10.1007/s00401-013-1128-3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
213 Lian H, Litvinchuk A, Chiang AC, Aithmitti N, Jankowsky JL, Zheng H. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease. J Neurosci 2016;36:577-89. [PMID: 26758846 DOI: 10.1523/JNEUROSCI.2117-15.2016] [Cited by in Crossref: 217] [Cited by in F6Publishing: 145] [Article Influence: 36.2] [Reference Citation Analysis]
214 Fervenza FC, Smith RJ, Sethi S. Association of a novel complement factor H mutation with severe crescentic and necrotizing glomerulonephritis. Am J Kidney Dis 2012;60:126-32. [PMID: 22542290 DOI: 10.1053/j.ajkd.2012.03.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
215 Hart T, Yang X, Pal U, Lin YP. Identification of Lyme borreliae proteins promoting vertebrate host blood-specific spirochete survival in Ixodes scapularis nymphs using artificial feeding chambers. Ticks Tick Borne Dis 2018;9:1057-63. [PMID: 29653905 DOI: 10.1016/j.ttbdis.2018.03.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
216 Kourtzelis I, Rafail S. The dual role of complement in cancer and its implication in anti-tumor therapy. Ann Transl Med 2016;4:265. [PMID: 27563652 DOI: 10.21037/atm.2016.06.26] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
217 Yuan X, Chang CY, You R, Shan M, Gu BH, Madison MC, Diehl G, Perusich S, Song LZ, Cornwell L, Rossen RD, Wetsel R, Kimal R, Coarfa C, Eltzschig HK, Corry DB, Kheradmand F. Cigarette smoke-induced reduction of C1q promotes emphysema. JCI Insight 2019;5:124317. [PMID: 31112138 DOI: 10.1172/jci.insight.124317] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
218 Huang Y, Cao W, Shi K, Mi R, Lu K, Han X, Chen Z. Protective efficacy of recombinant Cryptosporidium parvum CpPRP1 sushi domain against C. tyzzeri infection in mice. Parasite Immunol 2017;39. [PMID: 28599077 DOI: 10.1111/pim.12449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
219 Singh B, Su Y, Riesbeck K. Vitronectin in host pathogen interactions and antimicrobial therapeutic applications. Open Life Sciences 2011;6:973-80. [DOI: 10.2478/s11535-011-0077-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
220 Bosco A, Anderson SR, Breen KT, Romero CO, Steele MR, Chiodo VA, Boye SL, Hauswirth WW, Tomlinson S, Vetter ML. Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma. Mol Ther 2018;26:2379-96. [PMID: 30217731 DOI: 10.1016/j.ymthe.2018.08.017] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
221 Zhao W, Ding Y, Lu J, Zhang T, Chen D, Zhang H, Zeng C, Liu Z, Chen H. Genetic analysis of the complement pathway in C3 glomerulopathy. Nephrol Dial Transplant 2018;33:1919-27. [PMID: 29566171 DOI: 10.1093/ndt/gfy033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
222 Hofer J, Forster F, Isenman DE, Wahrmann M, Leitner J, Hölzl MA, Kovarik JJ, Stockinger H, Böhmig GA, Steinberger P, Zlabinger GJ. Ig-like transcript 4 as a cellular receptor for soluble complement fragment C4d. FASEB J 2016;30:1492-503. [PMID: 26678451 DOI: 10.1096/fj.15-275594] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
223 Guillonneau X, Eandi CM, Paques M, Sahel J, Sapieha P, Sennlaub F. On phagocytes and macular degeneration. Progress in Retinal and Eye Research 2017;61:98-128. [DOI: 10.1016/j.preteyeres.2017.06.002] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 14.0] [Reference Citation Analysis]
224 Sethi S, Fervenza FC, Zhang Y, Smith RJ. Secondary focal and segmental glomerulosclerosis associated with single-nucleotide polymorphisms in the genes encoding complement factor H and C3. Am J Kidney Dis 2012;60:316-21. [PMID: 22594991 DOI: 10.1053/j.ajkd.2012.04.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
225 Feng Y, Wang Y, Li L, Wu L, Hoffmann S, Gretz N, Hammes HP. Gene expression profiling of vasoregression in the retina--involvement of microglial cells. PLoS One 2011;6:e16865. [PMID: 21379381 DOI: 10.1371/journal.pone.0016865] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
226 Cipriani V, Matharu BK, Khan JC, Shahid H, Stanton CM, Hayward C, Wright AF, Bunce C, Clayton DG, Moore AT, Yates JR. Genetic variation in complement regulators and susceptibility to age-related macular degeneration. Immunobiology 2012;217:158-61. [PMID: 22024702 DOI: 10.1016/j.imbio.2011.09.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
227 Weiss S, Rosendahl A, Czesla D, Meyer-Schwesinger C, Stahl RA, Ehmke H, Kurts C, Zipfel PF, Köhl J, Wenzel UO. The complement receptor C5aR1 contributes to renal damage but protects the heart in angiotensin II-induced hypertension. Am J Physiol Renal Physiol 2016;310:F1356-65. [PMID: 27053686 DOI: 10.1152/ajprenal.00040.2016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
228 Ricciuti B, Lamberti G, Andrini E, Genova C, De Giglio A, Bianconi V, Sahebkar A, Chiari R, Pirro M. Antibody-drug conjugates for lung cancer in the era of personalized oncology. Semin Cancer Biol 2021;69:268-78. [PMID: 31899248 DOI: 10.1016/j.semcancer.2019.12.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
229 Laskowski J, Renner B, Pickering MC, Serkova NJ, Smith-Jones PM, Clambey ET, Nemenoff RA, Thurman JM. Complement factor H-deficient mice develop spontaneous hepatic tumors. J Clin Invest 2020;130:4039-54. [PMID: 32369457 DOI: 10.1172/JCI135105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
230 Rojana-udomsart A, Mitrpant C, Bundell C, Price L, Luo YB, Fabian V, Wilton SD, Hollingsworth P, Mastaglia FL. Complement-mediated muscle cell lysis: a possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM). J Neuroimmunol 2013;264:65-70. [PMID: 24041831 DOI: 10.1016/j.jneuroim.2013.08.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
231 Nilojan J, Bathige S, Thulasitha W, Kwon H, Jung S, Kim M, Nam B, Lee J. Transcriptional profiling, molecular cloning, and functional analysis of C1 inhibitor, the main regulator of the complement system in black rockfish, Sebastes schlegelii. Fish & Shellfish Immunology 2018;75:263-73. [DOI: 10.1016/j.fsi.2018.02.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
232 Skjoedt MO, Roversi P, Hummelshøj T, Palarasah Y, Rosbjerg A, Johnson S, Lea SM, Garred P. Crystal structure and functional characterization of the complement regulator mannose-binding lectin (MBL)/ficolin-associated protein-1 (MAP-1). J Biol Chem 2012;287:32913-21. [PMID: 22854970 DOI: 10.1074/jbc.M112.386680] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
233 Luo S, Hartmann A, Dahse H, Skerka C, Zipfel PF. Secreted pH-Regulated Antigen 1 of Candida albicans Blocks Activation and Conversion of Complement C3. J I 2010;185:2164-73. [DOI: 10.4049/jimmunol.1001011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
234 Melgaço JG, Veloso CE, Pacheco-Moreira LF, Vitral CL, Pinto MA. Complement System as a Target for Therapies to Control Liver Regeneration/Damage in Acute Liver Failure Induced by Viral Hepatitis. J Immunol Res 2018;2018:3917032. [PMID: 30402508 DOI: 10.1155/2018/3917032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
235 Freeley S, Kemper C, Le Friec G. The "ins and outs" of complement-driven immune responses. Immunol Rev 2016;274:16-32. [PMID: 27782335 DOI: 10.1111/imr.12472] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 13.2] [Reference Citation Analysis]
236 Tang Y, Li H, Li J, Liu Y, Li Y, Zhou J, Zhou J, Lu X, Zhao W, Hou J, Wang XY, Chen Z, Zuo D. Macrophage scavenger receptor 1 contributes to pathogenesis of fulminant hepatitis via neutrophil-mediated complement activation. J Hepatol 2018;68:733-43. [PMID: 29154963 DOI: 10.1016/j.jhep.2017.11.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
237 Atkinson JP, Du Clos TW, Mold C, Kulkarni H, Hourcade D, Wu X. The Human Complement System. Clinical Immunology. Elsevier; 2019. pp. 299-317.e1. [DOI: 10.1016/b978-0-7020-6896-6.00021-1] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
238 Kjældgaard AL, Pilely K, Olsen KS, Pedersen SW, Lauritsen AØ, Møller K, Garred P. Amyotrophic lateral sclerosis: The complement and inflammatory hypothesis. Mol Immunol 2018;102:14-25. [PMID: 29933890 DOI: 10.1016/j.molimm.2018.06.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
239 Asavapanumas N, Tradtrantip L, Verkman AS. Targeting the complement system in neuromyelitis optica spectrum disorder. Expert Opin Biol Ther 2021;21:1073-86. [PMID: 33513036 DOI: 10.1080/14712598.2021.1884223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Heimbach L, Li Z, Berkowitz P, Zhao M, Li N, Rubenstein DS, Diaz LA, Liu Z. The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid. J Biol Chem 2011;286:15003-9. [PMID: 21393236 DOI: 10.1074/jbc.M111.221036] [Cited by in Crossref: 48] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
241 Middleton O, Wheadon H, Michie AM. Classical Complement Pathway. Encyclopedia of Immunobiology. Elsevier; 2016. pp. 318-24. [DOI: 10.1016/b978-0-12-374279-7.02014-2] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
242 Tam JC, Bidgood SR, McEwan WA, James LC. Intracellular sensing of complement C3 activates cell autonomous immunity. Science 2014;345:1256070. [PMID: 25190799 DOI: 10.1126/science.1256070] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 11.0] [Reference Citation Analysis]
243 Gropp K, Schild L, Schindler S, Hube B, Zipfel PF, Skerka C. The yeast Candida albicans evades human complement attack by secretion of aspartic proteases. Mol Immunol 2009;47:465-75. [PMID: 19880183 DOI: 10.1016/j.molimm.2009.08.019] [Cited by in Crossref: 94] [Cited by in F6Publishing: 86] [Article Influence: 7.2] [Reference Citation Analysis]
244 Brodszki N, Frazer-Abel A, Grumach AS, Kirschfink M, Litzman J, Perez E, Seppänen MRJ, Sullivan KE, Jolles S. European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management. J Clin Immunol 2020;40:576-91. [PMID: 32064578 DOI: 10.1007/s10875-020-00754-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
245 Lucidarme J, Tan L, Exley RM, Findlow J, Borrow R, Tang CM. Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein. Clin Vaccine Immunol 2011;18:1002-14. [PMID: 21508163 DOI: 10.1128/CVI.00055-11] [Cited by in Crossref: 69] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
246 Hart TM, Dupuis AP 2nd, Tufts DM, Blom AM, Starkey SR, Rego ROM, Ram S, Kraiczy P, Kramer LD, Diuk-Wasser MA, Kolokotronis SO, Lin YP. Host tropism determination by convergent evolution of immunological evasion in the Lyme disease system. PLoS Pathog 2021;17:e1009801. [PMID: 34324600 DOI: 10.1371/journal.ppat.1009801] [Reference Citation Analysis]
247 Ruan CC, Gao PJ. Role of Complement-Related Inflammation and Vascular Dysfunction in Hypertension. Hypertension 2019;73:965-71. [PMID: 30929519 DOI: 10.1161/HYPERTENSIONAHA.118.11210] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
248 Grafals M, Thurman JM. The Role of Complement in Organ Transplantation. Front Immunol 2019;10:2380. [PMID: 31636644 DOI: 10.3389/fimmu.2019.02380] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
249 Prechl J. A generalized quantitative antibody homeostasis model: maintenance of global antibody equilibrium by effector functions. Clin Transl Immunology 2017;6:e161. [PMID: 29201362 DOI: 10.1038/cti.2017.50] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
250 Scambi C, Ugolini S, Tonello M, Bortolami O, De Franceschi L, Castagna A, Lotti V, Corbella M, Raffaelli R, Caramaschi P, Mattia E, Biasi D, Ruffatti A. Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome. Am J Reprod Immunol 2019;82. [DOI: 10.1111/aji.13185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
251 Barnum SR. Complement: A primer for the coming therapeutic revolution. Pharmacol Ther 2017;172:63-72. [PMID: 27914981 DOI: 10.1016/j.pharmthera.2016.11.014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
252 Shaw PX, Stiles T, Douglas C, Ho D, Fan W, Du H, Xiao X. Oxidative stress, innate immunity, and age-related macular degeneration. AIMS Mol Sci 2016;3:196-221. [PMID: 27239555 DOI: 10.3934/molsci.2016.2.196] [Cited by in Crossref: 80] [Cited by in F6Publishing: 84] [Article Influence: 13.3] [Reference Citation Analysis]
253 Thurman JM, Panzer SE, Le Quintrec M. The role of complement in antibody mediated transplant rejection. Mol Immunol 2019;112:240-6. [PMID: 31195225 DOI: 10.1016/j.molimm.2019.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
254 Kusner LL, Halperin JA, Kaminski HJ. Cell surface complement regulators moderate experimental myasthenia gravis pathology. Muscle Nerve 2013;47:33-40. [PMID: 23042232 DOI: 10.1002/mus.23448] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
255 Mulay SR, Linkermann A, Anders HJ. Necroinflammation in Kidney Disease. J Am Soc Nephrol 2016;27:27-39. [PMID: 26334031 DOI: 10.1681/ASN.2015040405] [Cited by in Crossref: 115] [Cited by in F6Publishing: 59] [Article Influence: 16.4] [Reference Citation Analysis]
256 Rentka A, Harsfalvi J, Szucs G, Szekanecz Z, Szodoray P, Koroskenyi K, Kemeny-Beke A. Membrane array and multiplex bead analysis of tear cytokines in systemic sclerosis. Immunol Res 2016;64:619-26. [PMID: 26687127 DOI: 10.1007/s12026-015-8763-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
257 Danobeitia JS, Djamali A, Fernandez LA. The role of complement in the pathogenesis of renal ischemia-reperfusion injury and fibrosis. Fibrogenesis Tissue Repair 2014;7:16. [PMID: 25383094 DOI: 10.1186/1755-1536-7-16] [Cited by in Crossref: 57] [Cited by in F6Publishing: 1] [Article Influence: 7.1] [Reference Citation Analysis]
258 Rowley JA, Reid RC, Poon EKY, Wu KC, Lim J, Lohman RJ, Hamidon JK, Yau MK, Halili MA, Durek T, Iyer A, Fairlie DP. Potent Thiophene Antagonists of Human Complement C3a Receptor with Anti-Inflammatory Activity. J Med Chem 2020;63:529-41. [PMID: 31910011 DOI: 10.1021/acs.jmedchem.9b00927] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
259 Arcavi M, Ceballo F, Caracciolo MB, Lazarowski A. Paroxysmal nocturnal hemoglobinuria: Test to monitor the action of eculizumab treatment. Int J Lab Hematol 2020;42:335-40. [PMID: 32202389 DOI: 10.1111/ijlh.13186] [Reference Citation Analysis]
260 Morad HO, Belete SC, Read T, Shaw AM. Time-course analysis of C3a and C5a quantifies the coupling between the upper and terminal Complement pathways in vitro. J Immunol Methods 2015;427:13-8. [PMID: 26391915 DOI: 10.1016/j.jim.2015.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
261 Weiner LM, Surana R, Wang S. Monoclonal antibodies: versatile platforms for cancer immunotherapy. Nat Rev Immunol. 2010;10:317-327. [PMID: 20414205 DOI: 10.1038/nri2744] [Cited by in Crossref: 773] [Cited by in F6Publishing: 904] [Article Influence: 64.4] [Reference Citation Analysis]
262 El-Assaad AM, Kieslich CA, Gorham RD Jr, Morikis D. Electrostatic exploration of the C3d-FH4 interaction using a computational alanine scan. Mol Immunol 2011;48:1844-50. [PMID: 21683447 DOI: 10.1016/j.molimm.2011.05.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
263 Lynch AM, Salmon JE. Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications. Placenta 2010;31:561-7. [PMID: 20427084 DOI: 10.1016/j.placenta.2010.03.010] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 6.0] [Reference Citation Analysis]
264 Irmscher S, Brix SR, Zipfel SLH, Halder LD, Mutlutürk S, Wulf S, Girdauskas E, Reichenspurner H, Stahl RAK, Jungnickel B, Wiech T, Zipfel PF, Skerka C. Serum FHR1 binding to necrotic-type cells activates monocytic inflammasome and marks necrotic sites in vasculopathies. Nat Commun 2019;10:2961. [PMID: 31273197 DOI: 10.1038/s41467-019-10766-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
265 Garcia BL, Ramyar KX, Ricklin D, Lambris JD, Geisbrecht BV. Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteins. Adv Exp Med Biol 2012;946:113-33. [PMID: 21948365 DOI: 10.1007/978-1-4614-0106-3_7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
266 Woodburn SC, Bollinger JL, Wohleb ES. The semantics of microglia activation: neuroinflammation, homeostasis, and stress. J Neuroinflammation 2021;18:258. [PMID: 34742308 DOI: 10.1186/s12974-021-02309-6] [Reference Citation Analysis]
267 Whitmore SS, Sohn EH, Chirco KR, Drack AV, Stone EM, Tucker BA, Mullins RF. Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy. Prog Retin Eye Res 2015;45:1-29. [PMID: 25486088 DOI: 10.1016/j.preteyeres.2014.11.005] [Cited by in Crossref: 95] [Cited by in F6Publishing: 100] [Article Influence: 11.9] [Reference Citation Analysis]
268 Meyers KE, Liapis H, Atta MG. American Society of Nephrology clinical pathological conference. Clin J Am Soc Nephrol 2014;9:818-28. [PMID: 24651072 DOI: 10.2215/CJN.12481213] [Reference Citation Analysis]
269 Riihilä P, Nissinen L, Farshchian M, Kivisaari A, Ala-Aho R, Kallajoki M, Grénman R, Meri S, Peltonen S, Peltonen J, Kähäri VM. Complement factor I promotes progression of cutaneous squamous cell carcinoma. J Invest Dermatol 2015;135:579-88. [PMID: 25184960 DOI: 10.1038/jid.2014.376] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
270 McCullough JW, Renner B, Thurman JM. The role of the complement system in acute kidney injury. Semin Nephrol 2013;33:543-56. [PMID: 24161039 DOI: 10.1016/j.semnephrol.2013.08.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
271 Buhlmann D, Eberhardt HU, Medyukhina A, Prodinger WM, Figge MT, Zipfel PF, Skerka C. FHR3 Blocks C3d-Mediated Coactivation of Human B Cells. J Immunol 2016;197:620-9. [PMID: 27279373 DOI: 10.4049/jimmunol.1600053] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
272 Luan NM, Teramura Y, Iwata H. Immobilization of soluble complement receptor 1 on islets. Biomaterials 2011;32:4539-45. [DOI: 10.1016/j.biomaterials.2011.03.017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
273 Luque A, Serrano I, Aran JM. Complement components as promoters of immunological tolerance in dendritic cells. Semin Cell Dev Biol 2019;85:143-52. [PMID: 29155220 DOI: 10.1016/j.semcdb.2017.11.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
274 Mu L, Yin X, Wu H, Han K, Guo Z, Ye J. MAp34 Regulates the Non-specific Cell Immunity of Monocytes/Macrophages and Inhibits the Lectin Pathway of Complement Activation in a Teleost Fish. Front Immunol 2020;11:1706. [PMID: 32903484 DOI: 10.3389/fimmu.2020.01706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
275 Perkins SJ, Nan R, Li K, Khan S, Miller A. Complement factor H-ligand interactions: self-association, multivalency and dissociation constants. Immunobiology 2012;217:281-97. [PMID: 22137027 DOI: 10.1016/j.imbio.2011.10.003] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 4.9] [Reference Citation Analysis]
276 Li PY, Bearoff F, Zhu P, Fan Z, Zhu Y, Fan M, Cort L, Kambayashi T, Blankenhorn EP, Cheng H. PEGylation enables subcutaneously administered nanoparticles to induce antigen-specific immune tolerance. J Control Release 2021;331:164-75. [PMID: 33450320 DOI: 10.1016/j.jconrel.2021.01.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
277 Lubbers R, van Essen MF, van Kooten C, Trouw LA. Production of complement components by cells of the immune system. Clin Exp Immunol 2017;188:183-94. [PMID: 28249350 DOI: 10.1111/cei.12952] [Cited by in Crossref: 174] [Cited by in F6Publishing: 167] [Article Influence: 34.8] [Reference Citation Analysis]
278 Shuptrine CW, Surana R, Weiner LM. Monoclonal antibodies for the treatment of cancer. Semin Cancer Biol 2012;22:3-13. [PMID: 22245472 DOI: 10.1016/j.semcancer.2011.12.009] [Cited by in Crossref: 99] [Cited by in F6Publishing: 92] [Article Influence: 9.9] [Reference Citation Analysis]
279 Holt BA, Bellavia MC, Potter D, White D, Stowell SR, Sulchek T. Fc microparticles can modulate the physical extent and magnitude of complement activity. Biomater Sci 2017;5:463-74. [PMID: 28067347 DOI: 10.1039/c6bm00608f] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
280 Asimakopoulos JV, Terpos E, Papageorgiou L, Kampouropoulou O, Christoulas D, Giakoumis A, Samarkos M, Vaiopoulos G, Konstantopoulos K, Angelopoulou MK, Vassilakopoulos TP, Meletis J. The presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone-marrow derived phenomenon. Med Sci Monit 2014;20:123-39. [PMID: 24463881 DOI: 10.12659/MSM.889727] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
281 Marcinkiewicz AL, Lieknina I, Kotelovica S, Yang X, Kraiczy P, Pal U, Lin YP, Tars K. Eliminating Factor H-Binding Activity of Borrelia burgdorferi CspZ Combined with Virus-Like Particle Conjugation Enhances Its Efficacy as a Lyme Disease Vaccine. Front Immunol 2018;9:181. [PMID: 29472926 DOI: 10.3389/fimmu.2018.00181] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
282 Thurman JM, Nester CM. All Things Complement. Clin J Am Soc Nephrol 2016;11:1856-66. [PMID: 27340286 DOI: 10.2215/CJN.01710216] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 7.2] [Reference Citation Analysis]
283 Abu-Humaidan AH, Ananthoju N, Mohanty T, Sonesson A, Alberius P, Schmidtchen A, Garred P, Sørensen OE. The epidermal growth factor receptor is a regulator of epidermal complement component expression and complement activation. J Immunol 2014;192:3355-64. [PMID: 24591374 DOI: 10.4049/jimmunol.1302305] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
284 Boisson B, Quartier P, Casanova JL. Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind. Curr Opin Immunol 2015;32:90-105. [PMID: 25645939 DOI: 10.1016/j.coi.2015.01.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 7.1] [Reference Citation Analysis]
285 Thielen AJF, Zeerleder S, Wouters D. Consequences of dysregulated complement regulators on red blood cells. Blood Rev 2018;32:280-8. [PMID: 29397262 DOI: 10.1016/j.blre.2018.01.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
286 Toomey CB, Johnson LV, Bowes Rickman C. Complement factor H in AMD: Bridging genetic associations and pathobiology. Prog Retin Eye Res 2018;62:38-57. [PMID: 28928087 DOI: 10.1016/j.preteyeres.2017.09.001] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 11.0] [Reference Citation Analysis]
287 Pilosof S, Korine C, Moore MS, Krasnov BR. Effects of sewage-water contamination on the immune response of a desert bat. Mammalian Biology 2014;79:183-8. [DOI: 10.1016/j.mambio.2013.10.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
288 Koustasa Mishra PK, Rajan P, Joshi P. Complement C9 binding site and the anti-microbial activity of caprine vitronectin are localized in close proximity in the N-terminal region of the protein. Microb Pathog 2020;149:104111. [PMID: 32135222 DOI: 10.1016/j.micpath.2020.104111] [Reference Citation Analysis]
289 Garcia BL, Summers BJ, Ramyar KX, Tzekou A, Lin Z, Ricklin D, Lambris JD, Laity JH, Geisbrecht BV. A structurally dynamic N-terminal helix is a key functional determinant in staphylococcal complement inhibitor (SCIN) proteins. J Biol Chem 2013;288:2870-81. [PMID: 23233676 DOI: 10.1074/jbc.M112.426858] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
290 Lynch AM, Wagner BD, Giclas PC, West NA, Gibbs RS, Holers VM. The Relationship of Longitudinal Levels of Complement Bb During Pregnancy with Preeclampsia. Am J Reprod Immunol 2016;75:104-11. [PMID: 26510395 DOI: 10.1111/aji.12439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
291 Mihlan M, Stippa S, Józsi M, Zipfel PF. Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H. Cell Death Differ 2009;16:1630-40. [PMID: 19680263 DOI: 10.1038/cdd.2009.103] [Cited by in Crossref: 95] [Cited by in F6Publishing: 96] [Article Influence: 7.3] [Reference Citation Analysis]
292 O'Bier NS, Patel DT, Oliver LD Jr, Miller DP, Marconi RT. Development of an FhbB based chimeric vaccinogen that elicits antibodies that block Factor H binding and cleavage by the periopathogen Treponema denticola. Mol Oral Microbiol 2021;36:50-7. [PMID: 33219611 DOI: 10.1111/omi.12325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
293 Jiménez-Reinoso A, Marin AV, Regueiro JR. Complement in basic processes of the cell. Mol Immunol 2017;84:10-6. [PMID: 27919436 DOI: 10.1016/j.molimm.2016.11.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
294 Alic L, Papac-Milicevic N, Czamara D, Rudnick RB, Ozsvar-Kozma M, Hartmann A, Gurbisz M, Hoermann G, Haslinger-Hutter S, Zipfel PF, Skerka C, Binder EB, Binder CJ. A genome-wide association study identifies key modulators of complement factor H binding to malondialdehyde-epitopes. Proc Natl Acad Sci U S A 2020;117:9942-51. [PMID: 32321835 DOI: 10.1073/pnas.1913970117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
295 Anand D, Kumar U, Kanjilal M, Kaur S, Das N. Leucocyte complement receptor 1 (CR1/CD35) transcript and its correlation with the clinical disease activity in rheumatoid arthritis patients. Clin Exp Immunol 2014;176:327-35. [PMID: 24433281 DOI: 10.1111/cei.12274] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
296 Suresh R, Chandrasekaran P, Sutterwala FS, Mosser DM. Complement-mediated 'bystander' damage initiates host NLRP3 inflammasome activation. J Cell Sci 2016;129:1928-39. [PMID: 27006116 DOI: 10.1242/jcs.179291] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
297 Yang J, Snijders MLH, Haasnoot GW, van Kooten C, Mallat M, de Fijter JW, Clahsen-van Groningen MC, Claas FHJ, Eikmans M. Elevated intragraft expression of innate immunity and cell death-related markers is a risk factor for adverse graft outcome. Transpl Immunol 2018;48:39-46. [PMID: 29475090 DOI: 10.1016/j.trim.2018.02.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
298 Laranjeira S, Symmonds M, Palace J, Payne SJ, Orlowski P. A mathematical model of cellular swelling in Neuromyelitis optica. J Theor Biol 2017;433:39-48. [PMID: 28843390 DOI: 10.1016/j.jtbi.2017.08.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
299 Haleem KS, Ali YM, Yesilkaya H, Kohler T, Hammerschmidt S, Andrew PW, Schwaeble WJ, Lynch NJ. The Pneumococcal Surface Proteins PspA and PspC Sequester Host C4-Binding Protein To Inactivate Complement C4b on the Bacterial Surface. Infect Immun 2019;87:e00742-18. [PMID: 30323030 DOI: 10.1128/IAI.00742-18] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
300 Makou E, Bailey RG, Johnston H, Parkin JD, Hulme AN, Hähner G, Barlow PN. Combining SPR with atomic-force microscopy enables single-molecule insights into activation and suppression of the complement cascade. J Biol Chem 2019;294:20148-63. [PMID: 31719147 DOI: 10.1074/jbc.RA119.010913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
301 Alexander JJ, Chaves L, Chang A, Quigg RJ. The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice. Kidney Int 2012;82:961-8. [PMID: 22832515 DOI: 10.1038/ki.2012.249] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
302 Alawieh A, Tomlinson S. Injury site-specific targeting of complement inhibitors for treating stroke. Immunol Rev 2016;274:270-80. [PMID: 27782326 DOI: 10.1111/imr.12470] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
303 Lo MW, Woodruff TM. Complement: Bridging the innate and adaptive immune systems in sterile inflammation. J Leukoc Biol 2020;108:339-51. [PMID: 32182389 DOI: 10.1002/JLB.3MIR0220-270R] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
304 Rahmati Nezhad P, Riihilä P, Piipponen M, Kallajoki M, Meri S, Nissinen L, Kähäri VM. Complement factor I upregulates expression of matrix metalloproteinase-13 and -2 and promotes invasion of cutaneous squamous carcinoma cells. Exp Dermatol 2021. [PMID: 33813765 DOI: 10.1111/exd.14349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
305 Lopez CM, Wallich R, Riesbeck K, Skerka C, Zipfel PF. Candida albicans uses the surface protein Gpm1 to attach to human endothelial cells and to keratinocytes via the adhesive protein vitronectin. PLoS One 2014;9:e90796. [PMID: 24625558 DOI: 10.1371/journal.pone.0090796] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
306 Loveless S, Neal JW, Howell OW, Harding KE, Sarkies P, Evans R, Bevan RJ, Hakobyan S, Harris CL, Robertson NP, Morgan BP. Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis. Brain Pathol 2018;28:507-20. [PMID: 28707765 DOI: 10.1111/bpa.12546] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
307 Schwab J, Hammerschmidt C, Richter D, Skerka C, Matuschka FR, Wallich R, Zipfel PF, Kraiczy P. Borrelia valaisiana resist complement-mediated killing independently of the recruitment of immune regulators and inactivation of complement components. PLoS One 2013;8:e53659. [PMID: 23320099 DOI: 10.1371/journal.pone.0053659] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
308 Top O, Parsons J, Bohlender LL, Michelfelder S, Kopp P, Busch-Steenberg C, Hoernstein SNW, Zipfel PF, Häffner K, Reski R, Decker EL. Recombinant Production of MFHR1, A Novel Synthetic Multitarget Complement Inhibitor, in Moss Bioreactors. Front Plant Sci 2019;10:260. [PMID: 30949184 DOI: 10.3389/fpls.2019.00260] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
309 Zhang X, Hou HT, Wang J, Liu XC, Yang Q, He GW. Plasma Proteomic Study in Pulmonary Arterial Hypertension Associated with Congenital Heart Diseases. Sci Rep 2016;6:36541. [PMID: 27886187 DOI: 10.1038/srep36541] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
310 Marcos CM, de Oliveira HC, de Melo WC, da Silva JF, Assato PA, Scorzoni L, Rossi SA, de Paula E Silva AC, Mendes-Giannini MJ, Fusco-Almeida AM. Anti-Immune Strategies of Pathogenic Fungi. Front Cell Infect Microbiol 2016;6:142. [PMID: 27896220 DOI: 10.3389/fcimb.2016.00142] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
311 Rudnick RB, Chen Q, Stea ED, Hartmann A, Papac-Milicevic N, Person F, Wiesener M, Binder CJ, Wiech T, Skerka C, Zipfel PF. FHR5 Binds to Laminins, Uses Separate C3b and Surface-Binding Sites, and Activates Complement on Malondialdehyde-Acetaldehyde Surfaces. J Immunol 2018;200:2280-90. [PMID: 29483359 DOI: 10.4049/jimmunol.1701641] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
312 Prasada RT, Lakshmi PT, Parvathy R, Murugavel S, Karuna D, Paritosh J. Identification of second arginine-glycine-aspartic acid motif of ovine vitronectin as the complement C9 binding site and its implication in bacterial infection: Second RGD motif of vitronectin binds C9. Microbiol Immunol 2017;61:75-84. [DOI: 10.1111/1348-0421.12468] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
313 Engberg AE, Nilsson PH, Huang S, Fromell K, Hamad OA, Mollnes TE, Rosengren-holmberg JP, Sandholm K, Teramura Y, Nicholls IA, Nilsson B, Ekdahl KN. Prediction of inflammatory responses induced by biomaterials in contact with human blood using protein fingerprint from plasma. Biomaterials 2015;36:55-65. [DOI: 10.1016/j.biomaterials.2014.09.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
314 Błogowski W, Dołęgowska B, Sałata D, Budkowska M, Domański L, Starzyńska T. Clinical analysis of perioperative complement activity during ischemia/reperfusion injury following renal transplantation. Clin J Am Soc Nephrol 2012;7:1843-51. [PMID: 22904122 DOI: 10.2215/CJN.02200312] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
315 Stoermer KA, Morrison TE. Complement and viral pathogenesis. Virology. 2011;411:362-373. [PMID: 21292294 DOI: 10.1016/j.virol.2010.12.045] [Cited by in Crossref: 162] [Cited by in F6Publishing: 145] [Article Influence: 14.7] [Reference Citation Analysis]
316 Wagner EK, Raychaudhuri S, Villalonga MB, Java A, Triebwasser MP, Daly MJ, Atkinson JP, Seddon JM. Mapping rare, deleterious mutations in Factor H: Association with early onset, drusen burden, and lower antigenic levels in familial AMD. Sci Rep 2016;6:31531. [PMID: 27572114 DOI: 10.1038/srep31531] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
317 Maugeri A, Barchitta M, Mazzone MG, Giuliano F, Agodi A. Complement System and Age-Related Macular Degeneration: Implications of Gene-Environment Interaction for Preventive and Personalized Medicine. Biomed Res Int 2018;2018:7532507. [PMID: 30225264 DOI: 10.1155/2018/7532507] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
318 Bettoni S, Bresin E, Remuzzi G, Noris M, Donadelli R. Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase. J Biol Chem. 2016;291:8214-8230. [PMID: 26903516 DOI: 10.1074/jbc.m115.693119] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
319 da Silva GP, Fernandes DC, Vigliano MV, da Fonseca EN, Santos SVM, Marques PR, Justo MDG, Sabino KCDC, Coelho MGP. Flavonoid-enriched fraction from Echinodorus macrophyllus aqueous extract exhibits high in-vitro and in-vivo anti-inflammatory activity. Journal of Pharmacy and Pharmacology 2016;68:1584-96. [DOI: 10.1111/jphp.12620] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
320 Pedersen H, Jensen RK, Jensen JMB, Fox R, Pedersen DV, Olesen HG, Hansen AG, Christiansen D, Mazarakis SMM, Lojek N, Hansen P, Gadeberg TAF, Zarantonello A, Laursen NS, Mollnes TE, Johnson MB, Stevens B, Thiel S, Andersen GR. A Complement C3-Specific Nanobody for Modulation of the Alternative Cascade Identifies the C-Terminal Domain of C3b as Functional in C5 Convertase Activity. J Immunol 2020;205:2287-300. [PMID: 32938727 DOI: 10.4049/jimmunol.2000752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
321 Liszewski MK, Atkinson JP. Too Much of a Good Thing at the Site of Tissue Injury: The Instructive Example of the Complement System Predisposing to Thrombotic Microangiopathy. Hematology 2011;2011:9-14. [DOI: 10.1182/asheducation-2011.1.9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
322 Sethi S, Nester CM, Smith RJ. Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. Kidney Int. 2012;81:434-441. [PMID: 22157657 DOI: 10.1038/ki.2011.399] [Cited by in Crossref: 142] [Cited by in F6Publishing: 110] [Article Influence: 12.9] [Reference Citation Analysis]
323 Zhang Y, Xu B, Kinoshita N, Yoshida Y, Tasaki M, Fujinaka H, Magdeldin S, Yaoita E, Yamamoto T. Label-free quantitative proteomic analysis reveals strong involvement of complement alternative and terminal pathways in human glomerular sclerotic lesions. Journal of Proteomics 2015;123:89-100. [DOI: 10.1016/j.jprot.2015.03.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
324 Schramm EC, Staten NR, Zhang Z, Bruce SS, Kellner C, Atkinson JP, Kyttaris VC, Tsokos GC, Petri M, Sander Connolly E, Olson PK. A quantitative lateral flow assay to detect complement activation in blood. Anal Biochem 2015;477:78-85. [PMID: 25660530 DOI: 10.1016/j.ab.2015.01.024] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
325 Binder CJ, Papac-Milicevic N, Witztum JL. Innate sensing of oxidation-specific epitopes in health and disease. Nat Rev Immunol 2016;16:485-97. [PMID: 27346802 DOI: 10.1038/nri.2016.63] [Cited by in Crossref: 155] [Cited by in F6Publishing: 142] [Article Influence: 25.8] [Reference Citation Analysis]
326 Lindblom RP, Ström M, Heinig M, Al Nimer F, Aeinehband S, Berg A, Dominguez CA, Vijayaraghavan S, Zhang XM, Harnesk K, Zelano J, Hübner N, Cullheim S, Darreh-Shori T, Diez M, Piehl F. Unbiased expression mapping identifies a link between the complement and cholinergic systems in the rat central nervous system. J Immunol 2014;192:1138-53. [PMID: 24353269 DOI: 10.4049/jimmunol.1301233] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
327 Kim H, Meyer K, Di Bisceglie AM, Ray R. Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components. PLoS One 2014;9:e101422. [PMID: 24983375 DOI: 10.1371/journal.pone.0101422] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
328 Geller A, Yan J. The Role of Membrane Bound Complement Regulatory Proteins in Tumor Development and Cancer Immunotherapy. Front Immunol 2019;10:1074. [PMID: 31164885 DOI: 10.3389/fimmu.2019.01074] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 10.3] [Reference Citation Analysis]
329 Phieler J, Garcia-Martin R, Lambris JD, Chavakis T. The role of the complement system in metabolic organs and metabolic diseases. Semin Immunol. 2013;25:47-53. [PMID: 23684628 DOI: 10.1016/j.smim.2013.04.003] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 9.1] [Reference Citation Analysis]
330 Garlatti V, Chouquet A, Lunardi T, Vivès R, Païdassi H, Lortat-Jacob H, Thielens NM, Arlaud GJ, Gaboriaud C. Cutting edge: C1q binds deoxyribose and heparan sulfate through neighboring sites of its recognition domain. J Immunol 2010;185:808-12. [PMID: 20548024 DOI: 10.4049/jimmunol.1000184] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
331 Rangaswamy US, Cotter CR, Cheng X, Jin H, Chen Z. CD55 is a key complement regulatory protein that counteracts complement-mediated inactivation of Newcastle Disease Virus. J Gen Virol 2016;97:1765-70. [PMID: 27153814 DOI: 10.1099/jgv.0.000498] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
332 Thomsen T, Schlosser A, Holmskov U, Sorensen GL. Ficolins and FIBCD1: soluble and membrane bound pattern recognition molecules with acetyl group selectivity. Mol Immunol 2011;48:369-81. [PMID: 21071088 DOI: 10.1016/j.molimm.2010.09.019] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
333 Pyaram K, Yadav VN, Reza MJ, Sahu A. Virus–complement interactions: an assiduous struggle for dominance. Future Virology 2010;5:709-30. [DOI: 10.2217/fvl.10.60] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
334 Laskowski J, Renner B, Le Quintrec M, Panzer S, Hannan JP, Ljubanovic D, Ruseva MM, Borza DB, Antonioli AH, Pickering MC. Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury. Kidney Int. 2016;90:109-122. [PMID: 27165610 DOI: 10.1016/j.kint.2016.02.036] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
335 Zhang HP, Wu Y, Liu J, Jiang J, Geng XR, Yang G, Mo L, Liu ZQ, Liu ZG, Yang PC. TSP1-producing B cells show immune regulatory property and suppress allergy-related mucosal inflammation. Sci Rep 2013;3:3345. [PMID: 24736213 DOI: 10.1038/srep03345] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
336 Pan WW, Lin F, Fort PE. The innate immune system in diabetic retinopathy. Prog Retin Eye Res 2021;:100940. [PMID: 33429059 DOI: 10.1016/j.preteyeres.2021.100940] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
337 Alzhanova D, Früh K. Modulation of the host immune response by cowpox virus. Microbes Infect 2010;12:900-9. [PMID: 20673807 DOI: 10.1016/j.micinf.2010.07.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
338 Kalchishkova N, Fürst CM, Heinegård D, Blom AM. NC4 Domain of cartilage-specific collagen IX inhibits complement directly due to attenuation of membrane attack formation and indirectly through binding and enhancing activity of complement inhibitors C4B-binding protein and factor H. J Biol Chem 2011;286:27915-26. [PMID: 21659506 DOI: 10.1074/jbc.M111.242834] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
339 Carnero Contentti E, Correale J. Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies. J Neuroinflammation 2021;18:208. [PMID: 34530847 DOI: 10.1186/s12974-021-02249-1] [Reference Citation Analysis]
340 Vacchelli E, Pol J, Bloy N, Eggermont A, Cremer I, Fridman WH, Galon J, Marabelle A, Kohrt H, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. Oncoimmunology 2015;4:e985940. [PMID: 25949870 DOI: 10.4161/2162402X.2014.985940] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
341 Zaferani A, Talsma D, Richter MK, Daha MR, Navis GJ, Seelen MA, van den Born J. Heparin/heparan sulphate interactions with complement--a possible target for reduction of renal function loss? Nephrol Dial Transplant. 2014;29:515-522. [PMID: 23880790 DOI: 10.1093/ndt/gft243] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
342 Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol 2011;31:341-8. [PMID: 21839367 DOI: 10.1016/j.semnephrol.2011.06.005] [Cited by in Crossref: 116] [Cited by in F6Publishing: 88] [Article Influence: 10.5] [Reference Citation Analysis]
343 Giles BM, Boackle SA. Linking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosus. Immunol Res 2013;55:10-21. [PMID: 22941560 DOI: 10.1007/s12026-012-8345-z] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
344 Bie B, Wu J, Foss JF, Naguib M. Activation of mGluR1 Mediates C1q-Dependent Microglial Phagocytosis of Glutamatergic Synapses in Alzheimer's Rodent Models. Mol Neurobiol 2019;56:5568-85. [PMID: 30652266 DOI: 10.1007/s12035-019-1467-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
345 Haurat MF, Scott NE, Di Venanzio G, Lopez J, Pluvinage B, Boraston AB, Ferracane MJ, Feldman MF. The Glycoprotease CpaA Secreted by Medically Relevant Acinetobacter Species Targets Multiple O-Linked Host Glycoproteins. mBio 2020;11:e02033-20. [PMID: 33024038 DOI: 10.1128/mBio.02033-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
346 Holmquist E, Okroj M, Nodin B, Jirström K, Blom AM. Sushi domain‐containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase. FASEB j 2013;27:2355-66. [DOI: 10.1096/fj.12-222042] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
347 Schmidt FL, Sürth V, Berg TK, Lin YP, Hovius JW, Kraiczy P. Interaction between Borrelia miyamotoi variable major proteins Vlp15/16 and Vlp18 with plasminogen and complement. Sci Rep 2021;11:4964. [PMID: 33654183 DOI: 10.1038/s41598-021-84533-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
348 Zipfel PF, Mache C, Müller D, Licht C, Wigger M, Skerka C; for the European DEAP-HUS Study Group. DEAP-HUS: Deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome. Pediatr Nephrol 2010;25:2009-19. [DOI: 10.1007/s00467-010-1446-9] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
349 Lung T, Risch L, Risch M, Sakem B, Würzner R, Nydegger U. The utility of complement assays in clinical immunology: A comprehensive review. J Autoimmun 2018;95:191-200. [PMID: 30391025 DOI: 10.1016/j.jaut.2018.10.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
350 Blickensdorf M, Timme S, Figge MT. Comparative Assessment of Aspergillosis by Virtual Infection Modeling in Murine and Human Lung. Front Immunol 2019;10:142. [PMID: 30804941 DOI: 10.3389/fimmu.2019.00142] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
351 Kremlitzka M, Polgár A, Fülöp L, Kiss E, Poór G, Erdei A. Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients. Int Immunol 2013;25:25-33. [PMID: 22962438 DOI: 10.1093/intimm/dxs090] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
352 Luo S, Dasari P, Reiher N, Hartmann A, Jacksch S, Wende E, Barz D, Niemiec MJ, Jacobsen I, Beyersdorf N, Hünig T, Klos A, Skerka C, Zipfel PF. The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments. Mol Immunol 2018;93:266-77. [PMID: 28860090 DOI: 10.1016/j.molimm.2017.07.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
353 Jog NR, Blanco I, Lee I, Putterman C, Caricchio R. Urinary high-mobility group box-1 associates specifically with lupus nephritis class V. Lupus 2016;25:1551-7. [PMID: 27075010 DOI: 10.1177/0961203316644331] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
354 Chen JJ, Han BS, Xu SG, Vu H, Farrow JW, Rodman CL, Zhu Y, Wang WZ. Hypersensitivity toward bacterial stimuli in patients with age-related macular degeneration. APMIS 2016;124:406-13. [PMID: 26853231 DOI: 10.1111/apm.12511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
355 Genewsky A, Jost I, Busch C, Huber C, Stindl J, Skerka C, Zipfel PF, Rohrer B, Strauß O. Activation of endogenously expressed ion channels by active complement in the retinal pigment epithelium. Pflugers Arch 2015;467:2179-91. [PMID: 25427445 DOI: 10.1007/s00424-014-1656-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
356 Dai Y, Huo X, Zhang Y, Yang T, Li M, Xu X. Elevated lead levels and changes in blood morphology and erythrocyte CR1 in preschool children from an e-waste area. Science of The Total Environment 2017;592:51-9. [DOI: 10.1016/j.scitotenv.2017.03.080] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 7.4] [Reference Citation Analysis]
357 Tabacco S, Giannini A, Garufi C, Botta A, Salvi S, Del Sordo G, Benedetti Panici P, Lanzone A, De Carolis S. Complementemia in pregnancies with antiphospholipid syndrome. Lupus 2019;28:1503-9. [PMID: 31623520 DOI: 10.1177/0961203319882507] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
358 DeAngelis RA, Reis ES, Ricklin D, Lambris JD. Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis. Immunobiology 2012;217:1097-105. [PMID: 22964235 DOI: 10.1016/j.imbio.2012.07.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
359 Gialeli C, Gungor B, Blom AM. Novel potential inhibitors of complement system and their roles in complement regulation and beyond. Mol Immunol 2018;102:73-83. [PMID: 30217334 DOI: 10.1016/j.molimm.2018.05.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
360 Chen Y, Chu JMT, Chang RCC, Wong GTC. The Complement System in the Central Nervous System: From Neurodevelopment to Neurodegeneration. Biomolecules 2022;12:337. [PMID: 35204837 DOI: 10.3390/biom12020337] [Reference Citation Analysis]
361 Reid RC, Yau MK, Singh R, Hamidon JK, Reed AN, Chu P, Suen JY, Stoermer MJ, Blakeney JS, Lim J, Faber JM, Fairlie DP. Downsizing a human inflammatory protein to a small molecule with equal potency and functionality. Nat Commun 2013;4:2802. [PMID: 24257095 DOI: 10.1038/ncomms3802] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
362 Kolev M, Markiewski MM. Targeting complement-mediated immunoregulation for cancer immunotherapy. Semin Immunol 2018;37:85-97. [PMID: 29454575 DOI: 10.1016/j.smim.2018.02.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
363 Linetsky M, Bondelid KS, Losovskiy S, Gabyak V, Rullo MJ, Stiadle TI, Munjapara V, Saxena P, Ma D, Cheng YS, Howes AM, Udeigwe E, Salomon RG. 4-Hydroxy-7-oxo-5-heptenoic Acid Lactone Is a Potent Inducer of the Complement Pathway in Human Retinal Pigmented Epithelial Cells. Chem Res Toxicol 2018;31:666-79. [PMID: 29883119 DOI: 10.1021/acs.chemrestox.8b00028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
364 Miller DP, McDowell JV, Rhodes DV, Allard A, Caimano M, Bell JK, Marconi RT. Sequence divergence in the Treponema denticola FhbB protein and its impact on factor H binding. Mol Oral Microbiol 2013;28:316-30. [PMID: 23601078 DOI: 10.1111/omi.12027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
365 Jalink M, de Boer ECW, Evers D, Havinga MQ, Vos JMI, Zeerleder S, de Haas M, Jongerius I. Halting targeted and collateral damage to red blood cells by the complement system. Semin Immunopathol 2021. [PMID: 34191092 DOI: 10.1007/s00281-021-00859-8] [Reference Citation Analysis]
366 Nordling S, Hong J, Fromell K, Edin F, Brännström J, Larsson R, Nilsson B, Magnusson PU. Vascular repair utilising immobilised heparin conjugate for protection against early activation of inflammation and coagulation. Thromb Haemost 2015;113:1312-22. [PMID: 25740465 DOI: 10.1160/TH14-09-0724] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
367 Huber G, Bánki Z, Lengauer S, Stoiber H. Emerging role for complement in HIV infection: . Current Opinion in HIV and AIDS 2011;6:419-26. [DOI: 10.1097/coh.0b013e3283495a26] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
368 Luo S, Poltermann S, Kunert A, Rupp S, Zipfel PF. Immune evasion of the human pathogenic yeast Candida albicans: Pra1 is a Factor H, FHL-1 and plasminogen binding surface protein. Mol Immunol 2009;47:541-50. [PMID: 19850343 DOI: 10.1016/j.molimm.2009.07.017] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 6.0] [Reference Citation Analysis]
369 Brock SR, Parmely MJ. Francisella tularensis Confronts the Complement System. Front Cell Infect Microbiol 2017;7:523. [PMID: 29312899 DOI: 10.3389/fcimb.2017.00523] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
370 Howard JF Jr. Myasthenia gravis: the role of complement at the neuromuscular junction. Ann N Y Acad Sci 2018;1412:113-28. [PMID: 29266249 DOI: 10.1111/nyas.13522] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 9.2] [Reference Citation Analysis]
371 Afshar-Kharghan V. The role of the complement system in cancer. J Clin Invest 2017;127:780-9. [PMID: 28248200 DOI: 10.1172/JCI90962] [Cited by in Crossref: 163] [Cited by in F6Publishing: 115] [Article Influence: 32.6] [Reference Citation Analysis]
372 Hallström T, Siegel C, Mörgelin M, Kraiczy P, Skerka C, Zipfel PF. CspA from Borrelia burgdorferi inhibits the terminal complement pathway. mBio 2013;4:e00481-13. [PMID: 23943762 DOI: 10.1128/mBio.00481-13] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
373 Lassek C, Burghartz M, Chaves-Moreno D, Otto A, Hentschker C, Fuchs S, Bernhardt J, Jauregui R, Neubauer R, Becher D, Pieper DH, Jahn M, Jahn D, Riedel K. A metaproteomics approach to elucidate host and pathogen protein expression during catheter-associated urinary tract infections (CAUTIs). Mol Cell Proteomics 2015;14:989-1008. [PMID: 25673765 DOI: 10.1074/mcp.M114.043463] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
374 Mishra N, Mohata M, Narang R, Lakshmy R, Hazarika A, Pandey RM, Das N, Luthra K. Altered Expression of Complement Regulatory Proteins CD35, CD46, CD55, and CD59 on Leukocyte Subsets in Individuals Suffering From Coronary Artery Disease. Front Immunol 2019;10:2072. [PMID: 31555286 DOI: 10.3389/fimmu.2019.02072] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
375 Sandholm K, Henningsson AJ, Säve S, Bergström S, Forsberg P, Jonsson N, Ernerudh J, Ekdahl KN. Early cytokine release in response to live Borrelia burgdorferi Sensu Lato Spirochetes is largely complement independent. PLoS One 2014;9:e108013. [PMID: 25265036 DOI: 10.1371/journal.pone.0108013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
376 Liu X, Lieberman J. Knocking 'em Dead: Pore-Forming Proteins in Immune Defense. Annu Rev Immunol 2020;38:455-85. [PMID: 32004099 DOI: 10.1146/annurev-immunol-111319-023800] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
377 Pollmächer J, Figge MT. Deciphering chemokine properties by a hybrid agent-based model of Aspergillus fumigatus infection in human alveoli. Front Microbiol 2015;6:503. [PMID: 26074897 DOI: 10.3389/fmicb.2015.00503] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
378 Poolpol K, Orth-Höller D, Speth C, Zipfel PF, Skerka C, de Córdoba SR, Brockmeyer J, Bielaszewska M, Würzner R. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family. Mol Immunol 2014;58:77-84. [PMID: 24317278 DOI: 10.1016/j.molimm.2013.11.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
379 Bjanes E, Nizet V. More than a Pore: Nonlytic Antimicrobial Functions of Complement and Bacterial Strategies for Evasion. Microbiol Mol Biol Rev 2021;85:e00177-20. [PMID: 33504655 DOI: 10.1128/MMBR.00177-20] [Reference Citation Analysis]
380 Lian H, Zheng H. Signaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease. J Neurochem 2016;136:475-91. [PMID: 26546579 DOI: 10.1111/jnc.13424] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
381 Marcinkiewicz AL, Lieknina I, Yang X, Lederman PL, Hart TM, Yates J, Chen WH, Bottazzi ME, Mantis NJ, Kraiczy P, Pal U, Tars K, Lin YP. The Factor H-Binding Site of CspZ as a Protective Target against Multistrain, Tick-Transmitted Lyme Disease. Infect Immun 2020;88:e00956-19. [PMID: 32122944 DOI: 10.1128/IAI.00956-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
382 Goutaudier V, Perrochia H, Mucha S, Bonnet M, Delmas S, Garo F, Garrigue V, Lepreux S, Pernin V, Serre JE, Szwarc I, Merville P, Ramounau-Pigot A, René C, Visentin J, Morgan BP, Frémeaux-Bacchi V, Mourad G, Couzi L, Le Quintrec M. C5b9 Deposition in Glomerular Capillaries Is Associated With Poor Kidney Allograft Survival in Antibody-Mediated Rejection. Front Immunol 2019;10:235. [PMID: 30906289 DOI: 10.3389/fimmu.2019.00235] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
383 Marcinkiewicz AL, Dupuis AP 2nd, Zamba-Campero M, Nowak N, Kraiczy P, Ram S, Kramer LD, Lin YP. Blood treatment of Lyme borreliae demonstrates the mechanism of CspZ-mediated complement evasion to promote systemic infection in vertebrate hosts. Cell Microbiol 2019;21:e12998. [PMID: 30571845 DOI: 10.1111/cmi.12998] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
384 Corrêa RR, Machado JR, da Silva MV, Helmo FR, Guimarães CS, Rocha LP, Faleiros AC, dos Reis MA. The importance of C4d in biopsies of kidney transplant recipients. Clin Dev Immunol 2013;2013:678180. [PMID: 23935649 DOI: 10.1155/2013/678180] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
385 Ruiz-Molina N, Parsons J, Müller M, Hoernstein SNW, Bohlender LL, Pumple S, Zipfel PF, Häffner K, Reski R, Decker EL. A synthetic protein as efficient multitarget regulator against complement over-activation. Commun Biol 2022;5:152. [PMID: 35194132 DOI: 10.1038/s42003-022-03094-5] [Reference Citation Analysis]
386 Michielsen LA, van Zuilen AD, Kardol-Hoefnagel T, Verhaar MC, Otten HG. Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant Outcome. Front Immunol 2018;9:972. [PMID: 29867953 DOI: 10.3389/fimmu.2018.00972] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
387 Tsai HM. Excessive activation of the complement system in atypical hemolytic uremic syndrome: is it ready for prime time? Kidney Int 2010;77:267-9. [PMID: 20118898 DOI: 10.1038/ki.2009.467] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
388 Chen XH, Ruan CC, Ge Q, Ma Y, Xu JZ, Zhang ZB, Lin JR, Chen DR, Zhu DL, Gao PJ. Deficiency of Complement C3a and C5a Receptors Prevents Angiotensin II-Induced Hypertension via Regulatory T Cells. Circ Res 2018;122:970-83. [PMID: 29437833 DOI: 10.1161/CIRCRESAHA.117.312153] [Cited by in Crossref: 42] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
389 Michels MAHM, van de Kar NCAJ, van den Bos RM, van der Velden TJAM, van Kraaij SAW, Sarlea SA, Gracchi V, Oosterveld MJS, Volokhina EB, van den Heuvel LPWJ. Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy. Front Immunol 2019;10:1350. [PMID: 31263464 DOI: 10.3389/fimmu.2019.01350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
390 Trevisi P, Corrent E, Messori S, Formica S, Priori D, Bosi P. Supplementary tryptophan downregulates the expression of genes induced by the gut microbiota in healthy weaned pigs susceptible to enterotoxigenic Escherichia coli F4. Livestock Science 2012;147:96-103. [DOI: 10.1016/j.livsci.2012.04.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
391 Li Q, Ma C, Fu Y, He Y, Yu Y, Du D, Yao H, Lu C, Zhang W. Factor H specifically capture novel Factor H-binding proteins of Streptococcus suis and contribute to the virulence of the bacteria. Microbiol Res 2017;196:17-25. [PMID: 28164787 DOI: 10.1016/j.micres.2016.11.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
392 Fervenza FC, Sethi S. Circulating complement levels and C3 glomerulopathy. Clin J Am Soc Nephrol 2014;9:1829-31. [PMID: 25341723 DOI: 10.2215/CJN.09620914] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
393 Jiang C, Zhang J, Yao J, Liu S, Li Y, Song L, Li C, Wang X, Liu Z. Complement regulatory protein genes in channel catfish and their involvement in disease defense response. Developmental & Comparative Immunology 2015;53:33-41. [DOI: 10.1016/j.dci.2015.06.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
394 Hallström T, Mörgelin M, Barthel D, Raguse M, Kunert A, Hoffmann R, Skerka C, Zipfel PF. Dihydrolipoamide Dehydrogenase of Pseudomonas aeruginosa Is a Surface-Exposed Immune Evasion Protein That Binds Three Members of the Factor H Family and Plasminogen. J I 2012;189:4939-50. [DOI: 10.4049/jimmunol.1200386] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
395 Pollmächer J, Timme S, Schuster S, Brakhage AA, Zipfel PF, Figge MT. Deciphering the Counterplay of Aspergillus fumigatus Infection and Host Inflammation by Evolutionary Games on Graphs. Sci Rep 2016;6:27807. [PMID: 27291424 DOI: 10.1038/srep27807] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
396 Burwick RM, Feinberg BB. Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Am J Obstet Gynecol 2020:S0002-9378(20)31129-7. [PMID: 32986992 DOI: 10.1016/j.ajog.2020.09.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
397 Barbour TD, Pickering MC, Cook HT. Recent insights into C3 glomerulopathy. Nephrol Dial Transplant. 2013;28:1685-1693. [PMID: 23479095 DOI: 10.1093/ndt/gfs430] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
398 Brown AJ, Gow NA, Warris A, Brown GD. Memory in Fungal Pathogens Promotes Immune Evasion, Colonisation, and Infection. Trends in Microbiology 2019;27:219-30. [DOI: 10.1016/j.tim.2018.11.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
399 Achila D, Liu A, Banerjee R, Li Y, Martinez-Hackert E, Zhang JR, Yan H. Structural determinants of host specificity of complement Factor H recruitment by Streptococcus pneumoniae. Biochem J 2015;465:325-35. [PMID: 25330773 DOI: 10.1042/BJ20141069] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
400 Frye AM, Hart TM, Tufts DM, Ram S, Diuk-Wasser MA, Kraiczy P, Blom AM, Lin YP. A soft tick Ornithodoros moubata salivary protein OmCI is a potent inhibitor to prevent avian complement activation. Ticks Tick Borne Dis 2020;11:101354. [PMID: 31866440 DOI: 10.1016/j.ttbdis.2019.101354] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
401 Galluzzi L, Vacchelli E, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zucman-Rossi J, Zitvogel L, Kroemer G. Trial Watch: Monoclonal antibodies in cancer therapy. Oncoimmunology. 2012;1:28-37. [PMID: 22720209 DOI: 10.4161/onci.1.1.17938] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 75.0] [Reference Citation Analysis]
402 Austermeier S, Pekmezović M, Porschitz P, Lee S, Kichik N, Moyes DL, Ho J, Kotowicz NK, Naglik JR, Hube B, Gresnigt MS. Albumin Neutralizes Hydrophobic Toxins and Modulates Candida albicans Pathogenicity. mBio 2021;12:e0053121. [PMID: 34154403 DOI: 10.1128/mBio.00531-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
403 Noris M, Remuzzi G. Overview of complement activation and regulation. Semin Nephrol. 2013;33:479-492. [PMID: 24161035 DOI: 10.1016/j.semnephrol.2013.08.001] [Cited by in Crossref: 350] [Cited by in F6Publishing: 309] [Article Influence: 43.8] [Reference Citation Analysis]
404 Stoute JA. Complement receptor 1 and malaria: CR1 and Malaria. Cellular Microbiology 2011;13:1441-50. [DOI: 10.1111/j.1462-5822.2011.01648.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
405 Motamed-Gorji N, Matin N, Tabatabaie O, Pavone P, Romano C, Falsaperla R, Vitaliti G. Biological Drugs in Guillain-Barré Syndrome: An Update. Curr Neuropharmacol 2017;15:938-50. [PMID: 27964705 DOI: 10.2174/1570159X14666161213114904] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
406 Chighizola CB, Lonati PA, Trespidi L, Meroni PL, Tedesco F. The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy. Front Immunol 2020;11:2084. [PMID: 32973817 DOI: 10.3389/fimmu.2020.02084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
407 Liu G, Gradstedt H, Ermert D, Englund E, Singh B, Su Y, Johansson ME, Aspberg A, Agarwal V, Riesbeck K, Blom AM. Moraxella catarrhalis Evades Host Innate Immunity via Targeting Cartilage Oligomeric Matrix Protein. J I 2016;196:1249-58. [DOI: 10.4049/jimmunol.1502071] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
408 Zhao H, Cao G, Chen H, Li H, Zhou J. Evaluation of hemocompatibility and hemostasis of a bioflocculant. Colloids and Surfaces B: Biointerfaces 2017;159:712-9. [DOI: 10.1016/j.colsurfb.2017.08.054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
409 Lian H, Yang L, Cole A, Sun L, Chiang AC, Fowler SW, Shim DJ, Rodriguez-Rivera J, Taglialatela G, Jankowsky JL, Lu HC, Zheng H. NFκB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer's disease. Neuron 2015;85:101-15. [PMID: 25533482 DOI: 10.1016/j.neuron.2014.11.018] [Cited by in Crossref: 228] [Cited by in F6Publishing: 225] [Article Influence: 28.5] [Reference Citation Analysis]
410 Qiao P, Dang E, Cao T, Fang H, Zhang J, Qiao H, Wang G. Dysregulation of mCD46 and sCD46 contribute to the pathogenesis of bullous pemphigoid. Sci Rep 2017;7:145. [PMID: 28273946 DOI: 10.1038/s41598-017-00235-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
411 Oyong DA, Loughland JR, SheelaNair A, Andrew D, Rivera FDL, Piera KA, William T, Grigg MJ, Barber BE, Haque A, Engwerda CR, McCarthy JS, Anstey NM, Boyle MJ. Loss of complement regulatory proteins on red blood cells in mild malarial anaemia and in Plasmodium falciparum induced blood-stage infection. Malar J 2019;18:312. [PMID: 31533836 DOI: 10.1186/s12936-019-2962-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
412 Loveless S, Neal JW, Howell OW, Harding KE, Sarkies P, Evans R, Bevan RJ, Hakobyan S, Harris CL, Robertson NP, Morgan BP. Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis. Brain Pathol 2018;28:507-20. [PMID: 28707765 DOI: 10.1111/bpa.12546] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
413 Lage SL, Wong CS, Amaral EP, Sturdevant D, Hsu DC, Rupert A, Wilson EMP, Qasba SS, Naqvi NS, Laidlaw E, Lisco A, Manion M, Sereti I. Classical complement and inflammasome activation converge in CD14highCD16- monocytes in HIV associated TB-immune reconstitution inflammatory syndrome. PLoS Pathog 2021;17:e1009435. [PMID: 33788899 DOI: 10.1371/journal.ppat.1009435] [Reference Citation Analysis]
414 Ma Y, Liu Y, Zhang Z, Yang GY. Significance of Complement System in Ischemic Stroke: A Comprehensive Review. Aging Dis 2019;10:429-62. [PMID: 31011487 DOI: 10.14336/AD.2019.0119] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 11.7] [Reference Citation Analysis]
415 Eyolfson E, Khan A, Mychasiuk R, Lohman AW. Microglia dynamics in adolescent traumatic brain injury. J Neuroinflammation 2020;17:326. [PMID: 33121516 DOI: 10.1186/s12974-020-01994-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
416 Kaarniranta K, Xu H, Kauppinen A. Mechanistical retinal drug targets and challenges. Adv Drug Deliv Rev 2018;126:177-84. [PMID: 29698626 DOI: 10.1016/j.addr.2018.04.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
417 Arias-Cabrales C, Rodriguez-Garcia E, Gimeno J, Benito D, Pérez-Sáez MJ, Redondo-Pachón D, Buxeda A, Burballa C, Crespo M, Riera M, Pascual J. Role of C5aR1 and C5L2 Receptors in Ischemia-Reperfusion Injury. J Clin Med 2021;10:974. [PMID: 33801177 DOI: 10.3390/jcm10050974] [Reference Citation Analysis]
418 Pickering M, Cook HT. Complement and glomerular disease: new insights: . Current Opinion in Nephrology and Hypertension 2011;20:271-7. [DOI: 10.1097/mnh.0b013e328345848b] [Cited by in Crossref: 61] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
419 Damgaard C, Holmstrup P, Van Dyke TE, Nielsen CH. The complement system and its role in the pathogenesis of periodontitis: current concepts. J Periodontal Res 2015;50:283-93. [PMID: 25040158 DOI: 10.1111/jre.12209] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
420 Zewde N, Gorham RD Jr, Dorado A, Morikis D. Quantitative Modeling of the Alternative Pathway of the Complement System. PLoS One 2016;11:e0152337. [PMID: 27031863 DOI: 10.1371/journal.pone.0152337] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
421 Piscione TD, Licht C. Genetics of proteinuria: an overview of gene mutations associated with nonsyndromic proteinuric glomerulopathies. Adv Chronic Kidney Dis 2011;18:273-89. [PMID: 21782134 DOI: 10.1053/j.ackd.2011.06.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
422 Ding Y, Zhao W, Zhang T, Qiang H, Lu J, Su X, Wen S, Xu F, Zhang M, Zhang H, Zeng C, Liu Z, Chen H. A haplotype in CFH family genes confers high risk of rare glomerular nephropathies. Sci Rep 2017;7:6004. [PMID: 28729648 DOI: 10.1038/s41598-017-05173-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
423 Summers BJ, Garcia BL, Woehl JL, Ramyar KX, Yao X, Geisbrecht BV. Identification of peptidic inhibitors of the alternative complement pathway based on Staphylococcus aureus SCIN proteins. Mol Immunol 2015;67:193-205. [PMID: 26052070 DOI: 10.1016/j.molimm.2015.05.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
424 Marconi RT. Gene Regulation, Two Component Regulatory Systems, and Adaptive Responses in Treponema Denticola. Curr Top Microbiol Immunol 2018;415:39-62. [PMID: 29026924 DOI: 10.1007/82_2017_66] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
425 Doorduijn DJ, Rooijakkers SHM, Heesterbeek DAC. How the Membrane Attack Complex Damages the Bacterial Cell Envelope and Kills Gram‐Negative Bacteria. BioEssays 2019;41:1900074. [DOI: 10.1002/bies.201900074] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
426 Woodruff TM, Nandakumar KS, Tedesco F. Inhibiting the C5-C5a receptor axis. Mol Immunol 2011;48:1631-42. [PMID: 21549429 DOI: 10.1016/j.molimm.2011.04.014] [Cited by in Crossref: 203] [Cited by in F6Publishing: 188] [Article Influence: 18.5] [Reference Citation Analysis]
427 Koch TK, Reuter M, Barthel D, Böhm S, van den Elsen J, Kraiczy P, Zipfel PF, Skerka C. Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b. PLoS One 2012;7:e47638. [PMID: 23071827 DOI: 10.1371/journal.pone.0047638] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 4.5] [Reference Citation Analysis]
428 Wikel SK. Ticks and Tick-Borne Infections: Complex Ecology, Agents, and Host Interactions. Vet Sci 2018;5:E60. [PMID: 29925800 DOI: 10.3390/vetsci5020060] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 10.3] [Reference Citation Analysis]
429 Zipfel PF, Heinen S, Skerka C. Thrombotic microangiopathies: new insights and new challenges. Curr Opin Nephrol Hypertens 2010;19:372-8. [PMID: 20539230 DOI: 10.1097/MNH.0b013e32833aff4a] [Cited by in Crossref: 40] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
430 Singh DK, Tóth R, Gácser A. Mechanisms of Pathogenic Candida Species to Evade the Host Complement Attack. Front Cell Infect Microbiol 2020;10:94. [PMID: 32232011 DOI: 10.3389/fcimb.2020.00094] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
431 Kumar NA, Kunnakkadan U, Thomas S, Johnson JB. In the Crosshairs: RNA Viruses OR Complement? Front Immunol 2020;11:573583. [PMID: 33133089 DOI: 10.3389/fimmu.2020.573583] [Reference Citation Analysis]
432 Kozlowski MR. RPE cell senescence: a key contributor to age-related macular degeneration. Med Hypotheses 2012;78:505-10. [PMID: 22296808 DOI: 10.1016/j.mehy.2012.01.018] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 5.2] [Reference Citation Analysis]
433 Sethi S, Fervenza FC, Zhang Y, Nasr SH, Leung N, Vrana J, Cramer C, Nester CM, Smith RJ. Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement. Clin J Am Soc Nephrol. 2011;6:1009-1017. [PMID: 21415311 DOI: 10.2215/cjn.07110810] [Cited by in Crossref: 117] [Cited by in F6Publishing: 63] [Article Influence: 10.6] [Reference Citation Analysis]
434 Kiapour AM, Sieker JT, Proffen BL, Lam TT, Fleming BC, Murray MM. Synovial fluid proteome changes in ACL injury-induced posttraumatic osteoarthritis: Proteomics analysis of porcine knee synovial fluid. PLoS One 2019;14:e0212662. [PMID: 30822327 DOI: 10.1371/journal.pone.0212662] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
435 Rodrigues PRS, Picco N, Morgan BP, Ghazal P. Sepsis target validation for repurposing and combining complement and immune checkpoint inhibition therapeutics. Expert Opin Drug Discov 2021;16:537-51. [PMID: 33206027 DOI: 10.1080/17460441.2021.1851186] [Reference Citation Analysis]
436 Wei Y, Ji Y, Guo H, Zhi X, Han S, Zhang Y, Gao Y, Chang Y, Yan D, Li K, Liu DX, Sun S. CD59 association with infectious bronchitis virus particles protects against antibody-dependent complement-mediated lysis. J Gen Virol 2017;98:2725-30. [PMID: 29068273 DOI: 10.1099/jgv.0.000962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
437 Hammerschmidt C, Koenigs A, Siegel C, Hallström T, Skerka C, Wallich R, Zipfel PF, Kraiczy P. Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes. Infect Immun 2014;82:380-92. [PMID: 24191298 DOI: 10.1128/IAI.01094-13] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
438 Zhao L, Huang L, Zhang X. Osteoimmunology: memorandum for rheumatologists. Sci China Life Sci 2016;59:1241-58. [DOI: 10.1007/s11427-016-5105-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
439 Datta S, Cano M, Ebrahimi K, Wang L, Handa JT. The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog Retin Eye Res 2017;60:201-18. [PMID: 28336424 DOI: 10.1016/j.preteyeres.2017.03.002] [Cited by in Crossref: 237] [Cited by in F6Publishing: 229] [Article Influence: 47.4] [Reference Citation Analysis]
440 Kraiczy P. Travelling between Two Worlds: Complement as a Gatekeeper for an Expanded Host Range of Lyme Disease Spirochetes. Vet Sci 2016;3:E12. [PMID: 29056721 DOI: 10.3390/vetsci3020012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
441 Noris M, Remuzzi G. Cardiovascular complications in atypical haemolytic uraemic syndrome. Nat Rev Nephrol 2014;10:174-80. [DOI: 10.1038/nrneph.2013.280] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
442 Meri S. Complement activation in diseases presenting with thrombotic microangiopathy. Eur J Intern Med 2013;24:496-502. [PMID: 23743117 DOI: 10.1016/j.ejim.2013.05.009] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 6.4] [Reference Citation Analysis]
443 Oldenborg PA. CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease. ISRN Hematol 2013;2013:614619. [PMID: 23401787 DOI: 10.1155/2013/614619] [Cited by in Crossref: 104] [Cited by in F6Publishing: 108] [Article Influence: 11.6] [Reference Citation Analysis]
444 Khan MA, Assiri AM, Broering DC. Complement and macrophage crosstalk during process of angiogenesis in tumor progression. J Biomed Sci 2015;22:58. [PMID: 26198107 DOI: 10.1186/s12929-015-0151-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 6.4] [Reference Citation Analysis]
445 Taylor RP, Lindorfer MA. The role of complement in mAb-based therapies of cancer. Methods 2014;65:18-27. [PMID: 23886909 DOI: 10.1016/j.ymeth.2013.07.027] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
446 Rosa TF, Flammersfeld A, Ngwa CJ, Kiesow M, Fischer R, Zipfel PF, Skerka C, Pradel G. The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement. Cell Microbiol 2016;18:573-90. [PMID: 26457721 DOI: 10.1111/cmi.12535] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
447 Battin C, De Sousa Linhares A, Paster W, Isenman DE, Wahrmann M, Leitner J, Zlabinger GJ, Steinberger P, Hofer J. Neuropilin-1 Acts as a Receptor for Complement Split Products. Front Immunol 2019;10:2209. [PMID: 31572401 DOI: 10.3389/fimmu.2019.02209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
448 Hajishengallis G, Maekawa T, Abe T, Hajishengallis E, Lambris JD. Complement Involvement in Periodontitis: Molecular Mechanisms and Rational Therapeutic Approaches. Adv Exp Med Biol 2015;865:57-74. [PMID: 26306443 DOI: 10.1007/978-3-319-18603-0_4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
449 Fishelson Z, Kirschfink M. Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention. Front Immunol 2019;10:752. [PMID: 31024572 DOI: 10.3389/fimmu.2019.00752] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
450 Macor P, Secco E, Mezzaroba N, Zorzet S, Durigutto P, Gaiotto T, De Maso L, Biffi S, Garrovo C, Capolla S, Tripodo C, Gattei V, Marzari R, Tedesco F, Sblattero D. Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. Leukemia 2015;29:406-14. [DOI: 10.1038/leu.2014.185] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
451 Zipfel PF, Lauer N. Defective Complement Action and Control Defines Disease Pathology for Retinal and Renal Disorders and Provides a Basis for New Therapeutic Approaches. In: Lambris JD, Holers VM, Ricklin D, editors. Complement Therapeutics. Boston: Springer US; 2013. pp. 173-87. [DOI: 10.1007/978-1-4614-4118-2_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
452 Taylor RP, Lindorfer MA. Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies. Semin Immunol 2016;28:309-16. [PMID: 27009480 DOI: 10.1016/j.smim.2016.03.003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
453 Yin C, Ackermann S, Ma Z, Mohanta SK, Zhang C, Li Y, Nietzsche S, Westermann M, Peng L, Hu D, Bontha SV, Srikakulapu P, Beer M, Megens RTA, Steffens S, Hildner M, Halder LD, Eckstein HH, Pelisek J, Herms J, Roeber S, Arzberger T, Borodovsky A, Habenicht L, Binder CJ, Weber C, Zipfel PF, Skerka C, Habenicht AJR. ApoE attenuates unresolvable inflammation by complex formation with activated C1q. Nat Med 2019;25:496-506. [PMID: 30692699 DOI: 10.1038/s41591-018-0336-8] [Cited by in Crossref: 94] [Cited by in F6Publishing: 77] [Article Influence: 31.3] [Reference Citation Analysis]
454 Pio R, Ajona D, Lambris JD. Complement inhibition in cancer therapy. Semin Immunol 2013;25:54-64. [PMID: 23706991 DOI: 10.1016/j.smim.2013.04.001] [Cited by in Crossref: 90] [Cited by in F6Publishing: 86] [Article Influence: 10.0] [Reference Citation Analysis]
455 Thiriard A, Raze D, Locht C. Diversion of complement-mediated killing by Bordetella. Microbes Infect 2018;20:512-20. [PMID: 29454132 DOI: 10.1016/j.micinf.2018.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
456 Romanelli E, Merkler D, Mezydlo A, Weil MT, Weber MS, Nikić I, Potz S, Meinl E, Matznick FE, Kreutzfeldt M, Ghanem A, Conzelmann KK, Metz I, Brück W, Routh M, Simons M, Bishop D, Misgeld T, Kerschensteiner M. Myelinosome formation represents an early stage of oligodendrocyte damage in multiple sclerosis and its animal model. Nat Commun 2016;7:13275. [PMID: 27848954 DOI: 10.1038/ncomms13275] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
457 Kang S, Yang M, He S, Wang Y, Chen X, Chen YQ, Hong Z, Liu J, Jiang G, Chen Q, Zhou Z, Zhou Z, Huang Z, Huang X, He H, Zheng W, Liao HX, Xiao F, Shan H, Chen S. A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation. Nat Commun 2021;12:2697. [PMID: 33976229 DOI: 10.1038/s41467-021-23036-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
458 Wu YQ, Qu H, Sfyroera G, Tzekou A, Kay BK, Nilsson B, Nilsson Ekdahl K, Ricklin D, Lambris JD. Protection of nonself surfaces from complement attack by factor H-binding peptides: implications for therapeutic medicine. J Immunol 2011;186:4269-77. [PMID: 21339361 DOI: 10.4049/jimmunol.1003802] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 5.9] [Reference Citation Analysis]
459 Hajishengallis G, Abe T, Maekawa T, Hajishengallis E, Lambris JD. Role of complement in host-microbe homeostasis of the periodontium. Semin Immunol 2013;25:65-72. [PMID: 23684627 DOI: 10.1016/j.smim.2013.04.004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
460 Nagayama A, Ellisen LW, Chabner B, Bardia A. Antibody–Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest Developments. Targ Oncol 2017;12:719-39. [DOI: 10.1007/s11523-017-0535-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
461 Qiao P, Dang EL, Fang H, Zhang JY, Li B, Shen SX, Luo YX, Lei J, Shao S, Qiao HJ, Wang G. Decreased expression levels of complement regulator CD55 contribute to the development of bullous pemphigoid. Oncotarget 2018;9:35517-27. [PMID: 30473747 DOI: 10.18632/oncotarget.21216] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
462 Alexander MP, Fervenza FC, De Vriese AS, Smith RJH, Nasr SH, Cornell LD, Herrera Hernandez LP, Zhang Y, Sethi S. C3 glomerulonephritis and autoimmune disease: more than a fortuitous association? J Nephrol 2016;29:203-9. [DOI: 10.1007/s40620-015-0218-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
463 Kelly UL, Grigsby D, Cady MA, Landowski M, Skiba NP, Liu J, Remaley AT, Klingeborn M, Bowes Rickman C. High-density lipoproteins are a potential therapeutic target for age-related macular degeneration. J Biol Chem 2020;295:13601-16. [PMID: 32737203 DOI: 10.1074/jbc.RA119.012305] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
464 Hart T, Nguyen NTT, Nowak NA, Zhang F, Linhardt RJ, Diuk-Wasser M, Ram S, Kraiczy P, Lin YP. Polymorphic factor H-binding activity of CspA protects Lyme borreliae from the host complement in feeding ticks to facilitate tick-to-host transmission. PLoS Pathog 2018;14:e1007106. [PMID: 29813137 DOI: 10.1371/journal.ppat.1007106] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
465 Osaka M, Ito S, Honda M, Inomata Y, Egashira K, Yoshida M. Critical role of the C5a-activated neutrophils in high-fat diet-induced vascular inflammation. Sci Rep 2016;6:21391. [PMID: 26893238 DOI: 10.1038/srep21391] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
466 Vacchelli E, Eggermont A, Galon J, Sautès-Fridman C, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Monoclonal antibodies in cancer therapy. Oncoimmunology 2013;2:e22789. [PMID: 23482847 DOI: 10.4161/onci.22789] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 8.5] [Reference Citation Analysis]
467 Ruscica M, Corsini A, Ferri N, Banach M, Sirtori CR. Clinical approach to the inflammatory etiology of cardiovascular diseases. Pharmacol Res 2020;159:104916. [PMID: 32445957 DOI: 10.1016/j.phrs.2020.104916] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
468 Xue X, Wu J, Ricklin D, Forneris F, Di Crescenzio P, Schmidt CQ, Granneman J, Sharp TH, Lambris JD, Gros P. Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses. Nat Struct Mol Biol 2017;24:643-51. [PMID: 28671664 DOI: 10.1038/nsmb.3427] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 11.8] [Reference Citation Analysis]
469 Giffin L, Damania B. KSHV: pathways to tumorigenesis and persistent infection. Adv Virus Res. 2014;88:111-159. [PMID: 24373311 DOI: 10.1016/b978-0-12-800098-4.00002-7] [Cited by in Crossref: 84] [Cited by in F6Publishing: 58] [Article Influence: 10.5] [Reference Citation Analysis]
470 Tacke RS, Tosello-Trampont A, Nguyen V, Mullins DW, Hahn YS. Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway. J Biol Chem. 2011;286:10847-10855. [PMID: 21282107 DOI: 10.1074/jbc.m110.217653] [Cited by in Crossref: 66] [Cited by in F6Publishing: 46] [Article Influence: 6.0] [Reference Citation Analysis]
471 Hofmeyer T, Schmelz S, Degiacomi MT, Dal Peraro M, Daneschdar M, Scrima A, van den Heuvel J, Heinz DW, Kolmar H. Arranged sevenfold: structural insights into the C-terminal oligomerization domain of human C4b-binding protein. J Mol Biol 2013;425:1302-17. [PMID: 23274142 DOI: 10.1016/j.jmb.2012.12.017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
472 Zhang Z, Yu D, Yuan J, Guo Y, Wang H, Zhang X. Cigarette smoking strongly modifies the association of complement factor H variant and the risk of lung cancer. Cancer Epidemiology 2012;36:e111-5. [DOI: 10.1016/j.canep.2011.11.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
473 Dimitrov JD, Planchais C, Roumenina LT, Vassilev TL, Kaveri SV, Lacroix-Desmazes S. Antibody polyreactivity in health and disease: statu variabilis. J Immunol 2013;191:993-9. [PMID: 23873158 DOI: 10.4049/jimmunol.1300880] [Cited by in Crossref: 72] [Cited by in F6Publishing: 58] [Article Influence: 8.0] [Reference Citation Analysis]
474 Nayer A, Asif A. Atypical hemolytic-uremic syndrome: a clinical review. Am J Ther. 2016;23:e151-e158. [PMID: 24681522 DOI: 10.1097/mjt.0b013e31829b59dc] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
475 Ruan C, Ma Y, Ge Q, Li Y, Zhu L, Zhang Y, Kong L, Wu Q, Li F, Cheng L, Zhao AZ, Zhu D, Gao P. Complement‐mediated inhibition of adiponectin regulates perivascular inflammation and vascular injury in hypertension. FASEB j 2017;31:1120-9. [DOI: 10.1096/fj.201600780r] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
476 Rozing MP, Durhuus JA, Krogh Nielsen M, Subhi Y, Kirkwood TB, Westendorp RG, Sørensen TL. Age-related macular degeneration: A two-level model hypothesis. Prog Retin Eye Res 2020;76:100825. [PMID: 31899290 DOI: 10.1016/j.preteyeres.2019.100825] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 10.7] [Reference Citation Analysis]
477 Ojha H, Panwar HS, Gorham RD Jr, Morikis D, Sahu A. Viral regulators of complement activation: structure, function and evolution. Mol Immunol 2014;61:89-99. [PMID: 24976595 DOI: 10.1016/j.molimm.2014.06.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
478 Prohászka Z, Nilsson B, Frazer-Abel A, Kirschfink M. Complement analysis 2016: Clinical indications, laboratory diagnostics and quality control. Immunobiology 2016;221:1247-58. [PMID: 27475991 DOI: 10.1016/j.imbio.2016.06.008] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
479 Zipfel PF. Complement and immune defense: from innate immunity to human diseases. Immunol Lett 2009;126:1-7. [PMID: 19616581 DOI: 10.1016/j.imlet.2009.07.005] [Cited by in Crossref: 82] [Cited by in F6Publishing: 73] [Article Influence: 6.3] [Reference Citation Analysis]
480 Schmidtko J, Peine S, El-Housseini Y, Pascual M, Meier P. Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab. Am J Kidney Dis. 2013;61:289-299. [PMID: 23141475 DOI: 10.1053/j.ajkd.2012.07.028] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 6.0] [Reference Citation Analysis]
481 Edström Hägerwall AM, Rydengård V, Fernlund P, Mörgelin M, Baumgarten M, Cole AM, Malmsten M, Kragelund BB, Sørensen OE. β-Microseminoprotein endows post coital seminal plasma with potent candidacidal activity by a calcium- and pH-dependent mechanism. PLoS Pathog 2012;8:e1002625. [PMID: 22496651 DOI: 10.1371/journal.ppat.1002625] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
482 Yoon YH, Hwang HJ, Sung HJ, Heo SH, Kim DS, Hong SH, Lee KH, Cho JY. Upregulation of Complement Factor H by SOCS-1/3⁻STAT4 in Lung Cancer. Cancers (Basel) 2019;11:E471. [PMID: 30987235 DOI: 10.3390/cancers11040471] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
483 Lee MS, Jones T, Song DY, Jang JH, Jung JU, Gao SJ. Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infection. PLoS Pathog 2014;10:e1004412. [PMID: 25254972 DOI: 10.1371/journal.ppat.1004412] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
484 Saadoun S, Papadopoulos MC. Role of membrane complement regulators in neuromyelitis optica. Mult Scler 2015;21:1644-54. [PMID: 25698168 DOI: 10.1177/1352458515571446] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
485 Wang X, Mooradian AD, Erdmann-Gilmore P, Zhang Q, Viner R, Davies SR, Huang KL, Bomgarden R, Van Tine BA, Shao J, Ding L, Li S, Ellis MJ, Rogers JC, Townsend RR, Fenyö D, Held JM. Breast tumors educate the proteome of stromal tissue in an individualized but coordinated manner. Sci Signal 2017;10:eaam8065. [PMID: 28790197 DOI: 10.1126/scisignal.aam8065] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
486 Li Q, Hu Y, Fei X, Du Y, Guo W, Chu D, Wang X, Wang S, Shi H. OmpC, a novel factor H-binding surface protein, is dispensable for the adherence and virulence of Salmonella enterica serovar Typhimurium. Vet Microbiol 2021;259:109157. [PMID: 34197978 DOI: 10.1016/j.vetmic.2021.109157] [Reference Citation Analysis]
487 Harder JM, Braine CE, Williams PA, Zhu X, MacNicoll KH, Sousa GL, Buchanan RA, Smith RS, Libby RT, Howell GR, John SWM. Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective. Proc Natl Acad Sci U S A 2017;114:E3839-48. [PMID: 28446616 DOI: 10.1073/pnas.1608769114] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 10.4] [Reference Citation Analysis]
488 Smith LC, Arizza V, Barela Hudgell MA, Barone G, Bodnar AG, Buckley KM, Cunsolo V, Dheilly NM, Franchi N, Fugmann SD, Furukawa R, Garcia-arraras J, Henson JH, Hibino T, Irons ZH, Li C, Lun CM, Majeske AJ, Oren M, Pagliara P, Pinsino A, Raftos DA, Rast JP, Samasa B, Schillaci D, Schrankel CS, Stabili L, Stensväg K, Sutton E. Echinodermata: The Complex Immune System in Echinoderms. In: Cooper EL, editor. Advances in Comparative Immunology. Cham: Springer International Publishing; 2018. pp. 409-501. [DOI: 10.1007/978-3-319-76768-0_13] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
489 Ramadass M, Ghebrehiwet B, Smith RJ, Kew RR. Generation of multiple fluid-phase C3b:plasma protein complexes during complement activation: possible implications in C3 glomerulopathies. J Immunol 2014;192:1220-30. [PMID: 24367026 DOI: 10.4049/jimmunol.1302288] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
490 Hirashio S, Satoh A, Arima T, Mandai K, Awaya T, Oshima K, Hara S, Masaki T. Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report. BMC Nephrol 2018;19:108. [PMID: 29724182 DOI: 10.1186/s12882-018-0905-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
491 Józsi M. Factor H Family Proteins in Complement Evasion of Microorganisms. Front Immunol 2017;8:571. [PMID: 28572805 DOI: 10.3389/fimmu.2017.00571] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
492 Röttgerding F, Wagemakers A, Koetsveld J, Fingerle V, Kirschfink M, Hovius JW, Zipfel PF, Wallich R, Kraiczy P. Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties. Sci Rep 2017;7:303. [PMID: 28331202 DOI: 10.1038/s41598-017-00412-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
493 Yang P, Baciu P, Kerrigan BC, Etheridge M, Sung E, Toimil BA, Berchuck JE, Jaffe GJ. Retinal pigment epithelial cell death by the alternative complement cascade: role of membrane regulatory proteins, calcium, PKC, and oxidative stress. Invest Ophthalmol Vis Sci 2014;55:3012-21. [PMID: 24677108 DOI: 10.1167/iovs.13-13554] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
494 Brangulis K, Akopjana I, Petrovskis I, Kazaks A, Kraiczy P, Tars K. Crystal structure of the membrane attack complex assembly inhibitor BGA71 from the Lyme disease agent Borrelia bavariensis. Sci Rep 2018;8:11286. [PMID: 30050126 DOI: 10.1038/s41598-018-29651-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
495 Li K, Gor J, Holers VM, Storek MJ, Perkins SJ. Solution structure of TT30, a novel complement therapeutic agent, provides insight into its joint binding to complement C3b and C3d. J Mol Biol 2012;418:248-63. [PMID: 22387467 DOI: 10.1016/j.jmb.2012.02.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
496 Yadav VN, Pyaram K, Ahmad M, Sahu A. Species selectivity in poxviral complement regulators is dictated by the charge reversal in the central complement control protein modules. J Immunol 2012;189:1431-9. [PMID: 22732591 DOI: 10.4049/jimmunol.1200946] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
497 Gupta N, Wakefield DN, Clapp WL, Garin EH. Use of C4d as a diagnostic tool to classify membranoproliferative glomerulonephritis. Nefrologia 2017;37:78-86. [PMID: 27595516 DOI: 10.1016/j.nefro.2016.05.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
498 Morgan M, Deuis JR, Woodruff TM, Lewis RJ, Vetter I. Role of complement anaphylatoxin receptors in a mouse model of acute burn-induced pain. Molecular Immunology 2018;94:68-74. [DOI: 10.1016/j.molimm.2017.12.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
499 Gan Z, Wang B, Zhou W, Lu Y, Zhu W, Tang J, Jian J, Wu Z. Molecular and functional characterization of CD59 from Nile tilapia (Oreochromis niloticus) involved in the immune response to Streptococcus agalactiae. Fish & Shellfish Immunology 2015;44:50-9. [DOI: 10.1016/j.fsi.2015.01.035] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
500 Fatoba O, Itokazu T, Yamashita T. Complement cascade functions during brain development and neurodegeneration. FEBS J 2021. [PMID: 33599083 DOI: 10.1111/febs.15772] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
501 Thielen AJF, van Baarsen IM, Jongsma ML, Zeerleder S, Spaapen RM, Wouters D. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research. J Immunol Methods 2018;456:15-22. [PMID: 29447841 DOI: 10.1016/j.jim.2018.02.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
502 Zipfel PF, Wiech T, Gröne HJ, Skerka C. Complement catalyzing glomerular diseases. Cell Tissue Res 2021;385:355-70. [PMID: 34613485 DOI: 10.1007/s00441-021-03485-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
503 Kiss MG, Binder CJ. The multifaceted impact of complement on atherosclerosis. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.03.014] [Reference Citation Analysis]
504 Tradtrantip L, Yao X, Su T, Smith AJ, Verkman AS. Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica. Acta Neuropathol 2017;134:35-44. [PMID: 28567523 DOI: 10.1007/s00401-017-1734-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
505 Levi C, Frémeaux-bacchi V, Zuber J, Rabant M, Devriese M, Snanoudj R, Scemla A, Amrouche L, Mejean A, Legendre C, Sberro-soussan R. Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome Recurrence. Transplantation 2017;101:2924-30. [DOI: 10.1097/tp.0000000000001909] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 3.4] [Reference Citation Analysis]
506 Oh SJ, Kim JH, Chung DH. NOD2-mediated suppression of CD55 on neutrophils enhances C5a generation during polymicrobial sepsis. PLoS Pathog 2013;9:e1003351. [PMID: 23675299 DOI: 10.1371/journal.ppat.1003351] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
507 Hinson SR, Lennon VA, Pittock SJ. Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders. Handb Clin Neurol. 2016;133:377-403. [PMID: 27112688 DOI: 10.1016/b978-0-444-63432-0.00021-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 20] [Article Influence: 7.2] [Reference Citation Analysis]
508 Szakács D, Kocsis A, Szász R, Gál P, Pál G. Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitors. J Biol Chem 2019;294:8227-37. [PMID: 30952698 DOI: 10.1074/jbc.RA119.008315] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
509 Riley SP, Patterson JL, Martinez JJ. The rickettsial OmpB β-peptide of Rickettsia conorii is sufficient to facilitate factor H-mediated serum resistance. Infect Immun 2012;80:2735-43. [PMID: 22615250 DOI: 10.1128/IAI.00349-12] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
510 Gómez BB, López-Cortés R, Casas-Nebra FJ, Vázquez-Estévez S, Pérez-Fentes D, Chantada-Vázquez MDP, Bravo SB, Núñez C. Detection of Circulating Serum Protein Biomarkers of Non-Muscle Invasive Bladder Cancer after Protein Corona-Silver Nanoparticles Analysis by SWATH-MS. Nanomaterials (Basel) 2021;11:2384. [PMID: 34578700 DOI: 10.3390/nano11092384] [Reference Citation Analysis]
511 Redman JM, Hill EM, AlDeghaither D, Weiner LM. Mechanisms of action of therapeutic antibodies for cancer. Mol Immunol 2015;67:28-45. [PMID: 25911943 DOI: 10.1016/j.molimm.2015.04.002] [Cited by in Crossref: 85] [Cited by in F6Publishing: 72] [Article Influence: 12.1] [Reference Citation Analysis]
512 Zand L, Kattah A, Fervenza FC, Smith RJ, Nasr SH, Zhang Y, Vrana JA, Leung N, Cornell LD, Sethi S. C3 glomerulonephritis associated with monoclonal gammopathy: a case series. Am J Kidney Dis 2013;62:506-14. [PMID: 23623956 DOI: 10.1053/j.ajkd.2013.02.370] [Cited by in Crossref: 115] [Cited by in F6Publishing: 98] [Article Influence: 12.8] [Reference Citation Analysis]
513 Zipfel PF, Wiech T, Stea ED, Skerka C. CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy. J Am Soc Nephrol 2020;31:241-56. [PMID: 31980588 DOI: 10.1681/ASN.2019050515] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
514 Nuutila J, Jalava-Karvinen P, Hohenthal U, Kotilainen P, Pelliniemi TT, Nikoskelainen J, Lilius EM. A rapid flow cytometric method for distinguishing between febrile bacterial and viral infections. J Microbiol Methods 2013;92:64-72. [PMID: 23154042 DOI: 10.1016/j.mimet.2012.11.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
515 Kimura Y, Zhou L, Miwa T, Song WC. Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury. J Clin Invest 2010;120:3545-54. [PMID: 20941861 DOI: 10.1172/jci41782] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
516 Liszewski MK, Elvington M, Kulkarni HS, Atkinson JP. Complement's hidden arsenal: New insights and novel functions inside the cell. Mol Immunol 2017;84:2-9. [PMID: 28196665 DOI: 10.1016/j.molimm.2017.01.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 7.4] [Reference Citation Analysis]
517 Halder LD, Babych S, Palme DI, Mansouri-Ghahnavieh E, Ivanov L, Ashonibare V, Langenhorst D, Prusty B, Rambach G, Wich M, Trinks N, Blango MG, Kornitzer D, Terpitz U, Speth C, Jungnickel B, Beyersdorf N, Zipfel PF, Brakhage AA, Skerka C. Candida albicans Induces Cross-Kingdom miRNA Trafficking in Human Monocytes To Promote Fungal Growth. mBio 2022;:e0356321. [PMID: 35132877 DOI: 10.1128/mbio.03563-21] [Reference Citation Analysis]
518 Mongan D, Sabherwal S, Susai SR, Föcking M, Cannon M, Cotter DR. Peripheral complement proteins in schizophrenia: A systematic review and meta-analysis of serological studies. Schizophr Res 2020;222:58-72. [PMID: 32456884 DOI: 10.1016/j.schres.2020.05.036] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
519 Voiculescu V, Calenic B, Ghita M, Lupu M, Caruntu A, Moraru L, Voiculescu S, Ion A, Greabu M, Ishkitiev N, Caruntu C. From Normal Skin to Squamous Cell Carcinoma: A Quest for Novel Biomarkers. Dis Markers 2016;2016:4517492. [PMID: 27642215 DOI: 10.1155/2016/4517492] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
520 Szeto GL, Lavik EB. Materials design at the interface of nanoparticles and innate immunity. J Mater Chem B 2016;4:1610-8. [PMID: 27453783 DOI: 10.1039/C5TB01825K] [Cited by in Crossref: 40] [Cited by in F6Publishing: 12] [Article Influence: 6.7] [Reference Citation Analysis]
521 Amari Chinchilla K, Vijayan M, Taveras Garcia B, Jim B. Complement-Mediated Disorders in Pregnancy. Adv Chronic Kidney Dis 2020;27:155-64. [PMID: 32553248 DOI: 10.1053/j.ackd.2020.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
522 O'Brien KB, Morrison TE, Dundore DY, Heise MT, Schultz-Cherry S. A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection. PLoS One 2011;6:e17377. [PMID: 21408070 DOI: 10.1371/journal.pone.0017377] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 5.9] [Reference Citation Analysis]
523 Uzawa A, Mori M, Uchida T, Masuda H, Ohtani R, Kuwabara S. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis. Clin Chim Acta 2016;453:131-3. [PMID: 26686775 DOI: 10.1016/j.cca.2015.12.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
524 McDowell JV, Frederick J, Miller DP, Goetting-Minesky MP, Goodman H, Fenno JC, Marconi RT. Identification of the primary mechanism of complement evasion by the periodontal pathogen, Treponema denticola. Mol Oral Microbiol 2011;26:140-9. [PMID: 21375704 DOI: 10.1111/j.2041-1014.2010.00598.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
525 Gustafsson MC, Lannergård J, Nilsson OR, Kristensen BM, Olsen JE, Harris CL, Ufret-Vincenty RL, Stålhammar-Carlemalm M, Lindahl G. Factor H binds to the hypervariable region of many Streptococcus pyogenes M proteins but does not promote phagocytosis resistance or acute virulence. PLoS Pathog 2013;9:e1003323. [PMID: 23637608 DOI: 10.1371/journal.ppat.1003323] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
526 Xu H, Chen M. Diabetic retinopathy and dysregulated innate immunity. Vision Res 2017;139:39-46. [PMID: 28571700 DOI: 10.1016/j.visres.2017.04.013] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 8.4] [Reference Citation Analysis]
527 Rosenthal SL, Kamboh MI. Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways. Curr Genet Med Rep 2014;2:85-101. [PMID: 24829845 DOI: 10.1007/s40142-014-0034-x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 88] [Article Influence: 12.1] [Reference Citation Analysis]
528 Li H, Chen J, Hu Y, Cai X, Zhang P. Elevated Serum C1q Levels in Children With Sepsis. Front Pediatr 2021;9:619899. [PMID: 33981650 DOI: 10.3389/fped.2021.619899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
529 Kim H, Erdman LK, Lu Z, Serghides L, Zhong K, Dhabangi A, Musoke C, Gerard C, Cserti-Gazdewich C, Liles WC, Kain KC. Functional roles for C5a and C5aR but not C5L2 in the pathogenesis of human and experimental cerebral malaria. Infect Immun 2014;82:371-9. [PMID: 24191300 DOI: 10.1128/IAI.01246-13] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
530 Buelli S, Zoja C, Remuzzi G, Morigi M. Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome. Microorganisms 2019;7:E15. [PMID: 30634669 DOI: 10.3390/microorganisms7010015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
531 Wenzel UO, Bode M, Köhl J, Ehmke H. A pathogenic role of complement in arterial hypertension and hypertensive end organ damage. American Journal of Physiology-Heart and Circulatory Physiology 2017;312:H349-54. [DOI: 10.1152/ajpheart.00759.2016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
532 Cabezas S, Bracho G, Aloia AL, Adamson PJ, Bonder CS, Smith JR, Gordon DL, Carr JM. Dengue Virus Induces Increased Activity of the Complement Alternative Pathway in Infected Cells. J Virol 2018;92:e00633-18. [PMID: 29743365 DOI: 10.1128/JVI.00633-18] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
533 Miller DP, McDowell JV, Bell JK, Goetting-Minesky MP, Fenno JC, Marconi RT. Analysis of the complement sensitivity of oral treponemes and the potential influence of FH binding, FH cleavage and dentilisin activity on the pathogenesis of periodontal disease. Mol Oral Microbiol 2014;29:194-207. [PMID: 24815960 DOI: 10.1111/omi.12054] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
534 Cao H, Zhang G, Ciociola K, Amaravadi L, Qiu Y, Wu J. An LC–MS/MS approach to assess total and free protein target in the serum of cynomolgus monkey. Bioanalysis 2019;11:393-406. [DOI: 10.4155/bio-2018-0294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
535 Santiesteban-Lores LE, Carneiro MC, Isaac L, Bavia L. Complement System in Alcohol-Associated Liver Disease. Immunol Lett 2021;236:37-50. [PMID: 34111475 DOI: 10.1016/j.imlet.2021.05.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
536 Okroj M, Holmquist E, King BC, Blom AM. Functional analyses of complement convertases using C3 and C5-depleted sera. PLoS One 2012;7:e47245. [PMID: 23071769 DOI: 10.1371/journal.pone.0047245] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
537 Chen M, Xu H. Parainflammation, chronic inflammation, and age-related macular degeneration. J Leukoc Biol 2015;98:713-25. [PMID: 26292978 DOI: 10.1189/jlb.3RI0615-239R] [Cited by in Crossref: 129] [Cited by in F6Publishing: 95] [Article Influence: 18.4] [Reference Citation Analysis]
538 Mahmoudi M, Nilsson PH, Mollnes TE, Roos D, Sullivan KE. Complement Deficiencies. In: Rezaei N, Aghamohammadi A, Notarangelo LD, editors. Primary Immunodeficiency Diseases. Berlin: Springer Berlin Heidelberg; 2017. pp. 437-60. [DOI: 10.1007/978-3-662-52909-6_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
539 Alexander JJ, Hack BK, Jacob A, Chang A, Haas M, Finberg RW, Quigg RJ. Abnormal immune complex processing and spontaneous glomerulonephritis in complement factor H-deficient mice with human complement receptor 1 on erythrocytes. J Immunol 2010;185:3759-67. [PMID: 20702729 DOI: 10.4049/jimmunol.1000683] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
540 Reiss T, Rosa TFA, Blaesius K, Bobbert RP, Zipfel PF, Skerka C, Pradel G. Cutting Edge: FHR-1 Binding Impairs Factor H-Mediated Complement Evasion by the Malaria Parasite Plasmodium falciparum. J Immunol 2018;201:3497-502. [PMID: 30455399 DOI: 10.4049/jimmunol.1800662] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
541 Sui Z, Li M, Sun L. Tongue sole ( Cynoglossus semilaevis ) CD59: A complement inhibitor that binds bacterial cells and promotes bacterial escape from the killing of fish serum. Fish & Shellfish Immunology 2016;58:442-8. [DOI: 10.1016/j.fsi.2016.09.051] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
542 Liu C, Ye X. Carbohydrate-based cancer vaccines: target cancer with sugar bullets. Glycoconj J 2012;29:259-71. [DOI: 10.1007/s10719-012-9399-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
543 Defendi F, Thielens NM, Clavarino G, Cesbron JY, Dumestre-Pérard C. The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease. Clin Rev Allergy Immunol 2020;58:229-51. [PMID: 31834594 DOI: 10.1007/s12016-019-08774-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
544 Papadopoulos MC, Bennett JL, Verkman AS. Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nat Rev Neurol. 2014;10:493-506. [PMID: 25112508 DOI: 10.1038/nrneurol.2014.141] [Cited by in Crossref: 148] [Cited by in F6Publishing: 135] [Article Influence: 18.5] [Reference Citation Analysis]
545 Zipfel PF, Lauer N, Skerka C. The Role of Complement in AMD. In: Lambris JD, Adamis AP, editors. Inflammation and Retinal Disease: Complement Biology and Pathology. New York: Springer; 2010. pp. 9-24. [DOI: 10.1007/978-1-4419-5635-4_2] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 6.0] [Reference Citation Analysis]
546 Charchaflieh J, Rushbrook J, Worah S, Zhang M. Activated Complement Factors as Disease Markers for Sepsis. Dis Markers 2015;2015:382463. [PMID: 26420913 DOI: 10.1155/2015/382463] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
547 Ermert D, Ram S, Laabei M. The hijackers guide to escaping complement: Lessons learned from pathogens. Mol Immunol 2019;114:49-61. [PMID: 31336249 DOI: 10.1016/j.molimm.2019.07.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
548 Heung LJ. Innate Immune Responses to Cryptococcus. J Fungi (Basel) 2017;3:35. [PMID: 28936464 DOI: 10.3390/jof3030035] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
549 Kościelska-Kasprzak K, Bartoszek D, Myszka M, Zabińska M, Klinger M. The complement cascade and renal disease. Arch Immunol Ther Exp (Warsz) 2014;62:47-57. [PMID: 24030732 DOI: 10.1007/s00005-013-0254-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
550 Viret C, Rozières A, Duclaux-Loras R, Boschetti G, Nancey S, Faure M. Regulation of anti-microbial autophagy by factors of the complement system. Microb Cell 2020;7:93-105. [PMID: 32274388 DOI: 10.15698/mic2020.04.712] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
551 Ignatius A, Schoengraf P, Kreja L, Liedert A, Recknagel S, Kandert S, Brenner RE, Schneider M, Lambris JD, Huber-Lang M. Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β. J Cell Biochem 2011;112:2594-605. [PMID: 21598302 DOI: 10.1002/jcb.23186] [Cited by in Crossref: 100] [Cited by in F6Publishing: 101] [Article Influence: 9.1] [Reference Citation Analysis]
552 Pahwa R, Kumar U, Das N. Modulation of PBMC-decay accelerating factor (PBMC-DAF) and cytokines in rheumatoid arthritis. Mol Cell Biochem 2016;414:85-94. [PMID: 26906204 DOI: 10.1007/s11010-016-2661-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
553 Saleh J, Al-Maqbali M, Abdel-Hadi D. Role of Complement and Complement-Related Adipokines in Regulation of Energy Metabolism and Fat Storage. Compr Physiol 2019;9:1411-29. [PMID: 31688967 DOI: 10.1002/cphy.c170037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
554 Huang Y. Evolution of compstatin family as therapeutic complement inhibitors. Expert Opin Drug Discov 2018;13:435-44. [PMID: 29402126 DOI: 10.1080/17460441.2018.1437139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
555 Scully CCG, Blakeney JS, Singh R, Hoang HN, Abbenante G, Reid RC, Fairlie DP. Selective Hexapeptide Agonists and Antagonists for Human Complement C3a Receptor. J Med Chem 2010;53:4938-48. [DOI: 10.1021/jm1003705] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
556 Akhtar-Schäfer I, Wang L, Krohne TU, Xu H, Langmann T. Modulation of three key innate immune pathways for the most common retinal degenerative diseases. EMBO Mol Med 2018;10:e8259. [PMID: 30224384 DOI: 10.15252/emmm.201708259] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 15.0] [Reference Citation Analysis]
557 Luo S, Blom AM, Rupp S, Hipler UC, Hube B, Skerka C, Zipfel PF. The pH-regulated antigen 1 of Candida albicans binds the human complement inhibitor C4b-binding protein and mediates fungal complement evasion. J Biol Chem 2011;286:8021-9. [PMID: 21212281 DOI: 10.1074/jbc.M110.130138] [Cited by in Crossref: 43] [Cited by in F6Publishing: 19] [Article Influence: 3.9] [Reference Citation Analysis]
558 Kahr WH. Complement halts angiogenesis gone wild. Blood 2010;116:4393-4. [PMID: 21109626 DOI: 10.1182/blood-2010-08-297648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
559 Lang SN, Germerodt S, Glock C, Skerka C, Zipfel PF, Schuster S. Molecular crypsis by pathogenic fungi using human factor H. A numerical model. PLoS One 2019;14:e0212187. [PMID: 30779817 DOI: 10.1371/journal.pone.0212187] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
560 Liszewski MK, Java A, Schramm EC, Atkinson JP. Complement Dysregulation and Disease: Insights from Contemporary Genetics. Annu Rev Pathol. 2017;12:25-52. [PMID: 27959629 DOI: 10.1146/annurev-pathol-012615-044145] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
561 Mahtout H, Chandad F, Rojo JM, Grenier D. Fusobacterium nucleatum Binding to Complement Regulatory Protein CD46 Modulates the Expression and Secretion of Cytokines and Matrix Metalloproteinases by Oral Epithelial Cells. Journal of Periodontology 2011;82:311-9. [DOI: 10.1902/jop.2010.100458] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
562 Dasari P, Heber SD, Beisele M, Torzewski M, Reifenberg K, Orning C, Fries A, Zapf AL, Baumeister S, Lingelbach K, Udomsangpetch R, Bhakdi SC, Reiss K, Bhakdi S. Digestive vacuole of Plasmodium falciparum released during erythrocyte rupture dually activates complement and coagulation. Blood 2012;119:4301-10. [PMID: 22403252 DOI: 10.1182/blood-2011-11-392134] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
563 Mevorach D. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system. Apoptosis 2010;15:1114-23. [PMID: 20683667 DOI: 10.1007/s10495-010-0530-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
564 Ribeiro GE, Leon LE, Perez R, Cuiza A, Vial PA, Ferres M, Mertz GJ, Vial C. Deletions in Genes Participating in Innate Immune Response Modify the Clinical Course of Andes Orthohantavirus Infection. Viruses 2019;11:E680. [PMID: 31349540 DOI: 10.3390/v11080680] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
565 Watkins LM, Neal JW, Loveless S, Michailidou I, Ramaglia V, Rees MI, Reynolds R, Robertson NP, Morgan BP, Howell OW. Complement is activated in progressive multiple sclerosis cortical grey matter lesions. J Neuroinflammation 2016;13:161. [PMID: 27333900 DOI: 10.1186/s12974-016-0611-x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 10.0] [Reference Citation Analysis]
566 Skerka C, Chen Q, Fremeaux-Bacchi V, Roumenina LT. Complement factor H related proteins (CFHRs). Mol Immunol. 2013;56:170-180. [PMID: 23830046 DOI: 10.1016/j.molimm.2013.06.001] [Cited by in Crossref: 145] [Cited by in F6Publishing: 130] [Article Influence: 16.1] [Reference Citation Analysis]
567 Mahtout H, Curt S, Chandad F, Rouabhia M, Grenier D. Effect of periodontopathogen lipopolysaccharides and proinflammatory cytokines on CD46, CD55, and CD59 gene/protein expression by oral epithelial cells. FEMS Immunol Med Microbiol 2011;62:295-303. [PMID: 21545652 DOI: 10.1111/j.1574-695X.2011.00813.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
568 Bu F, Borsa N, Gianluigi A, Smith RJ. Familial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects. Clin Dev Immunol 2012;2012:370426. [PMID: 23251215 DOI: 10.1155/2012/370426] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
569 Hajishengallis G. Complement and periodontitis. Biochem Pharmacol 2010;80:1992-2001. [PMID: 20599785 DOI: 10.1016/j.bcp.2010.06.017] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 5.0] [Reference Citation Analysis]
570 de Taeye SW, Kreuk L, van Dam AP, Hovius JW, Schuijt TJ. Complement evasion by Borrelia burgdorferi: it takes three to tango. Trends Parasitol 2013;29:119-28. [PMID: 23298533 DOI: 10.1016/j.pt.2012.12.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
571 Zhang FK, Hu RS, Elsheikha HM, Sheng ZA, Zhang WY, Zheng WB, Zhu XQ, He JJ. Global serum proteomic changes in water buffaloes infected with Fasciola gigantica. Parasit Vectors 2019;12:281. [PMID: 31159882 DOI: 10.1186/s13071-019-3533-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
572 Keller CW, Lopez JA, Wendel EM, Ramanathan S, Gross CC, Klotz L, Reindl M, Dale RC, Wiendl H, Rostásy K, Brilot F, Lünemann JD. Reply to "Investigating the Immunopathogenic Mechanisms Underlying MOGAD". Ann Neurol 2021. [PMID: 34862658 DOI: 10.1002/ana.26278] [Reference Citation Analysis]
573 Abu-Humaidan AH, Elvén M, Sonesson A, Garred P, Sørensen OE. Persistent Intracellular Staphylococcus aureus in Keratinocytes Lead to Activation of the Complement System with Subsequent Reduction in the Intracellular Bacterial Load. Front Immunol 2018;9:396. [PMID: 29545804 DOI: 10.3389/fimmu.2018.00396] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
574 Bao L, Haas M, Quigg RJ. Complement factor H deficiency accelerates development of lupus nephritis. J Am Soc Nephrol 2011;22:285-95. [PMID: 21148254 DOI: 10.1681/ASN.2010060647] [Cited by in Crossref: 76] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
575 Kim H, Meyer K, Di Bisceglie AM, Ray R. Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function. J Virol. 2013;87:5858-5867. [PMID: 23487461 DOI: 10.1128/jvi.00174-13] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
576 Thomson AS, Mai SH, Bouma G, Herdman M, Byrne M, Hottenstein CS, Minetti J, Trulli S, Taylor JD, White JR, Chen S. Structure and Functional Characterization of a Humanized Anti-CCL20 Antibody following Exposure to Serum Reveals the Formation of Immune Complex That Leads to Toxicity. J Immunol 2021;206:1067-76. [PMID: 33483346 DOI: 10.4049/jimmunol.2000336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
577 Macleod OJS, Bart JM, MacGregor P, Peacock L, Savill NJ, Hester S, Ravel S, Sunter JD, Trevor C, Rust S, Vaughan TJ, Minter R, Mohammed S, Gibson W, Taylor MC, Higgins MK, Carrington M. A receptor for the complement regulator factor H increases transmission of trypanosomes to tsetse flies. Nat Commun 2020;11:1326. [PMID: 32165615 DOI: 10.1038/s41467-020-15125-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
578 Tamura T, Cazander G, Rooijakkers SH, Trouw LA, Nibbering PH. Excretions/secretions from medicinal larvae (Lucilia sericata) inhibit complement activation by two mechanisms. Wound Repair Regen 2017;25:41-50. [PMID: 28019718 DOI: 10.1111/wrr.12504] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
579 Gadwa J, Karam SD. Deciphering the Intricate Roles of Radiation Therapy and Complement Activation in Cancer. Int J Radiat Oncol Biol Phys 2020;108:46-55. [PMID: 32629082 DOI: 10.1016/j.ijrobp.2020.06.067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
580 Huang J, Chen J, Xie Y, Liu Z. Subversion of the immune response of human pathogenic spirochetes. Clinical Laboratory Analysis. [DOI: 10.1002/jcla.24414] [Reference Citation Analysis]
581 Berends ET, Kuipers A, Ravesloot MM, Urbanus RT, Rooijakkers SH. Bacteria under stress by complement and coagulation. FEMS Microbiol Rev 2014;38:1146-71. [PMID: 25065463 DOI: 10.1111/1574-6976.12080] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 7.8] [Reference Citation Analysis]
582 Panwar HS, Ojha H, Ghosh P, Barage SH, Raut S, Sahu A. Molecular engineering of an efficient four-domain DAF-MCP chimera reveals the presence of functional modularity in RCA proteins. Proc Natl Acad Sci U S A 2019;116:9953-8. [PMID: 31036650 DOI: 10.1073/pnas.1818573116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
583 Galindo-Izquierdo M, Pablos Alvarez JL. Complement as a Therapeutic Target in Systemic Autoimmune Diseases. Cells 2021;10:148. [PMID: 33451011 DOI: 10.3390/cells10010148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
584 Lindblom RP, Aeinehband S, Ström M, Al Nimer F, Sandholm K, Khademi M, Nilsson B, Piehl F, Ekdahl KN. Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function. Clin Immunol 2016;166-167:89-95. [PMID: 27085202 DOI: 10.1016/j.clim.2016.04.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
585 Schaar V, Nordström T, Mörgelin M, Riesbeck K. Moraxella catarrhalis outer membrane vesicles carry β-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin. Antimicrob Agents Chemother 2011;55:3845-53. [PMID: 21576428 DOI: 10.1128/AAC.01772-10] [Cited by in Crossref: 77] [Cited by in F6Publishing: 51] [Article Influence: 7.0] [Reference Citation Analysis]
586 Nissinen L, Farshchian M, Riihilä P, Kähäri VM. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma. Cell Tissue Res 2016;365:691-702. [PMID: 27411692 DOI: 10.1007/s00441-016-2457-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
587 Speidl WS, Kastl SP, Huber K, Wojta J. Complement in atherosclerosis: friend or foe?: Complement in atherosclerosis: friend or foe? Journal of Thrombosis and Haemostasis 2011;9:428-40. [DOI: 10.1111/j.1538-7836.2010.04172.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 7.6] [Reference Citation Analysis]
588 Alfandary H, Davidovits M. Novel factor H mutation associated with familial membranoproliferative glomerulonephritis type I. Pediatr Nephrol 2015;30:2129-34. [DOI: 10.1007/s00467-015-3166-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
589 Hamad OA, Bäck J, Nilsson PH, Nilsson B, Ekdahl KN. Platelets, Complement, and Contact Activation: Partners in Inflammation and Thrombosis. In: Lambris JD, Hajishengallis G, editors. Current Topics in Innate Immunity II. New York: Springer; 2012. pp. 185-205. [DOI: 10.1007/978-1-4614-0106-3_11] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
590 Triebwasser MP, Roberson ED, Yu Y, Schramm EC, Wagner EK, Raychaudhuri S, Seddon JM, Atkinson JP. Rare Variants in the Functional Domains of Complement Factor H Are Associated With Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci 2015;56:6873-8. [PMID: 26501415 DOI: 10.1167/iovs.15-17432] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
591 Hallström T, Riesbeck K. Haemophilus influenzae and the complement system. Trends Microbiol 2010;18:258-65. [PMID: 20399102 DOI: 10.1016/j.tim.2010.03.007] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
592 Alawieh A, Elvington A, Tomlinson S. Complement in the Homeostatic and Ischemic Brain. Front Immunol 2015;6:417. [PMID: 26322048 DOI: 10.3389/fimmu.2015.00417] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 7.0] [Reference Citation Analysis]
593 Zhu W, Wang Z, Hu S, Gong Y, Liu Y, Song H, Ding X, Fu Y, Yan Y. Human C5-specific single-chain variable fragment ameliorates brain injury in a model of NMOSD. Neurol Neuroimmunol Neuroinflamm 2019;6:e561. [PMID: 31044149 DOI: 10.1212/NXI.0000000000000561] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
594 Hebecker M, Józsi M. Factor H-related protein 4 activates complement by serving as a platform for the assembly of alternative pathway C3 convertase via its interaction with C3b protein. J Biol Chem 2012;287:19528-36. [PMID: 22518841 DOI: 10.1074/jbc.M112.364471] [Cited by in Crossref: 55] [Cited by in F6Publishing: 35] [Article Influence: 5.5] [Reference Citation Analysis]
595 Alves LA, de Carli TR, Harth-Chu EN, Mariano FS, Höfling JF, Stipp RN, Mattos-Graner RO. Oral streptococci show diversity in resistance to complement immunity. J Med Microbiol 2019;68:600-8. [PMID: 30843785 DOI: 10.1099/jmm.0.000955] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
596 Ramírez-Toloza G, Ferreira A. Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin. Front Microbiol 2017;8:1667. [PMID: 28919885 DOI: 10.3389/fmicb.2017.01667] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
597 Chester C, Marabelle A, Houot R, Kohrt HE. Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumors. Curr Opin Immunol 2015;33:1-8. [PMID: 25576932 DOI: 10.1016/j.coi.2014.12.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
598 Forneris F, Wu J, Xue X, Ricklin D, Lin Z, Sfyroera G, Tzekou A, Volokhina E, Granneman JC, Hauhart R, Bertram P, Liszewski MK, Atkinson JP, Lambris JD, Gros P. Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode. EMBO J 2016;35:1133-49. [PMID: 27013439 DOI: 10.15252/embj.201593673] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 10.2] [Reference Citation Analysis]
599 Albazli K, Kaminski HJ, Howard JF Jr. Complement Inhibitor Therapy for Myasthenia Gravis. Front Immunol 2020;11:917. [PMID: 32582144 DOI: 10.3389/fimmu.2020.00917] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
600 Smailhodzic D, van Asten F, Blom AM, Mohlin FC, den Hollander AI, van de Ven JP, van Huet RA, Groenewoud JM, Tian Y, Berendschot TT, Lechanteur YT, Fauser S, de Bruijn C, Daha MR, van der Wilt GJ, Hoyng CB, Klevering BJ. Zinc supplementation inhibits complement activation in age-related macular degeneration. PLoS One 2014;9:e112682. [PMID: 25393287 DOI: 10.1371/journal.pone.0112682] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
601 Hallström T, Uhde M, Singh B, Skerka C, Riesbeck K, Zipfel PF. Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack. PLoS One 2015;10:e0137630. [PMID: 26368530 DOI: 10.1371/journal.pone.0137630] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
602 Leaderer D, Cashman SM, Kumar-Singh R. Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59. J Gene Med 2015;17:101-15. [PMID: 25917932 DOI: 10.1002/jgm.2829] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
603 Švajger U, Rožman P. Induction of Tolerogenic Dendritic Cells by Endogenous Biomolecules: An Update. Front Immunol 2018;9:2482. [PMID: 30416505 DOI: 10.3389/fimmu.2018.02482] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
604 Luo S, Hu D, Wang M, Zipfel PF, Hu Y. Complement in Hemolysis- and Thrombosis- Related Diseases. Front Immunol 2020;11:1212. [PMID: 32754149 DOI: 10.3389/fimmu.2020.01212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
605 Heeringa SF, Cohen CD. Kidney diseases caused by complement dysregulation: acquired, inherited, and still more to come. Clin Dev Immunol. 2012;2012:695131. [PMID: 23227086 DOI: 10.1155/2012/695131] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
606 Kennedy AT, Schmidt CQ, Thompson JK, Weiss GE, Taechalertpaisarn T, Gilson PR, Barlow PN, Crabb BS, Cowman AF, Tham WH. Recruitment of Factor H as a Novel Complement Evasion Strategy for Blood-Stage Plasmodium falciparum Infection. J Immunol 2016;196:1239-48. [PMID: 26700768 DOI: 10.4049/jimmunol.1501581] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 7.6] [Reference Citation Analysis]
607 Moore GL, Chen H, Karki S, Lazar GA. Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions. MAbs 2010;2:181-9. [PMID: 20150767 DOI: 10.4161/mabs.2.2.11158] [Cited by in Crossref: 150] [Cited by in F6Publishing: 130] [Article Influence: 13.6] [Reference Citation Analysis]
608 West EE, Kolev M, Kemper C. Complement and the Regulation of T Cell Responses. Annu Rev Immunol 2018;36:309-38. [PMID: 29677470 DOI: 10.1146/annurev-immunol-042617-053245] [Cited by in Crossref: 83] [Cited by in F6Publishing: 72] [Article Influence: 27.7] [Reference Citation Analysis]
609 Waters AM, Licht C. aHUS caused by complement dysregulation: new therapies on the horizon. Pediatr Nephrol. 2011;26:41-57. [PMID: 20556434 DOI: 10.1007/s00467-010-1556-4] [Cited by in Crossref: 87] [Cited by in F6Publishing: 74] [Article Influence: 7.3] [Reference Citation Analysis]
610 Li J, Long D, Wu S, Wu X, Wei B, Chen D, Shao Y, Wang H, Cui L, Chen X, Yu L. Association of CFH polymorphism with susceptibility to sepsis caused by Pseudomonas aeruginosa in Chinese Han populations: A multi-center study. Gene 2020;722:144127. [PMID: 31525397 DOI: 10.1016/j.gene.2019.144127] [Reference Citation Analysis]
611 Talaat IM, Elemam NM, Saber-ayad M. Complement System: An Immunotherapy Target in Colorectal Cancer. Front Immunol 2022;13:810993. [DOI: 10.3389/fimmu.2022.810993] [Reference Citation Analysis]
612 Thurman JM, Renner B. Dynamic control of the complement system by modulated expression of regulatory proteins. Lab Invest 2011;91:4-11. [PMID: 20921948 DOI: 10.1038/labinvest.2010.173] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
613 Bussy C, Methven L, Kostarelos K. Hemotoxicity of carbon nanotubes. Adv Drug Deliv Rev 2013;65:2127-34. [PMID: 24211768 DOI: 10.1016/j.addr.2013.10.008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
614 Vaillancourt K, Bonifait L, Grignon L, Frenette M, Gottschalk M, Grenier D. Identification and characterization of a new cell surface protein possessing factor H-binding activity in the swine pathogen and zoonotic agent Streptococcus suis. Journal of Medical Microbiology 2013;62:1073-80. [DOI: 10.1099/jmm.0.057877-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
615 Lausen M, Christiansen G, Karred N, Winther R, Poulsen TBG, Palarasah Y, Birkelund S. Complement C3 opsonization of Chlamydia trachomatis facilitates uptake in human monocytes. Microbes Infect 2018;20:328-36. [PMID: 29729435 DOI: 10.1016/j.micinf.2018.04.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
616 Arias-Cabrales CE, Riera M, Pérez-Sáez MJ, Gimeno J, Benito D, Redondo D, Burballa C, Crespo M, Pascual J, Rodríguez E. Activation of final complement components after kidney transplantation as a marker of delayed graft function severity. Clin Kidney J 2021;14:1190-6. [PMID: 33841865 DOI: 10.1093/ckj/sfaa147] [Reference Citation Analysis]
617 Zhang L, Chen JY, Kerr C, Cobb BA, Maciejewski JP, Lin F. Reduced red blood cell surface level of Factor H as a mechanism underlying paroxysmal nocturnal hemoglobinuria. Leukemia 2021;35:1176-87. [PMID: 32814838 DOI: 10.1038/s41375-020-1008-5] [Reference Citation Analysis]
618 Yang C, Qi R, Yang B. Pathogenesis of Chronic Allograft Dysfunction Progress to Renal Fibrosis. Adv Exp Med Biol 2019;1165:101-16. [PMID: 31399963 DOI: 10.1007/978-981-13-8871-2_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
619 Kurolap A, Eshach Adiv O, Hershkovitz T, Tabib A, Karbian N, Paperna T, Mory A, Vachyan A, Slijper N, Steinberg R, Zohar Y, Mevorach D, Baris Feldman H. Eculizumab Is Safe and Effective as a Long-term Treatment for Protein-losing Enteropathy Due to CD55 Deficiency. J Pediatr Gastroenterol Nutr 2019;68:325-33. [PMID: 30418410 DOI: 10.1097/MPG.0000000000002198] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
620 Ehrlenbach S, Rosales A, Posch W, Wilflingseder D, Hermann M, Brockmeyer J, Karch H, Satchell SC, Würzner R, Orth-Höller D. Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells. Infect Immun 2013;81:2678-85. [PMID: 23690395 DOI: 10.1128/IAI.01079-12] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
621 Agarwal V, Talens S, Grandits AM, Blom AM. A Novel Interaction between Complement Inhibitor C4b-binding Protein and Plasminogen That Enhances Plasminogen Activation. J Biol Chem 2015;290:18333-42. [PMID: 26067271 DOI: 10.1074/jbc.M114.619494] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
622 Jokiranta TS. HUS and atypical HUS. Blood. 2017;129:2847-2856. [PMID: 28416508 DOI: 10.1182/blood-2016-11-709865] [Cited by in Crossref: 124] [Cited by in F6Publishing: 101] [Article Influence: 24.8] [Reference Citation Analysis]
623 Marcinkiewicz AL, Kraiczy P, Lin YP. There Is a Method to the Madness: Strategies to Study Host Complement Evasion by Lyme Disease and Relapsing Fever Spirochetes. Front Microbiol 2017;8:328. [PMID: 28303129 DOI: 10.3389/fmicb.2017.00328] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
624 Fleury C, Su YC, Hallström T, Sandblad L, Zipfel PF, Riesbeck K. Identification of a Haemophilus influenzae factor H-Binding lipoprotein involved in serum resistance. J Immunol 2014;192:5913-23. [PMID: 24835392 DOI: 10.4049/jimmunol.1303449] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
625 Dunkelberger JR, Song WC. Role and mechanism of action of complement in regulating T cell immunity. Mol Immunol. 2010;47:2176-2186. [PMID: 20603023 DOI: 10.1016/j.molimm.2010.05.008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 4.4] [Reference Citation Analysis]
626 Noris M, Donadelli R, Remuzzi G. Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy. Pediatr Nephrol 2019;34:1311-23. [PMID: 29948306 DOI: 10.1007/s00467-018-3989-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
627 Zipfel PF, Hallström T, Riesbeck K. Human complement control and complement evasion by pathogenic microbes – Tipping the balance. Molecular Immunology 2013;56:152-60. [DOI: 10.1016/j.molimm.2013.05.222] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 9.8] [Reference Citation Analysis]
628 Schott M, Grosskinsky S, Brenner C, Kraiczy P, Wallich R. Molecular characterization of the interaction of Borrelia parkeri and Borrelia turicatae with human complement regulators. Infect Immun 2010;78:2199-208. [PMID: 20231403 DOI: 10.1128/IAI.00089-10] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
629 Garcia BL, Summers BJ, Lin Z, Ramyar KX, Ricklin D, Kamath DV, Fu ZQ, Lambris JD, Geisbrecht BV. Diversity in the C3b [corrected] contact residues and tertiary structures of the staphylococcal complement inhibitor (SCIN) protein family. J Biol Chem 2012;287:628-40. [PMID: 22086928 DOI: 10.1074/jbc.M111.298984] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
630 Garcia BL, Zhi H, Wager B, Höök M, Skare JT. Borrelia burgdorferi BBK32 Inhibits the Classical Pathway by Blocking Activation of the C1 Complement Complex. PLoS Pathog 2016;12:e1005404. [PMID: 26808924 DOI: 10.1371/journal.ppat.1005404] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 9.2] [Reference Citation Analysis]
631 Di Tucci C, Schiavi MC, Faiano P, D'Oria O, Prata G, Sciuga V, Giannini A, Palaia I, Muzii L, Benedetti Panici P. Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers. Crit Rev Oncol Hematol 2018;128:30-42. [PMID: 29958629 DOI: 10.1016/j.critrevonc.2018.05.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
632 Eberhardt HU, Buhlmann D, Hortschansky P, Chen Q, Böhm S, Kemper MJ, Wallich R, Hartmann A, Hallström T, Zipfel PF, Skerka C. Human factor H-related protein 2 (CFHR2) regulates complement activation. PLoS One 2013;8:e78617. [PMID: 24260121 DOI: 10.1371/journal.pone.0078617] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
633 Bode J, Dutow P, Sommer K, Janik K, Glage S, Tümmler B, Munder A, Laudeley R, Sachse KW, Klos A. A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci. PLoS One 2012;7:e50327. [PMID: 23189195 DOI: 10.1371/journal.pone.0050327] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
634 Olivar R, Luque A, Naranjo-Gómez M, Quer J, García de Frutos P, Borràs FE, Rodríguez de Córdoba S, Blom AM, Aran JM. The α7β0 isoform of the complement regulator C4b-binding protein induces a semimature, anti-inflammatory state in dendritic cells. J Immunol 2013;190:2857-72. [PMID: 23390292 DOI: 10.4049/jimmunol.1200503] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
635 Chen Q, Manzke M, Hartmann A, Büttner M, Amann K, Pauly D, Wiesener M, Skerka C, Zipfel PF. Complement Factor H-Related 5-Hybrid Proteins Anchor Properdin and Activate Complement at Self-Surfaces. J Am Soc Nephrol. 2016;27:1413-1425. [PMID: 26432903 DOI: 10.1681/asn.2015020212] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 4.1] [Reference Citation Analysis]
636 Thurman JM, Le Quintrec M. Targeting the complement cascade: novel treatments coming down the pike. Kidney Int. 2016;90:746-752. [PMID: 27325183 DOI: 10.1016/j.kint.2016.04.018] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
637 Hertz CE, Bayarri-Olmos R, Kirketerp-Møller N, van Putten S, Pilely K, Skjoedt MO, Garred P. Chimeric Proteins Containing MAP-1 and Functional Domains of C4b-Binding Protein Reveal Strong Complement Inhibitory Capacities. Front Immunol 2018;9:1945. [PMID: 30210498 DOI: 10.3389/fimmu.2018.01945] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
638 Birmingham DJ, Hebert LA. The Complement System in Lupus Nephritis. Seminars in Nephrology 2015;35:444-54. [DOI: 10.1016/j.semnephrol.2015.08.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
639 Joseph C, Gattineni J. Complement disorders and hemolytic uremic syndrome. Curr Opin Pediatr 2013;25:209-15. [PMID: 23399570 DOI: 10.1097/MOP.0b013e32835df48a] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
640 Pringle ES, Firth MA, Chattha KS, Hodgins DC, Shewen PE. Expression of complement receptors 1 (CR1/CD35) and 2 (CR2/CD21), and co-signaling molecule CD19 in cattle. Dev Comp Immunol 2012;38:487-94. [PMID: 22989997 DOI: 10.1016/j.dci.2012.08.003] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
641 Tille A, Lehnert T, Zipfel PF, Figge MT. Quantification of Factor H Mediated Self vs. Non-self Discrimination by Mathematical Modeling. Front Immunol 2020;11:1911. [PMID: 33013842 DOI: 10.3389/fimmu.2020.01911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
642 Michels MAHM, van de Kar NCAJ, Okrój M, Blom AM, van Kraaij SAW, Volokhina EB, van den Heuvel LPWJ. Overactivity of Alternative Pathway Convertases in Patients With Complement-Mediated Renal Diseases. Front Immunol 2018;9:612. [PMID: 29670616 DOI: 10.3389/fimmu.2018.00612] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
643 Loeven MA, Rops AL, Berden JH, Daha MR, Rabelink TJ, van der Vlag J. The role of heparan sulfate as determining pathogenic factor in complement factor H-associated diseases. Molecular Immunology 2015;63:203-8. [DOI: 10.1016/j.molimm.2014.08.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
644 Dasari P, Koleci N, Shopova IA, Wartenberg D, Beyersdorf N, Dietrich S, Sahagún-Ruiz A, Figge MT, Skerka C, Brakhage AA, Zipfel PF. Enolase From Aspergillus fumigatus Is a Moonlighting Protein That Binds the Human Plasma Complement Proteins Factor H, FHL-1, C4BP, and Plasminogen. Front Immunol 2019;10:2573. [PMID: 31824478 DOI: 10.3389/fimmu.2019.02573] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
645 Laabei M, Ermert D. Catch Me if You Can: Streptococcus pyogenes Complement Evasion Strategies. J Innate Immun 2019;11:3-12. [PMID: 30269134 DOI: 10.1159/000492944] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
646 Campbell LK, Fleming-Canepa X, Webster RG, Magor KE. Tissue Specific Transcriptome Changes Upon Influenza A Virus Replication in the Duck. Front Immunol 2021;12:786205. [PMID: 34804075 DOI: 10.3389/fimmu.2021.786205] [Reference Citation Analysis]
647 Wenzel UO, Kemper C, Bode M. The role of complement in arterial hypertension and hypertensive end organ damage. Br J Pharmacol 2021;178:2849-62. [PMID: 32585035 DOI: 10.1111/bph.15171] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
648 Jiang H, Fan MN, Yang M, Lu C, Zhang M, Liu XH, Ma L. Association among Complement Factor H Autoantibodies, Deletions of CFHR, and the Risk of Atypical Hemolytic Uremic Syndrome. Int J Environ Res Public Health 2016;13:E1209. [PMID: 27929404 DOI: 10.3390/ijerph13121209] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
649 Weismann D, Hartvigsen K, Lauer N, Bennett KL, Scholl HP, Charbel Issa P, Cano M, Brandstätter H, Tsimikas S, Skerka C, Superti-Furga G, Handa JT, Zipfel PF, Witztum JL, Binder CJ. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 2011;478:76-81. [PMID: 21979047 DOI: 10.1038/nature10449] [Cited by in Crossref: 346] [Cited by in F6Publishing: 328] [Article Influence: 31.5] [Reference Citation Analysis]
650 Miller DP, Bell JK, McDowell JV, Conrad DH, Burgner JW, Héroux A, Marconi RT. Structure of factor H-binding protein B (FhbB) of the periopathogen, Treponema denticola: insights into progression of periodontal disease. J Biol Chem 2012;287:12715-22. [PMID: 22371503 DOI: 10.1074/jbc.M112.339721] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
651 Wang Y, Nanda V, Direnzo D, Ye J, Xiao S, Kojima Y, Howe KL, Jarr KU, Flores AM, Tsantilas P, Tsao N, Rao A, Newman AAC, Eberhard AV, Priest JR, Ruusalepp A, Pasterkamp G, Maegdefessel L, Miller CL, Lind L, Koplev S, Björkegren JLM, Owens GK, Ingelsson E, Weissman IL, Leeper NJ. Clonally expanding smooth muscle cells promote atherosclerosis by escaping efferocytosis and activating the complement cascade. Proc Natl Acad Sci U S A 2020;117:15818-26. [PMID: 32541024 DOI: 10.1073/pnas.2006348117] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
652 Buchner M, Brantner P, Stickel N, Prinz G, Burger M, Bär C, Dierks C, Pfeifer D, Ott A, Mertelsmann R, Gribben JG, Veelken H, Zirlik K. The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies. Br J Haematol 2010;151:167-78. [PMID: 20738306 DOI: 10.1111/j.1365-2141.2010.08316.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
653 Bertrand N, Leroux JC. The journey of a drug-carrier in the body: an anatomo-physiological perspective. J Control Release 2012;161:152-63. [PMID: 22001607 DOI: 10.1016/j.jconrel.2011.09.098] [Cited by in Crossref: 414] [Cited by in F6Publishing: 358] [Article Influence: 37.6] [Reference Citation Analysis]
654 Biswas B, Kumar U, Das N. Expression and significance of leukocyte membrane cofactor protein transcript in systemic lupus erythematosus. Lupus 2012;21:517-25. [DOI: 10.1177/0961203311434104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
655 Brooke CB, Schäfer A, Matsushima GK, White LJ, Johnston RE. Early activation of the host complement system is required to restrict central nervous system invasion and limit neuropathology during Venezuelan equine encephalitis virus infection. J Gen Virol 2012;93:797-806. [PMID: 22205717 DOI: 10.1099/vir.0.038281-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
656 Deshmukh AS, Peijs L, Beaudry JL, Jespersen NZ, Nielsen CH, Ma T, Brunner AD, Larsen TJ, Bayarri-Olmos R, Prabhakar BS, Helgstrand C, Severinsen MCK, Holst B, Kjaer A, Tang-Christensen M, Sanfridson A, Garred P, Privé GG, Pedersen BK, Gerhart-Hines Z, Nielsen S, Drucker DJ, Mann M, Scheele C. Proteomics-Based Comparative Mapping of the Secretomes of Human Brown and White Adipocytes Reveals EPDR1 as a Novel Batokine. Cell Metab 2019;30:963-975.e7. [PMID: 31668873 DOI: 10.1016/j.cmet.2019.10.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 12.3] [Reference Citation Analysis]
657 Goldmann T, Prinz M. Role of microglia in CNS autoimmunity. Clin Dev Immunol 2013;2013:208093. [PMID: 23840238 DOI: 10.1155/2013/208093] [Cited by in Crossref: 119] [Cited by in F6Publishing: 116] [Article Influence: 13.2] [Reference Citation Analysis]
658 Jabri Y, Biber J, Diaz-Lezama N, Grosche A, Pauly D. Cell-Type-Specific Complement Profiling in the ABCA4-/- Mouse Model of Stargardt Disease. Int J Mol Sci 2020;21:E8468. [PMID: 33187113 DOI: 10.3390/ijms21228468] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
659 Kourtzelis I, Magnusson PU, Kotlabova K, Lambris JD, Chavakis T. Regulation of Instant Blood Mediated Inflammatory Reaction (IBMIR) in Pancreatic Islet Xeno-Transplantation: Points for Therapeutic Interventions. In: Lambris JD, Ekdahl KN, Ricklin D, Nilsson B, editors. Immune Responses to Biosurfaces. Cham: Springer International Publishing; 2015. pp. 171-88. [DOI: 10.1007/978-3-319-18603-0_11] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
660 Moreno JA, Yuste C, Gutiérrez E, Sevillano ÁM, Rubio-Navarro A, Amaro-Villalobos JM, Praga M, Egido J. Haematuria as a risk factor for chronic kidney disease progression in glomerular diseases: A review. Pediatr Nephrol 2016;31:523-33. [PMID: 25980470 DOI: 10.1007/s00467-015-3119-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
661 Weismann D, Binder CJ. The innate immune response to products of phospholipid peroxidation. Biochim Biophys Acta 2012;1818:2465-75. [PMID: 22305963 DOI: 10.1016/j.bbamem.2012.01.018] [Cited by in Crossref: 104] [Cited by in F6Publishing: 107] [Article Influence: 10.4] [Reference Citation Analysis]
662 Poppelaars F, Faria B, Schwaeble W, Daha MR. The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases? J Clin Med 2021;10:4715. [PMID: 34682837 DOI: 10.3390/jcm10204715] [Reference Citation Analysis]
663 Barnum SR, Schein TN. The Complement System. The Complement FactsBook. Elsevier; 2018. pp. 7-20. [DOI: 10.1016/b978-0-12-810420-0.00002-x] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
664 Tan SM, Snelson M, Østergaard JA, Coughlan MT. The complement pathway: New insights into immunometabolic signalling in diabetic kidney disease. Antioxid Redox Signal 2021. [PMID: 34806406 DOI: 10.1089/ars.2021.0125] [Reference Citation Analysis]
665 Demirtürk M, Polat N, Güz G, Gürdal A, Altun İ, Gelincik A, Toz B, Oflaz H, Çolakoğlu B, Dal M, Büyüköztürk S. There is an increased risk of atherosclerosis in hereditary angioedema. International Immunopharmacology 2012;12:212-6. [DOI: 10.1016/j.intimp.2011.11.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
666 Lombardi E, Matte A, Risitano AM, Ricklin D, Lambris JD, De Zanet D, Jokiranta ST, Martinelli N, Scambi C, Salvagno G, Bisoffi Z, Colato C, Siciliano A, Bortolami O, Mazzuccato M, Zorzi F, De Marco L, De Franceschi L. Factor H interferes with the adhesion of sickle red cells to vascular endothelium: a novel disease-modulating molecule. Haematologica 2019;104:919-28. [PMID: 30630982 DOI: 10.3324/haematol.2018.198622] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
667 Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol 2012;11:535-44. [PMID: 22608667 DOI: 10.1016/S1474-4422(12)70133-3] [Cited by in Crossref: 293] [Cited by in F6Publishing: 144] [Article Influence: 29.3] [Reference Citation Analysis]
668 Lim W. Complement and the antiphospholipid syndrome. Curr Opin Hematol 2011;18:361-5. [PMID: 21730831 DOI: 10.1097/MOH.0b013e3283497f3e] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
669 Zipfel PF, Wolf G, John U, Kentouche K, Skerka C. Novel developments in thrombotic microangiopathies: is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura? Pediatr Nephrol 2011;26:1947-56. [DOI: 10.1007/s00467-011-1923-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
670 Willems E, Lorés-Motta L, Zanichelli A, Suffritti C, van der Flier M, van der Molen RG, Langereis JD, van Drongelen J, van den Heuvel LP, Volokhina E, van de Kar NC, Keizer-Garritsen J, Levin M, Herberg JA, Martinon-Torres F, Wessels HJ, de Breuk A, Fauser S, Hoyng CB, den Hollander AI, de Groot R, van Gool AJ, Gloerich J, de Jonge MI. Quantitative multiplex profiling of the complement system to diagnose complement-mediated diseases. Clin Transl Immunology 2020;9:e1225. [PMID: 33318796 DOI: 10.1002/cti2.1225] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
671 Lin Y, Irmscher S, Skerka C. Monitoring Surface Reactions by Combined Western Blot-ELISA Analysis. Methods Mol Biol 2019;1834:75-83. [PMID: 30324437 DOI: 10.1007/978-1-4939-8669-9_5] [Reference Citation Analysis]
672 Alves LA, Harth-Chu EN, Palma TH, Stipp RN, Mariano FS, Höfling JF, Abranches J, Mattos-Graner RO. The two-component system VicRK regulates functions associated with Streptococcus mutans resistance to complement immunity. Mol Oral Microbiol 2017;32:419-31. [PMID: 28382721 DOI: 10.1111/omi.12183] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
673 Tran HDN, Moonshi SS, Xu ZP, Ta HT. Influence of nanoparticles on the haemostatic balance: between thrombosis and haemorrhage. Biomater Sci 2021. [PMID: 34775503 DOI: 10.1039/d1bm01351c] [Reference Citation Analysis]
674 Deghmane AE, Taha MK. Invasive Bacterial Infections in Subjects with Genetic and Acquired Susceptibility and Impacts on Recommendations for Vaccination: A Narrative Review. Microorganisms 2021;9:467. [PMID: 33668334 DOI: 10.3390/microorganisms9030467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
675 Rosen AM, Stevens B. The Role of the Classical Complement Cascade in Synapse Loss During Development and Glaucoma. In: Lambris JD, Adamis AP, editors. Inflammation and Retinal Disease: Complement Biology and Pathology. New York: Springer; 2010. pp. 75-93. [DOI: 10.1007/978-1-4419-5635-4_6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
676 Kurolap A, Hagin D, Freund T, Fishman S, Zunz Henig N, Brazowski E, Yeshaya J, Naiman T, Pras E, Ablin JN, Baris Feldman H. CD55-deficiency in Jews of Bukharan descent is caused by the Cromer blood type Dr(a-) variant. Hum Genet 2022. [PMID: 35314883 DOI: 10.1007/s00439-021-02428-3] [Reference Citation Analysis]
677 Weinberger AW, Eddahabi C, Carstesen D, Zipfel PF, Walter P, Skerka C. Human complement factor H and factor H-like protein 1 are expressed in human retinal pigment epithelial cells. Ophthalmic Res 2014;51:59-66. [PMID: 24280833 DOI: 10.1159/000351624] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
678 Malik A, Thanekar U, Amarachintha S, Mourya R, Nalluri S, Bondoc A, Shivakumar P. "Complimenting the Complement": Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma. Front Oncol 2020;10:627701. [PMID: 33718121 DOI: 10.3389/fonc.2020.627701] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
679 Zhang H, Verkman AS. Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59. J Autoimmun 2014;53:67-77. [PMID: 24698947 DOI: 10.1016/j.jaut.2014.02.011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
680 Alegretti AP, Schneider L, Piccoli AK, Xavier RM. The role of complement regulatory proteins in peripheral blood cells of patients with systemic lupus erythematosus: review. Cell Immunol 2012;277:1-7. [PMID: 22795896 DOI: 10.1016/j.cellimm.2012.06.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
681 d'Enfert C, Kaune AK, Alaban LR, Chakraborty S, Cole N, Delavy M, Kosmala D, Marsaux B, Fróis-Martins R, Morelli M, Rosati D, Valentine M, Xie Z, Emritloll Y, Warn PA, Bequet F, Bougnoux ME, Bornes S, Gresnigt MS, Hube B, Jacobsen ID, Legrand M, Leibundgut-Landmann S, Manichanh C, Munro CA, Netea MG, Queiroz K, Roget K, Thomas V, Thoral C, Van den Abbeele P, Walker AW, Brown AJP. The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives. FEMS Microbiol Rev 2021;45:fuaa060. [PMID: 33232448 DOI: 10.1093/femsre/fuaa060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
682 Li X, Liu P, Gan S, Zhang C, Zheng Y, Jiang Y, Yuan Y. Mechanisms of Host-Pathogen Protein Complex Formation and Bacterial Immune Evasion of Streptococcus suis Protein Fhb. J Biol Chem 2016;291:17122-32. [PMID: 27342778 DOI: 10.1074/jbc.M116.719443] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
683 Salvadori M, Rosso G, Bertoni E. Complement involvement in kidney diseases: From physiopathology to therapeutical targeting. World J Nephrol 2015; 4(2): 169-184 [PMID: 25949931 DOI: 10.5527/wjn.v4.i2.169] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
684 Nur I, Harada H, Tsujikura M, Somamoto T, Nakao M. Molecular characterization and expression analysis of three membrane-bound complement regulatory protein isoforms in the ginbuna crucian carp Carassius auratus langsdorfii. Fish & Shellfish Immunology 2013;35:1333-7. [DOI: 10.1016/j.fsi.2013.08.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
685 Scambi C, Ugolini S, Jokiranta TS, De Franceschi L, Bortolami O, La Verde V, Guarini P, Caramaschi P, Ravagnani V, Martignoni G, Colato C, Pedron S, Benedetti F, Sorio M, Poli F, Biasi D. The local complement activation on vascular bed of patients with systemic sclerosis: a hypothesis-generating study. PLoS One 2015;10:e0114856. [PMID: 25658605 DOI: 10.1371/journal.pone.0114856] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
686